US6630328B2
(en)
|
1909-07-15 |
2003-10-07 |
Genencor International, Inc. |
Increasing production of proteins in gram-positive microorganisms
|
USRE31006E
(en)
*
|
1968-09-24 |
1982-08-03 |
Akzona Incorporated |
Process for the demonstration and determination of reaction components having specific binding affinity for each other
|
US4046636A
(en)
*
|
1974-06-20 |
1977-09-06 |
Syva Company |
Diazepam enzyme conjugates
|
US4203802A
(en)
*
|
1971-05-14 |
1980-05-20 |
Syva Company |
Inhibitable enzyme amplification assay
|
US4282325A
(en)
*
|
1971-05-14 |
1981-08-04 |
Syva Company |
Enzyme bound corticosteroids
|
US3905871A
(en)
*
|
1971-05-14 |
1975-09-16 |
Syva Co |
Lactam conjugates to enzymes
|
US4191613A
(en)
*
|
1971-05-14 |
1980-03-04 |
Syva Company |
Malate dehydrogenase conjugates for enzyme immunoassays
|
US4039385A
(en)
*
|
1972-05-08 |
1977-08-02 |
Syva Company |
Cardiac glycoside enzyme conjugates
|
NL171930C
(nl)
*
|
1972-05-11 |
1983-06-01 |
Akzo Nv |
Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
|
US3790447A
(en)
*
|
1972-07-05 |
1974-02-05 |
Abbott Lab |
Streptococci diagnostic method
|
US3975237A
(en)
*
|
1972-11-06 |
1976-08-17 |
Syva Company |
Compounds for enzyme amplification assay - - ecgonine analogs
|
US3966556A
(en)
*
|
1972-11-06 |
1976-06-29 |
Syva Company |
Compounds for enzyme amplification assay methadone analogs
|
US4040907A
(en)
*
|
1974-06-20 |
1977-08-09 |
Syva Company |
Iodothyronine enzyme conjugates
|
US4061466A
(en)
*
|
1974-10-16 |
1977-12-06 |
Ingvar Gosta Holger Sjoholm |
Biologically active composition and the use thereof
|
NL7501215A
(nl)
*
|
1975-02-01 |
1976-08-03 |
Akzo Nv |
Methode voor het aantonen en bepalen van een antigeen of antilichaam.
|
US4043872A
(en)
*
|
1975-02-20 |
1977-08-23 |
Syva Company |
Polyiodothyronine immunoassay
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
US4096138A
(en)
*
|
1975-12-08 |
1978-06-20 |
Scherr George H |
Immunological test procedure
|
US4166767A
(en)
*
|
1976-03-25 |
1979-09-04 |
Dainippon Pharmaceutical Co., Ltd. |
Insolubilized antibody
|
JPS5341420A
(en)
|
1976-09-29 |
1978-04-14 |
Mochida Pharm Co Ltd |
Immunochemically measuring methoa of hapten
|
GB1572220A
(en)
*
|
1976-10-07 |
1980-07-30 |
Mochida Pharm Co Ltd |
Immunochemical process of measuring physiologically active substances
|
US4098876A
(en)
*
|
1976-10-26 |
1978-07-04 |
Corning Glass Works |
Reverse sandwich immunoassay
|
US4134792A
(en)
*
|
1976-12-06 |
1979-01-16 |
Miles Laboratories, Inc. |
Specific binding assay with an enzyme modulator as a labeling substance
|
IT1153999B
(it)
*
|
1977-03-15 |
1987-01-21 |
Snam Progetti |
Composizione atta alla determinazione della triiodotironina e metodo diagnostico impiegante la stessa
|
IL51667A
(en)
*
|
1977-03-16 |
1979-10-31 |
Miles Yeda Ltd |
Immunoassay for the determination of a hapten
|
US4156081A
(en)
*
|
1977-04-15 |
1979-05-22 |
Syva Company |
Theophylline antigens and antibodies
|
IT1114861B
(it)
*
|
1977-05-12 |
1986-01-27 |
Sclavo Inst Sieroterapeut |
Metodo per la determinazione del contenuto di costituenti di fluidi biologici e mezzi adatti allo scopo
|
FR2422956A1
(fr)
*
|
1978-04-13 |
1979-11-09 |
Pasteur Institut |
Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
|
US5605800A
(en)
*
|
1978-04-13 |
1997-02-25 |
Institut Pasteur |
Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
|
DE2825650C3
(de)
*
|
1978-06-12 |
1981-02-05 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren zur Bestimmung des Thyroxin-bindungsindex im Serum
|
US4269938A
(en)
*
|
1979-03-08 |
1981-05-26 |
Eastman Kodak Company |
Assay of peroxidatively active materials
|
US4376825A
(en)
*
|
1979-05-07 |
1983-03-15 |
Syva Company |
Enzyme amplification compounds for assays for androgens
|
JPS55152459A
(en)
*
|
1979-05-18 |
1980-11-27 |
Yamasa Shoyu Co Ltd |
Method and reagent for measuring quantity of cyclic nucleotide
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
US4391904A
(en)
*
|
1979-12-26 |
1983-07-05 |
Syva Company |
Test strip kits in immunoassays and compositions therein
|
US4299916A
(en)
*
|
1979-12-26 |
1981-11-10 |
Syva Company |
Preferential signal production on a surface in immunoassays
|
US4347312A
(en)
*
|
1980-03-20 |
1982-08-31 |
Research Triangle Institute |
Detection of antibiotics in milk
|
JPS5714748A
(en)
*
|
1980-07-01 |
1982-01-26 |
Dainippon Pharmaceut Co Ltd |
Kit for quantitative determination of valproic acid and its method for quantitative determination
|
US4323647A
(en)
*
|
1980-10-15 |
1982-04-06 |
University Of Miami |
Steric hindrance enzyme immunoassay
|
EP0079962B1
(en)
*
|
1981-06-02 |
1985-08-28 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
US4604365A
(en)
*
|
1981-06-02 |
1986-08-05 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
US5703206A
(en)
*
|
1981-09-08 |
1997-12-30 |
Univ Rockefeller |
Macrophage inflammatory protein 2 (MIP-2)
|
US4419453A
(en)
*
|
1981-09-28 |
1983-12-06 |
The Dow Chemical Company |
Immunological agglutination assays with dyed or colored latex and kits
|
US4506009A
(en)
*
|
1982-03-30 |
1985-03-19 |
University Of California |
Heterogeneous immunoassay method
|
US4535057A
(en)
*
|
1982-07-26 |
1985-08-13 |
Amf Incorporated |
Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
|
US4530900A
(en)
*
|
1982-09-13 |
1985-07-23 |
Seragen Diagnostics Inc. |
Soluble insoluble polymers in enzymeimmunoassay
|
ZA841924B
(en)
*
|
1983-07-25 |
1984-10-31 |
Becton Dickinson Co |
Chromogenic tracers for use in an assay
|
EP0154631A4
(en)
*
|
1983-07-27 |
1985-11-25 |
American Hospital Supply Corp |
PROCESS FOR SELECTIVE NITRILE REDUCTION.
|
FR2550799B1
(fr)
*
|
1983-08-17 |
1986-02-21 |
Commissariat Energie Atomique |
Compose marque par une enzyme, son procede de preparation et son utilisation en enzymoimmunologie
|
DE3433652A1
(de)
*
|
1984-09-13 |
1986-03-20 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Immunchemisches messverfahren fuer haptene und proteine
|
US4713347A
(en)
*
|
1985-01-14 |
1987-12-15 |
Sensor Diagnostics, Inc. |
Measurement of ligand/anti-ligand interactions using bulk conductance
|
US4786594A
(en)
*
|
1986-05-14 |
1988-11-22 |
Syntex (U.S.A.) Inc. |
Enzyme immunoassay
|
WO1990002762A1
(en)
*
|
1988-09-02 |
1990-03-22 |
The Rockefeller University |
Macrophage-derived inflammatory mediator (mip-2)
|
EP0703296B1
(en)
|
1988-09-29 |
1998-07-22 |
Chiron Corporation |
Polynucleotide determination by displacement of a strand on a capture probe
|
CA2031109C
(en)
*
|
1990-07-27 |
1992-01-28 |
Susan J. Danielson |
Ligand analogs for immunoassays derived from dicarboxylic acid oxidation products
|
CA2029006C
(en)
*
|
1990-07-27 |
2001-07-17 |
Michael R. Detty |
Dicarboxylic acid oxidation products
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
US5268298A
(en)
*
|
1991-04-26 |
1993-12-07 |
Life Technologies, Inc. |
System for delivering oxygen to a cell culture medium
|
JP3183666B2
(ja)
*
|
1991-07-19 |
2001-07-09 |
アツセイ・リサーチ・インコーポレーテツド |
内因性サイトカイン類の測定方法およびキット
|
US5965379A
(en)
*
|
1991-07-19 |
1999-10-12 |
Cytimmune Sciences Inc. |
Method for measuring endogenous cytokines
|
US5464749A
(en)
|
1991-07-22 |
1995-11-07 |
Bayer Corporation |
Immunoassay of free substances in biological fluids
|
US5939524A
(en)
*
|
1991-12-09 |
1999-08-17 |
The Scripps Research Institute |
Platelet GPIII P1A1 and P1A2 epitopes, their preparation and use
|
US5624804A
(en)
*
|
1991-12-20 |
1997-04-29 |
The Rockefeller University |
Immunochemical detection of In vivo advanced glycosylation end products
|
US5354692A
(en)
*
|
1992-09-08 |
1994-10-11 |
Pacific Biotech, Inc. |
Analyte detection device including a hydrophobic barrier for improved fluid flow
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
US7326535B2
(en)
|
1993-09-15 |
2008-02-05 |
Ortho Diagnostic Systems Inc. |
Immunoreactive peptides from Epstein-Barr virus
|
US7060283B1
(en)
|
1992-09-15 |
2006-06-13 |
Ortho Diagnostic Systems, Inc. |
Immunoreactive peptides from Epstein-Barr virus
|
US5637467A
(en)
*
|
1992-10-13 |
1997-06-10 |
Behringwerke Ag |
Heterogeneous assay using a pendulous drop
|
US5801005A
(en)
*
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
US5869445A
(en)
*
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
US6953573B1
(en)
|
1993-03-17 |
2005-10-11 |
University Of Washington |
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
|
US6562333B1
(en)
|
1993-06-14 |
2003-05-13 |
Schering Corporation |
Purified mammalian CTLA-8 antigens and related reagents
|
US6495343B1
(en)
|
1993-06-18 |
2002-12-17 |
The Salk Institute For Biological Studies |
Cloning and recombinant production of CRF receptor(s)
|
US6638905B2
(en)
|
1993-06-18 |
2003-10-28 |
The Salk Institute For Biological Studies |
Cloning and recombinant production of CFR receptor(s)
|
US20040259113A1
(en)
*
|
1993-07-22 |
2004-12-23 |
Mayo Foundation For Medical Education And Research, Hybritech Incorporated |
Method for detection of metastatic prostate cancer
|
US5516639A
(en)
*
|
1993-07-22 |
1996-05-14 |
Mayo Foundation For Medical Education And Research |
Antibodies specific for human prostate glandular kallkrein
|
US6103237A
(en)
*
|
1993-07-22 |
2000-08-15 |
Hybritech Incorporated |
Stable variant hK2 polypeptide
|
US5684144A
(en)
*
|
1993-07-28 |
1997-11-04 |
University Of North Texas |
Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof
|
US6884590B1
(en)
|
1994-02-11 |
2005-04-26 |
Cedars-Sinai Medical Center |
Methods of screening for ulcerative colitis and crohn's disease
|
US5681699A
(en)
*
|
1994-02-11 |
1997-10-28 |
Cedars-Sinai Medical Center |
Methods of diagnosing ulcerative colitis and Crohn's disease
|
US6335160B1
(en)
*
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US6406855B1
(en)
|
1994-02-17 |
2002-06-18 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
WO1995030758A1
(en)
*
|
1994-05-10 |
1995-11-16 |
Mayo Foundation For Medical Education And Research |
Recombinant hk2 polypeptide
|
WO1995034640A1
(en)
*
|
1994-06-13 |
1995-12-21 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
US5589344A
(en)
*
|
1994-06-15 |
1996-12-31 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Test kit and method for competitive specific binding assay
|
CA2196797C
(en)
|
1994-08-12 |
2000-10-10 |
Donna M. Shattuck-Eidens |
In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene
|
DK0705902T3
(da)
|
1994-08-12 |
2002-03-11 |
Univ Utah Res Found |
17q-koblet bryst- og ovariecancerprædisponeringsgen
|
US6048837A
(en)
*
|
1994-08-17 |
2000-04-11 |
The Rockefeller University |
OB polypeptides as modulators of body weight
|
US6350730B1
(en)
|
1994-08-17 |
2002-02-26 |
The Rockefeller University |
OB polypeptides and modified forms as modulators of body weight
|
US6124439A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockefeller University |
OB polypeptide antibodies and method of making
|
US6124448A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockfeller University |
Nucleic acid primers and probes for the mammalian OB gene
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
US6001968A
(en)
|
1994-08-17 |
1999-12-14 |
The Rockefeller University |
OB polypeptides, modified forms and compositions
|
US6471956B1
(en)
|
1994-08-17 |
2002-10-29 |
The Rockefeller University |
Ob polypeptides, modified forms and compositions thereto
|
US6974666B1
(en)
*
|
1994-10-21 |
2005-12-13 |
Appymetric, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
US8236493B2
(en)
|
1994-10-21 |
2012-08-07 |
Affymetrix, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5633149A
(en)
|
1994-12-07 |
1997-05-27 |
Incyte Pharmaceuticals, Inc. |
Polynucleotide encoding novel chemokine expressed in inflamed adenoid
|
US7005509B1
(en)
|
1995-02-17 |
2006-02-28 |
Incyte Corporation |
Chemokine PANEC-1 polynucleotides and compositions and methods related thereto
|
US6506553B1
(en)
|
1995-03-30 |
2003-01-14 |
Ortho Diagnostics Systems, Inc. |
Method for diagnosis of Epstein-Barr virus associated disease
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5858661A
(en)
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
GB0112226D0
(en)
*
|
2001-05-18 |
2001-07-11 |
Danisco |
Method of improving dough and bread quality
|
CA2245835A1
(en)
|
1995-06-14 |
1997-01-03 |
The Regents Of The University Of California |
Novel high affinity human antibodies to tumor antigens
|
US5837492A
(en)
|
1995-12-18 |
1998-11-17 |
Myriad Genetics, Inc. |
Chromosome 13-linked breast cancer susceptibility gene
|
DE69625678T3
(de)
|
1995-12-18 |
2006-11-09 |
The University Of Utah Research Foundation, Salt Lake City |
Chromosom 13 verbundene Brustkrebsempfindlichkeitsgen BRCA2
|
US7282327B2
(en)
*
|
1996-01-23 |
2007-10-16 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
EP0880598A4
(en)
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
|
US20010018514A1
(en)
*
|
1998-07-31 |
2001-08-30 |
Mcgall Glenn H. |
Nucleic acid labeling compounds
|
US7291463B2
(en)
|
1996-01-23 |
2007-11-06 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US6965020B2
(en)
|
1996-01-23 |
2005-11-15 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US20040210045A1
(en)
*
|
1996-01-23 |
2004-10-21 |
Mcgall Glenn |
Nucleic acid labeling compounds
|
US7423143B2
(en)
*
|
1996-01-23 |
2008-09-09 |
Affymetrix. Inc. |
Nucleic acid labeling compounds
|
US6864059B2
(en)
*
|
1996-01-23 |
2005-03-08 |
Affymetrix, Inc. |
Biotin containing C-glycoside nucleic acid labeling compounds
|
US6924094B1
(en)
|
1996-02-08 |
2005-08-02 |
Affymetrix, Inc. |
Chip-based species identification and phenotypic characterization of microorganisms
|
WO1997029212A1
(en)
|
1996-02-08 |
1997-08-14 |
Affymetrix, Inc. |
Chip-based speciation and phenotypic characterization of microorganisms
|
EP1728875A3
(en)
|
1996-02-08 |
2007-05-09 |
Affymetrix, Inc. |
Chip-based speciation and phenotypic characterization of microorganisms
|
AU742668B2
(en)
*
|
1996-03-22 |
2002-01-10 |
Morehouse School Of Medicine |
Immunogenic compositions comprising porphyromonas gingivalis peptides and methods
|
US5882644A
(en)
*
|
1996-03-22 |
1999-03-16 |
Protein Design Labs, Inc. |
Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
|
US6942862B2
(en)
*
|
1996-04-01 |
2005-09-13 |
University Of Washington |
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
|
DK0912738T3
(da)
*
|
1996-05-22 |
2008-11-17 |
Viventia Biotech Inc |
Antigen-bindende-fragmenter der specifikt detekterer cancerceller, nukleotider der koder fragmenterne og anvendelse deraf til profylakse og detektion af cancere
|
US20050069923A1
(en)
*
|
1996-07-08 |
2005-03-31 |
Mullis Kary Banks |
Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
|
US6342349B1
(en)
|
1996-07-08 |
2002-01-29 |
Burstein Technologies, Inc. |
Optical disk-based assay devices and methods
|
US20050214827A1
(en)
*
|
1996-07-08 |
2005-09-29 |
Burstein Technologies, Inc. |
Assay device and method
|
JP2002514046A
(ja)
|
1996-07-08 |
2002-05-14 |
バースタイン テクノロジーズ,インコーポレイティド |
切断可能なシグナル因子の装置および方法
|
US6331275B1
(en)
|
1996-07-08 |
2001-12-18 |
Burstein Technologies, Inc. |
Spatially addressable, cleavable reflective signal elements, assay device and method
|
EP1947183B1
(en)
|
1996-08-16 |
2013-07-17 |
Merck Sharp & Dohme Corp. |
Mammalian cell surface antigens; related reagents
|
DK0932678T4
(da)
*
|
1996-09-24 |
2010-07-12 |
Genentech Inc |
En familie af gener kodende for apoptoserelaterede peptider, peptider kodet deraf og fremgangsmåder til anvendelse deraf
|
US20070299005A1
(en)
*
|
1996-09-24 |
2007-12-27 |
Tanox, Inc. |
Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
|
US6808880B2
(en)
*
|
1996-10-01 |
2004-10-26 |
Geron Corporation |
Method for detecting polynucleotides encoding telomerase
|
US6093809A
(en)
|
1996-10-01 |
2000-07-25 |
University Technology Corporation |
Telomerase
|
US6610839B1
(en)
*
|
1997-08-14 |
2003-08-26 |
Geron Corporation |
Promoter for telomerase reverse transcriptase
|
US6261836B1
(en)
|
1996-10-01 |
2001-07-17 |
Geron Corporation |
Telomerase
|
US7585622B1
(en)
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
US6475789B1
(en)
*
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
DE69723531T3
(de)
|
1996-10-01 |
2012-09-06 |
Geron Corp. |
Katalytische Untereinheit der menschlichen Telomerase
|
GB9907461D0
(en)
|
1999-03-31 |
1999-05-26 |
King S College London |
Neurite regeneration
|
US6479263B1
(en)
|
1996-11-14 |
2002-11-12 |
Baylor College Of Medicine |
Method for detection of micrometastatic prostate cancer
|
AU745234B2
(en)
|
1996-11-15 |
2002-03-14 |
Board Of Regents, The University Of Texas System |
Genetic test for equine severe combined immunodeficiency disease
|
EP1114864B9
(en)
|
1996-12-13 |
2013-05-08 |
Schering Corporation |
Mammalian cell surface antigens, related reagents
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
EP2172478A3
(en)
|
1997-02-07 |
2010-07-28 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Activity-dependent neurotrophic factor III (ADNF III)
|
US6268165B1
(en)
|
1997-03-19 |
2001-07-31 |
The Board Of Trustees Of The University Of Arkansas |
Methods for the early diagnosis of ovarian cancer
|
CA2285452A1
(en)
|
1997-04-01 |
1998-10-08 |
Calyx Therapeutics, Inc. |
Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
|
US20050013825A1
(en)
*
|
1997-04-18 |
2005-01-20 |
Geron Corporation |
Vaccine containing the catalytic subunit of telomerase for treating cancer
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
AU740333B2
(en)
|
1997-05-07 |
2001-11-01 |
Schering Corporation |
Human receptor proteins; related reagents and methods
|
US7115722B1
(en)
|
1997-05-22 |
2006-10-03 |
Viventia Biotech, Inc. |
Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
US7541151B2
(en)
|
1997-06-05 |
2009-06-02 |
Duke University |
Single-cell biosensor for the measurement of GPCR ligands in a test sample
|
US5891646A
(en)
*
|
1997-06-05 |
1999-04-06 |
Duke University |
Methods of assaying receptor activity and constructs useful in such methods
|
US6528271B1
(en)
|
1997-06-05 |
2003-03-04 |
Duke University |
Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
|
AU8259798A
(en)
|
1997-06-20 |
1999-01-04 |
George G Klee |
Method for detection of breast cancer
|
US20020122807A1
(en)
*
|
1998-07-07 |
2002-09-05 |
Dan Michael D. |
Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
AR014891A1
(es)
|
1997-07-09 |
2001-04-11 |
Schering Corp |
Genes aislados de proteinas de membranas de mamiferos; reactivos relacionados
|
US6228638B1
(en)
|
1997-07-11 |
2001-05-08 |
University Of North Texas, Health Science Center At Fort Worth |
Escherichia coli CSRB gene and RNA encoded thereby
|
US6762039B2
(en)
*
|
1997-07-15 |
2004-07-13 |
Genencor International, Inc. |
Bacillus subtillis with an inactivated cysteine protease-1
|
US20030157642A1
(en)
*
|
1997-07-15 |
2003-08-21 |
Caldwell Robert M. |
Increasing production of proteins in gram-positive microorganisms
|
US6723550B1
(en)
*
|
1997-07-15 |
2004-04-20 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US6506579B1
(en)
|
1997-07-15 |
2003-01-14 |
Genencor International, Inc. |
Increasing production of proteins in gram-positive microorganisms using SecG
|
US6521421B1
(en)
*
|
1997-07-16 |
2003-02-18 |
Genencor International, Inc. |
Expression vectors encoding Bacillus subtilis disulfide bond isomerase and methods of secreting proteins in gram-positive microorganisms using the same
|
PE20000183A1
(es)
|
1997-07-25 |
2000-03-11 |
Schering Corp |
Citoquinas de mamiferos y reactivos relacionados
|
PT1003861E
(pt)
|
1997-08-01 |
2007-01-31 |
Schering Corp |
Proteínas de membrana de células de mamíferos;reagentes relacionados
|
US6180411B1
(en)
|
1997-08-01 |
2001-01-30 |
The Regents Of The University Of California |
Light-triggered indicators that memorize analyte concentrations
|
US7252950B1
(en)
|
1997-09-04 |
2007-08-07 |
The Regents Of The University Of California |
Assays for detecting modulators of cytoskeletal function
|
US6521440B1
(en)
*
|
1997-09-15 |
2003-02-18 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US6300117B1
(en)
*
|
1997-09-15 |
2001-10-09 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US7378244B2
(en)
*
|
1997-10-01 |
2008-05-27 |
Geron Corporation |
Telomerase promoters sequences for screening telomerase modulators
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
MXPA00003705A
(es)
|
1997-10-17 |
2002-04-17 |
Univ South Florida |
Metodo para diagnosticar y monitorear deficiencias inmunes celulares.
|
GB9724629D0
(en)
*
|
1997-11-20 |
1998-01-21 |
Genencor Int Bv |
Alpha/beta hydrolase-fold enzymes
|
US6316241B1
(en)
*
|
1997-11-20 |
2001-11-13 |
Genencor International, Inc. |
Alpha/beta hydrolase-fold enzymes
|
GB9724627D0
(en)
|
1997-11-20 |
1998-01-21 |
Genencor Int Bv |
Gram positive microorganism formate pathway
|
US6528255B1
(en)
*
|
1997-12-30 |
2003-03-04 |
Genencor International, Inc. |
Proteases from gram positive organisms
|
US6465186B1
(en)
*
|
1997-12-30 |
2002-10-15 |
Genecor International, Inc. |
Proteases from gram positive organisms
|
GB9727470D0
(en)
*
|
1997-12-30 |
1998-02-25 |
Genencor Int Bv |
Proteases from gram positive organisms
|
US6599731B1
(en)
*
|
1997-12-30 |
2003-07-29 |
Genencor International, Inc. |
Proteases from gram positive organisms
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
US6780609B1
(en)
|
1998-10-23 |
2004-08-24 |
Genome Therapeutics Corporation |
High bone mass gene of 1.1q13.3
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
US6673914B1
(en)
|
1998-01-22 |
2004-01-06 |
John Wayne Cancer Institute |
Human tumor-associated gene
|
WO2000018885A1
(en)
|
1998-09-29 |
2000-04-06 |
Gamida Cell Ltd. |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
US6596501B2
(en)
|
1998-02-23 |
2003-07-22 |
Fred Hutchinson Cancer Research Center |
Method of diagnosing autoimmune disease
|
US6060260A
(en)
*
|
1998-02-27 |
2000-05-09 |
Dade Behring Inc. |
Methods for reducing adsorption in an assay
|
WO1999045124A2
(en)
|
1998-03-04 |
1999-09-10 |
Genencor International, Inc. |
Modified forms of pullulanase
|
WO1999047934A2
(en)
|
1998-03-20 |
1999-09-23 |
The Curators Of The University Of Missouri |
Early pregnancy diagnosis using pags (pregnancy-associated glycoproteins)
|
US8062908B2
(en)
*
|
1999-03-29 |
2011-11-22 |
Orasure Technologies, Inc. |
Device for collection and assay of oral fluids
|
US6303081B1
(en)
|
1998-03-30 |
2001-10-16 |
Orasure Technologies, Inc. |
Device for collection and assay of oral fluids
|
EP1086372B1
(en)
|
1998-03-30 |
2006-05-31 |
OraSure Technologies, Inc. |
Collection device for single step assay of oral fluids
|
AU3217599A
(en)
*
|
1998-03-31 |
1999-10-18 |
Genzyme Corporation |
Methods for the diagnosis and treatment of lung cancer
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
US7108968B2
(en)
*
|
1998-04-03 |
2006-09-19 |
Affymetrix, Inc. |
Mycobacterial rpoB sequences
|
US6872537B1
(en)
|
1998-04-14 |
2005-03-29 |
Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
WO1999053295A1
(en)
|
1998-04-14 |
1999-10-21 |
The Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
US6699969B1
(en)
|
1998-04-14 |
2004-03-02 |
The Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
AU4994899A
(en)
|
1998-07-13 |
2000-02-01 |
University Of South Florida |
Modulation of the phospholipase a2 pathway as a therapeutic
|
WO2000005582A2
(en)
*
|
1998-07-21 |
2000-02-03 |
Burstein Laboratories, Inc. |
Optical disc-based assay devices and methods
|
ES2188190T5
(es)
|
1998-07-21 |
2007-11-16 |
Danisco A/S |
Producto alimentario.
|
US6312689B1
(en)
|
1998-07-23 |
2001-11-06 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR2 antibodies and methods of use therefor
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
SE9803099D0
(sv)
|
1998-09-13 |
1998-09-13 |
Karolinska Innovations Ab |
Nucleic acid transfer
|
CA2343320A1
(en)
*
|
1998-09-18 |
2000-03-30 |
The Rockefeller University |
Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof
|
EP1115867A1
(en)
|
1998-09-21 |
2001-07-18 |
Schering Corporation |
Human interleukin-b50. therapeutic uses
|
EP0997476A3
(en)
|
1998-09-25 |
2000-07-19 |
Schering-Plough |
Antibodies to a mammalian Langerhans cell antigen and their uses
|
JP2002534122A
(ja)
|
1999-01-11 |
2002-10-15 |
シェーリング コーポレイション |
インターロイキン−17関連哺乳動物サイトカイン、それをコードするポリヌクレオチド、使用
|
EP2208782B1
(en)
|
1999-02-04 |
2017-05-31 |
Pluristem Ltd. |
Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
|
US6156515A
(en)
*
|
1999-02-09 |
2000-12-05 |
Urocor, Inc. |
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
|
JP2003500010A
(ja)
|
1999-03-11 |
2003-01-07 |
シェリング・コーポレーション |
哺乳動物サイトカイン;関連試薬および方法
|
KR20110102476A
(ko)
|
1999-05-13 |
2011-09-16 |
메디칼 리서취 카운실 |
Ox2 수용체 동족체
|
AU5011400A
(en)
|
1999-05-14 |
2000-12-05 |
Arbor Vita Corporation |
Molecular interactions in t cells
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
*
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
EP2258849A1
(en)
|
1999-06-01 |
2010-12-08 |
Schering Corporation |
Mammalian receptor proteins; related reagents and methods
|
US7534605B2
(en)
*
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
GB9914210D0
(en)
|
1999-06-17 |
1999-08-18 |
Danisco |
Promoter
|
EP1190082A4
(en)
*
|
1999-06-25 |
2003-07-02 |
Yissum Res Dev Co |
PROCESS FOR INDUCING ANGIOGENESIS USING MICROORGANES
|
US6531130B1
(en)
|
1999-07-06 |
2003-03-11 |
The Board Of Trustees Of The Leland Stanford University |
Treatment of demyelinating autoimmune disease with ordered peptides
|
WO2001009176A2
(en)
|
1999-07-30 |
2001-02-08 |
Schering Corporation |
Mammalian cytokines; related reagents
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7811981B2
(en)
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
EP1905832A3
(en)
|
1999-09-09 |
2009-09-09 |
Schering Corporation |
Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions
|
JP2004504003A
(ja)
|
1999-09-24 |
2004-02-12 |
モルフォゲン ファーマスーティカルズ インコーポレイテッド |
多能性胚様幹細胞、その組成物、方法および使用
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
US7332275B2
(en)
|
1999-10-13 |
2008-02-19 |
Sequenom, Inc. |
Methods for detecting methylated nucleotides
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
DE60030466T2
(de)
*
|
1999-11-19 |
2007-08-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Aspergillus niger beta-glukosidase gen, protein, sowie verwendungen derselben
|
EP1232185A2
(en)
|
1999-11-24 |
2002-08-21 |
Schering Corporation |
Methods of inhibiting metastasis
|
EP2336775A3
(en)
|
1999-12-06 |
2013-03-20 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
US6544792B1
(en)
*
|
1999-12-21 |
2003-04-08 |
Genencor International, Inc. |
Production of secreted polypeptides
|
US6544506B2
(en)
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
US7385106B2
(en)
*
|
2000-01-24 |
2008-06-10 |
Ramot At Tel Aviv University Ltd. |
Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
|
DE10003734A1
(de)
*
|
2000-01-28 |
2001-08-02 |
Bosch Gmbh Robert |
Detektionsverfahren und -vorrichtung
|
WO2001062942A2
(en)
*
|
2000-02-25 |
2001-08-30 |
Ludwig Institute For Cancer Research |
MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
US7829313B2
(en)
*
|
2000-03-24 |
2010-11-09 |
Eppendorf Array Technologies |
Identification and quantification of a plurality of biological (micro)organisms or their components
|
US7875442B2
(en)
*
|
2000-03-24 |
2011-01-25 |
Eppendorf Array Technologies |
Identification and quantification of a plurality of biological (micro)organisms or their components
|
US8288128B2
(en)
*
|
2004-11-18 |
2012-10-16 |
Eppendorf Array Technologies S.A. |
Real-time quantification of multiple targets on a micro-array
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
DE60142475D1
(de)
|
2000-03-27 |
2010-08-12 |
Technion Res And Dev Of Founda |
Einkettige haupthistokompatibilitätskomplexe der klasse i (mhc-i), kodierende konstrukte und methoden ihrer erzeugung
|
WO2001075078A1
(en)
|
2000-03-31 |
2001-10-11 |
The Scripps Research Institute |
HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
|
US20030108927A1
(en)
*
|
2000-04-03 |
2003-06-12 |
Kathryn Leishman |
Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
|
DE60136921D1
(de)
|
2000-04-18 |
2009-01-22 |
Schering Corp |
Medizinische Verwendung von IL-174 Agonisten und Antagonisten
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
PT1287130E
(pt)
|
2000-05-10 |
2008-09-01 |
Schering Corp |
Proteínas de subunidades de receptores de citocinas de mamífero, métodos e reagentes relacionados
|
US7422743B2
(en)
|
2000-05-10 |
2008-09-09 |
Schering Corporation |
Mammalian receptor protein DCRS5;methods of treatment
|
EP1433792A3
(en)
|
2000-05-25 |
2004-11-17 |
Schering Corporation |
Human receptor proteins, related reagents and methods
|
WO2005000087A2
(en)
*
|
2003-06-03 |
2005-01-06 |
Chiron Corporation |
Gene products differentially expressed in cancerous colon cells and their methods of use ii
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
US6958214B2
(en)
*
|
2000-07-10 |
2005-10-25 |
Sequenom, Inc. |
Polymorphic kinase anchor proteins and nucleic acids encoding the same
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
EP1810978B1
(en)
|
2000-08-08 |
2013-02-13 |
St. Jude Children's Research Hospital |
Group B streptococcus polypeptides nucleic acids and therapeutic composition and vaccines thereof
|
EP2359854B1
(en)
|
2000-08-08 |
2013-10-09 |
Technion Research and Development Foundation, Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis
|
US20030114410A1
(en)
*
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
GB0020498D0
(en)
|
2000-08-18 |
2000-10-11 |
Sterix Ltd |
Compound
|
EP1683874A3
(en)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
|
ATE549347T1
(de)
|
2000-09-08 |
2012-03-15 |
Schering Corp |
Gene von säugetiere, und damit verbundene reagentien, methoden
|
DE60142840D1
(de)
|
2000-09-08 |
2010-09-30 |
Univ Texas |
Durch phagendisplay identifizierte zielpeptide des menschen und der maus
|
US6673623B1
(en)
|
2000-09-12 |
2004-01-06 |
Novocure, Inc. |
Methods and compositions that control lipid production
|
AU2001292749A1
(en)
*
|
2000-09-18 |
2002-03-26 |
Genencor International, Inc. |
Twin-arginine translocation in bacillus
|
US7632522B2
(en)
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
AU2001295850A1
(en)
*
|
2000-09-28 |
2002-04-08 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
US7045283B2
(en)
|
2000-10-18 |
2006-05-16 |
The Regents Of The University Of California |
Methods of high-throughput screening for internalizing antibodies
|
US20050136431A1
(en)
*
|
2000-11-03 |
2005-06-23 |
Oakley Robert H. |
Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
|
US7163800B2
(en)
*
|
2000-11-03 |
2007-01-16 |
Molecular Devices Corporation |
Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
|
US7018812B2
(en)
|
2000-11-03 |
2006-03-28 |
Duke University |
Modified G-protein coupled receptors
|
US6890734B2
(en)
|
2000-11-10 |
2005-05-10 |
Schering Corporation |
Nucleic acids encoding a cytokine receptor complex
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
IL155940A0
(en)
|
2000-11-17 |
2003-12-23 |
Vascular Biogenics Ltd |
Promoters exhibiting endothelial cell specificity and method of using same
|
EP1341543A4
(en)
|
2000-11-24 |
2009-09-02 |
Vascular Biogenics Ltd |
METHODS INVOLVING DEFINED OXIDE PHOSPHOLIPIDS, AND COMPOSITIONS CONTAINING THE SAME, FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
|
US20020172980A1
(en)
*
|
2000-11-27 |
2002-11-21 |
Phan Brigitte Chau |
Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
|
US20030003464A1
(en)
*
|
2000-11-27 |
2003-01-02 |
Phan Brigitte C. |
Dual bead assays including optical biodiscs and methods relating thereto
|
US20040248093A1
(en)
*
|
2000-11-27 |
2004-12-09 |
Coombs James Howard |
Magneto-optical bio-discs and systems including related methods
|
AU2002252773A1
(en)
*
|
2000-11-29 |
2002-06-11 |
Lynkeus Boitech Gmbh |
Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
|
IL155941A0
(en)
*
|
2000-11-30 |
2003-12-23 |
Yeda Res & Dev |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
KR20030067696A
(ko)
|
2000-11-30 |
2003-08-14 |
모렉큐랄 스킨케어 리미티드 |
질병의 진단 및 치료
|
US20020165149A1
(en)
*
|
2000-12-08 |
2002-11-07 |
Kranz David M. |
Mutated class II major histocompatibility proteins
|
US7087395B1
(en)
|
2001-01-16 |
2006-08-08 |
Quest Diagnostics Investments Incorporated |
Vitamin D assay
|
GB0101762D0
(en)
*
|
2001-01-23 |
2001-03-07 |
Medical Res Council |
Method
|
AU2002230061A1
(en)
*
|
2001-01-31 |
2002-08-12 |
Tolaren |
Induction of tolerance by apoptotic and/or necrotic cells
|
US20050202098A1
(en)
*
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
AU2002244247B2
(en)
|
2001-03-01 |
2007-12-13 |
Harbor Biosciences, Inc. |
Use of certain steroids for treatment of blood cell deficiencies
|
CA2440615A1
(en)
|
2001-03-12 |
2002-09-19 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US20030104410A1
(en)
*
|
2001-03-16 |
2003-06-05 |
Affymetrix, Inc. |
Human microarray
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
US20030220475A1
(en)
*
|
2001-04-03 |
2003-11-27 |
Fields Howard A. |
Neutralizing immunogenic hev polypepetides
|
US7618789B2
(en)
*
|
2001-04-06 |
2009-11-17 |
The United States Of America As Represented By The Secretary Of Department Of Health And Human Services |
Use of semenogelin in the diagnosis, prognosis and treatment of cancer
|
DE60234094D1
(de)
|
2001-05-11 |
2009-12-03 |
Ludwig Inst For Cancer Res Ltd |
Spezifische bindungsproteine und ihre verwendung
|
US20110313230A1
(en)
|
2001-05-11 |
2011-12-22 |
Terrance Grant Johns |
Specific binding proteins and uses thereof
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
AU2002339115B2
(en)
|
2001-05-18 |
2007-03-15 |
Dupont Nutrition Biosciences Aps |
Method of preparing a dough with an enzyme
|
WO2002094985A2
(en)
|
2001-05-22 |
2002-11-28 |
Merck & Co., Inc. |
Beta-secretase substrates and uses thereof
|
US20090324612A1
(en)
*
|
2001-06-05 |
2009-12-31 |
Kaufman Daniel L |
Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule
|
WO2002099069A2
(en)
*
|
2001-06-05 |
2002-12-12 |
The Regents Of The University Of California |
Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
US20070190534A1
(en)
*
|
2001-06-11 |
2007-08-16 |
Genesis Genomics Inc. |
Mitochondrial sites and genes associated with prostate cancer
|
MXPA04000397A
(es)
*
|
2001-07-19 |
2004-03-18 |
Yissum Res Dev Co |
Polipeptidos que tienen actividad catalitica de isomerasa de carotenoides, acidos nucleicos que los codifican y usos de los mismos.
|
DE60237696D1
(de)
*
|
2001-08-01 |
2010-10-28 |
Univ Utah |
Am n-terminus trunkierte isoformen von zyklischen phosphodiesterasen pde3a
|
US6833441B2
(en)
|
2001-08-01 |
2004-12-21 |
Abmaxis, Inc. |
Compositions and methods for generating chimeric heteromultimers
|
US20030082596A1
(en)
*
|
2001-08-08 |
2003-05-01 |
Michael Mittmann |
Methods of genetic analysis of probes: test3
|
US20060073530A1
(en)
*
|
2001-08-15 |
2006-04-06 |
Olaf Schneewind |
Methods and compositions involving sortase B
|
WO2003017817A2
(en)
|
2001-08-16 |
2003-03-06 |
Bar Ilan University |
Diagnosis, prevention and treatment of cancer
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
EP1438583B1
(en)
|
2001-09-20 |
2009-09-16 |
Board of Regents, The University of Texas System |
Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
|
AU2002330102A1
(en)
*
|
2001-09-28 |
2003-04-14 |
Aspenbio, Inc. |
Bovine pregnancy test
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
AU2002334997A1
(en)
|
2001-10-12 |
2003-04-22 |
Schering Corporation |
Use of bispecific antibodies to regulate immune responses
|
CN100506284C
(zh)
|
2001-10-19 |
2009-07-01 |
脉管生物生长有限公司 |
多核苷酸构建体、药物组合物以及靶向的下调血管生成和抗癌的治疗方法
|
US7175983B2
(en)
*
|
2001-11-02 |
2007-02-13 |
Abmaxis, Inc. |
Adapter-directed display systems
|
AU2002366097B2
(en)
|
2001-11-20 |
2008-09-18 |
Monsanto Technology Llc |
Compositions and methods for accurate early pregnancy diagnosis
|
US6952704B2
(en)
*
|
2001-11-26 |
2005-10-04 |
Microsoft Corporation |
Extending a directory schema independent of schema modification
|
US8178128B2
(en)
*
|
2001-12-05 |
2012-05-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Nanoparticles containing polymeric nucleic acid homologs
|
AU2002359721A1
(en)
*
|
2001-12-19 |
2003-07-09 |
Bristol-Myers Squibb Company |
Pichia pastoris formate dehydrogenase and uses therefor
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
US7341844B2
(en)
*
|
2002-01-16 |
2008-03-11 |
Regents Of The University Of Minnesota |
Methods for diagnosing autism
|
IL152904A0
(en)
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
WO2003062404A1
(en)
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
|
WO2003062278A1
(en)
|
2002-01-25 |
2003-07-31 |
G2 Therapies Ltd |
MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
EP2077277A1
(en)
|
2002-02-01 |
2009-07-08 |
Schering Corporation |
Use of mammalian cytokine; related reagents
|
US6992176B2
(en)
*
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
AU2003216341A1
(en)
*
|
2002-02-20 |
2003-09-09 |
Dyax Corporation |
Mhc-peptide complex binding ligands
|
WO2003072799A2
(en)
|
2002-02-22 |
2003-09-04 |
The Government Of The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Brother of the regulator of imprinted sites (boris)
|
US7053188B2
(en)
|
2002-02-22 |
2006-05-30 |
Purdue Research Foundation |
Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
|
WO2003078567A2
(en)
*
|
2002-03-18 |
2003-09-25 |
Gamida-Cell Ltd. |
Methods of inducing differentiation in ex vivo expanded stem cells
|
US20030182669A1
(en)
*
|
2002-03-19 |
2003-09-25 |
Rockman Howard A. |
Phosphoinositide 3-kinase mediated inhibition of GPCRs
|
US7611723B2
(en)
*
|
2002-03-26 |
2009-11-03 |
Nanocyte Inc. |
Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
|
US7332585B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
CA2391438A1
(en)
*
|
2002-05-01 |
2003-11-01 |
Procyon Biopharma Inc. |
Psp94 diagnostic reagents and assays
|
US7534580B2
(en)
*
|
2002-05-01 |
2009-05-19 |
Ambrilia Biopharma Inc. |
PSP94 diagnostic reagents and assays
|
EP1501863A4
(en)
|
2002-05-03 |
2007-01-24 |
Sequenom Inc |
KINASE ANCHOR PROTEIN, PEPTIDES AND RELATED METHODS THEREOF
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
ATE474045T1
(de)
|
2002-05-30 |
2010-07-15 |
Sloan Kettering Inst Cancer |
Kinasesuppressor der ras-inaktivierung zur therapie von durch ras vermittelter tumorgenese
|
WO2003102595A1
(en)
*
|
2002-05-31 |
2003-12-11 |
Genetype Pty Ltd |
Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
|
US7290215B2
(en)
*
|
2002-06-03 |
2007-10-30 |
Microsoft Corporation |
Dynamic wizard interface system and method
|
US7504215B2
(en)
|
2002-07-12 |
2009-03-17 |
Affymetrix, Inc. |
Nucleic acid labeling methods
|
JP2005533102A
(ja)
*
|
2002-07-12 |
2005-11-04 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム |
微小器官によって生物学的プロセスを誘発する方法と装置
|
US20040175378A1
(en)
|
2002-07-15 |
2004-09-09 |
Board Of Regents, The University Of Texas System |
Selected antibody compositions and methods for binding to aminophospholipids
|
US6916474B2
(en)
|
2002-07-15 |
2005-07-12 |
Board Of Regents, The University Of Texas System |
Antibodies with increased affinities for anthrax antigens
|
US7794716B2
(en)
|
2002-07-25 |
2010-09-14 |
Glenveigh Pharmaceuticals, Llc |
Antibody composition and passive immunization against pregnancy-induced hypertension
|
EP2561889A3
(en)
|
2002-08-01 |
2013-04-03 |
Yeda Research and Development Co. Ltd. |
Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
|
EA200500330A1
(ru)
*
|
2002-08-10 |
2006-06-30 |
Йейл Юниверсити |
Антагонисты nogo рецепторов
|
CA2496867A1
(en)
|
2002-08-28 |
2004-03-11 |
Hollis-Eden Pharmaceuticals, Inc. |
Therapeutic treatment methods
|
BR0314155A
(pt)
|
2002-09-09 |
2005-07-05 |
Arbor Vita Corp |
Métodos para diagnosticar câncer cervical
|
WO2004029246A2
(en)
|
2002-09-26 |
2004-04-08 |
K.U.Leuven Research And Development |
Integrase cofactor
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
JP2006514614A
(ja)
|
2002-10-24 |
2006-05-11 |
ステリックス リミテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1型および2型のインヒビター
|
AU2003284968A1
(en)
*
|
2002-10-25 |
2004-05-13 |
University Of South Florida |
Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
|
EP2295980A1
(en)
|
2002-10-30 |
2011-03-16 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Molecules and methods using same for measuring non-transferrin bound iron
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
AU2002352938B8
(en)
*
|
2002-11-26 |
2009-10-08 |
The University Of Chicago |
Materials and methods for preventing and treating microbe-mediated epithelial disorders
|
AU2003302701A1
(en)
*
|
2002-11-29 |
2004-06-23 |
Technion Research And Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
AU2003298706A1
(en)
|
2002-12-04 |
2004-06-23 |
Applera Corporation |
Multiplex amplification of polynucleotides
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
AU2003286410A1
(en)
|
2002-12-12 |
2004-06-30 |
R.B.T (Rakuto Bio Technologies) Ltd. |
Methods of producing lignin peroxidase and its use in skin and hair lightening
|
ES2571355T3
(es)
|
2002-12-16 |
2016-05-24 |
Technion Res & Dev Foundation |
Sistema de cultivo sin células alimentadoras ni xenocontaminantes para células madre embrionarias humanas
|
AU2002953431A0
(en)
*
|
2002-12-19 |
2003-01-09 |
Murdoch University |
BmpB Novel Nucleotide and Amino Acid Sequences and Diagnostic and Therapeutic Uses Thereof
|
ATE546548T1
(de)
|
2003-01-02 |
2012-03-15 |
Rappaport Family Inst For Res |
Verfahren zur prognose des nutzens einer antioxidationshemmenden therapie zur vorbeugung von herz-kreislauf-erkrankungen bei hyperglykämischen patienten
|
US20040229245A1
(en)
*
|
2003-01-06 |
2004-11-18 |
Anton Bittner |
Methods and algorithms for performing quality control during gene expression profiling on DNA microarray technology
|
WO2004060791A1
(en)
*
|
2003-01-07 |
2004-07-22 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures encapsulating a foreign material and method of manufacturing same
|
US7955814B2
(en)
|
2003-01-17 |
2011-06-07 |
Danisco A/S |
Method
|
CN102021205A
(zh)
|
2003-01-17 |
2011-04-20 |
丹尼斯科公司 |
制备蛋白质酯和蛋白质亚基酯的方法
|
US20050196766A1
(en)
|
2003-12-24 |
2005-09-08 |
Soe Jorn B. |
Proteins
|
MXPA05007653A
(es)
|
2003-01-17 |
2005-09-30 |
Danisco |
Metodo.
|
CA2514179A1
(en)
*
|
2003-01-24 |
2004-08-12 |
Duke University |
Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera
|
WO2004106925A2
(en)
*
|
2003-03-03 |
2004-12-09 |
Nagaoka & Co.Ltd. |
Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
|
US7786071B2
(en)
|
2003-03-04 |
2010-08-31 |
Yeda Research And Development Co. Ltd. |
Pon polypeptides polynucleotides encoding same and compositions and methods utilizing same
|
EP1599608A4
(en)
*
|
2003-03-05 |
2007-07-18 |
Genetic Technologies Ltd |
Identification of fetal DNA and fetal cell marker in maternal plasma or serum
|
CA2517959A1
(en)
*
|
2003-03-07 |
2004-09-16 |
Gamida-Cell Ltd. |
Expansion of renewable stem cell populations using modulators of pi 3-kinase
|
EP1603511B1
(en)
|
2003-03-07 |
2011-01-26 |
New England Medical Center Hospitals, Inc. |
Treatment of igai deposition diseases
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
ATE517926T1
(de)
|
2003-04-04 |
2011-08-15 |
Yeda Res & Dev |
Antikörper zur hemmung der aktivität von mmp-2 und mmp-9
|
CA2520023C
(en)
|
2003-04-08 |
2013-02-05 |
Yeda Research And Development Co. Ltd |
Stem cells having increased sensitivity to sdf-1 and methods of generating and using same
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US20040209246A1
(en)
*
|
2003-04-15 |
2004-10-21 |
Agouron Pharmaceuticals, Inc. |
Dual reporter/dye reduction methodology for evaluating antiviral and cytotoxicity of hepatitis C virus inhibitors
|
EA009643B1
(ru)
*
|
2003-04-16 |
2008-02-28 |
Йейл Юниверсити |
Лечение состояний, включающих амилоидные бляшки
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
US7554007B2
(en)
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
RU2350653C2
(ru)
|
2003-05-22 |
2009-03-27 |
Эводжин Лтд. |
Способы повышения толерантности к абиотическому стрессу и/или биомассы у растений и получаемые таким образом растения
|
AU2005234725B2
(en)
*
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
EP1636333A4
(en)
*
|
2003-06-19 |
2007-10-24 |
Evogene Ltd |
NUCLEOTIDE SEQUENCES FOR REGULATING GENE EXPRESSION IN VEGETABLE TRICHROMES, AND HYBRID GENES AND METHODS IN WHICH THEY INTERVENE
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
EP2719394B1
(en)
|
2003-06-30 |
2015-07-29 |
Tel Aviv University Future Technology Development L.P. |
Peptides for treating amyloid-associated diseases
|
WO2005014795A2
(en)
|
2003-08-08 |
2005-02-17 |
Genenews Inc. |
Osteoarthritis biomarkers and uses thereof
|
US20050064479A1
(en)
*
|
2003-08-12 |
2005-03-24 |
Affymetrix, Inc. |
Compounds and methods for post incorporation labeling of nucleic acids
|
CA2535901A1
(en)
|
2003-08-14 |
2005-02-24 |
Exelixis, Inc. |
Ups as modifiers of the beta catenin pathway and methods of use
|
JP2007518394A
(ja)
*
|
2003-08-14 |
2007-07-12 |
ザ バイオ バランス コーポレイション |
細菌菌株、該細菌菌株を含む組成物、およびそのプロバイオティクス使用
|
JP4711963B2
(ja)
|
2003-09-15 |
2011-06-29 |
オクラホマ メディカル リサーチ ファウンデーション |
炎症性疾患および自己免疫疾患を診断、治療および評価するためにサイトカインアッセイを用いる方法
|
US20050064435A1
(en)
*
|
2003-09-24 |
2005-03-24 |
Xing Su |
Programmable molecular barcodes
|
WO2005031362A2
(en)
|
2003-10-02 |
2005-04-07 |
Ramot At Tel Aviv University Ltd. |
Novel antibacterial agents and methods of identifying and utilizing same
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
CA2541535C
(en)
|
2003-10-07 |
2013-12-10 |
Yeda Research And Development Co. Ltd. |
Antibodies to nik, their preparation and use
|
BRPI0415742A
(pt)
*
|
2003-10-23 |
2006-12-19 |
Pfizer Producs Inc |
vacina para a doença periodontal
|
US20050227251A1
(en)
|
2003-10-23 |
2005-10-13 |
Robert Darnell |
Method of purifying RNA binding protein-RNA complexes
|
AR046833A1
(es)
|
2003-11-10 |
2005-12-28 |
Schering Corp |
Anticuerpos anti-interleuquina-10
|
CA2547459C
(en)
|
2003-11-30 |
2013-10-08 |
Yeda Research And Development Co. Ltd |
Modulators of nik-siva complex formation for treating immune disorders
|
JP2007521248A
(ja)
|
2003-12-10 |
2007-08-02 |
ミレニアム ファーマシューティカルズ, インコーポレイテッド |
ヒト化抗ccr2抗体および該抗体を使用する方法
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
WO2005061018A1
(en)
|
2003-12-22 |
2005-07-07 |
Regentis Biomaterials Ltd. |
Matrix comprising naturally-occurring protein backbone
|
AU2004308964B2
(en)
|
2003-12-23 |
2010-09-16 |
Arbor Vita Corporation |
Antibodies for oncogenic strains of HPV and methods of their use
|
WO2008090395A1
(en)
|
2007-01-25 |
2008-07-31 |
Danisco A/S |
Production of a lipid acyltransferase from transformed bacillus licheniformis cells
|
KR101169265B1
(ko)
|
2003-12-24 |
2012-08-02 |
대니스코 에이/에스 |
단백질
|
GB0716126D0
(en)
*
|
2007-08-17 |
2007-09-26 |
Danisco |
Process
|
US7718408B2
(en)
*
|
2003-12-24 |
2010-05-18 |
Danisco A/S |
Method
|
US8007847B2
(en)
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
US20050186646A1
(en)
*
|
2004-01-26 |
2005-08-25 |
Cruz Miguel A. |
Rapid assay to detect ADAMTS-13 activity
|
EP1713900A4
(en)
*
|
2004-01-27 |
2009-06-17 |
Compugen Ltd |
METHOD AND SYSTEMS FOR COMMENTING BIOMOLECULAR SEQUENCES
|
US20070178462A1
(en)
*
|
2004-02-18 |
2007-08-02 |
Uebele Victor N |
Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha1h, encoded proteins and methods of use thereof
|
US7767792B2
(en)
|
2004-02-20 |
2010-08-03 |
Ludwig Institute For Cancer Research Ltd. |
Antibodies to EGF receptor epitope peptides
|
GB0403864D0
(en)
|
2004-02-20 |
2004-03-24 |
Ucl Ventures |
Modulator
|
WO2005085475A1
(en)
|
2004-03-01 |
2005-09-15 |
Applera Corporation |
Methods, compositions and kits for use in polynucleotide amplification
|
JP2007526337A
(ja)
|
2004-03-02 |
2007-09-13 |
アクセルロン ファーマ インコーポレーテッド |
Alk7およびミオスタチン阻害剤ならびにその使用
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
GB0405637D0
(en)
|
2004-03-12 |
2004-04-21 |
Danisco |
Protein
|
CN101072797B
(zh)
|
2004-03-12 |
2012-05-09 |
瓦斯基因治疗公司 |
结合ephb4、抑制血管发生和肿瘤生长的抗体
|
JP2007533755A
(ja)
*
|
2004-04-20 |
2007-11-22 |
ザ ユニヴァーシティ オヴ シカゴ |
高分子量peg様化合物を含む治療薬送達システム
|
EP2400030B1
(en)
|
2004-05-18 |
2016-01-20 |
The Board of Trustees of the Leland Stanford Junior University |
Detection of protein translocation by beta-galactosidase reporter fragment complementation
|
JP4651663B2
(ja)
|
2004-05-28 |
2011-03-16 |
アジェンシス,インコーポレイテッド |
Pscaタンパク質に結合する抗体および関連分子
|
ES2665463T3
(es)
|
2004-06-14 |
2018-04-25 |
Evogene Ltd. |
Polinucleótidos y polipéptidos implicados en el desarrollo de fibra vegetal y métodos de uso de los mismos
|
US8034553B2
(en)
|
2004-06-24 |
2011-10-11 |
Kimberly-Clark Worldwide, Inc. |
Biomarkers for wound healing
|
ITBO20040412A1
(it)
*
|
2004-07-01 |
2004-10-01 |
Eurodent Spa |
Lampada dentale particolarmente per ambulatori medico-dentistici
|
US8680062B2
(en)
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2006006172A2
(en)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
EP2267108A1
(en)
|
2004-07-16 |
2010-12-29 |
Danisco A/S |
Enzymatic oil-degumming method
|
WO2006014798A2
(en)
*
|
2004-07-27 |
2006-02-09 |
Mount Sinai School Of Medicine |
Methods and compositions for using sax2
|
CA2579790A1
(en)
*
|
2004-07-30 |
2006-02-09 |
Mount Sinai School Of Medicine Of New York University |
Npc1l1 and npc1l1 inhibitors and methods of use thereof
|
US20060073168A1
(en)
*
|
2004-08-11 |
2006-04-06 |
Stephens David S |
Neisseria meningitidis serogroup a capsular polysaccharide acetyltransferase, methods and compositions
|
WO2006021894A2
(en)
|
2004-08-26 |
2006-03-02 |
Engeneic Gene Therapy Pty Limited |
Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells
|
FI20050753A
(fi)
|
2004-09-03 |
2006-03-04 |
Licentia Oy |
Uudet peptidit
|
ES2345993T3
(es)
|
2004-09-14 |
2010-10-07 |
The Regents Of The University Of Colorado, A Body Corporate |
Metodo para el tratamiento con bucindolol basado en direccionamiento genetico.
|
WO2006030442A2
(en)
|
2004-09-16 |
2006-03-23 |
Gamida-Cell Ltd. |
Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
|
AU2005287090A1
(en)
|
2004-09-18 |
2006-03-30 |
Department Of Veterans Affairs |
Therapeutic agents targeting the NCca-ATP channel and methods of use thereof
|
CN101043891A
(zh)
|
2004-09-18 |
2007-09-26 |
巴尔的摩马里兰大学 |
靶向NCCa-ATP通道的治疗剂及其使用方法
|
SI1797127T1
(sl)
*
|
2004-09-24 |
2017-09-29 |
Amgen Inc. |
Modificirane fc-molekule
|
EP1805319B1
(en)
*
|
2004-09-29 |
2014-09-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Recombinant human t2 rnase and uses thereof
|
CN101065491B
(zh)
|
2004-09-29 |
2012-01-11 |
胶原植物有限公司 |
生产胶原的植物及其生成和使用方法
|
GB0422052D0
(en)
|
2004-10-04 |
2004-11-03 |
Dansico As |
Enzymes
|
US7390489B2
(en)
*
|
2004-10-08 |
2008-06-24 |
Komed Co., Ltd. |
Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody
|
US7781402B2
(en)
*
|
2004-10-12 |
2010-08-24 |
Closed Loop Therapies Ltd. |
Methods and implantable devices for treating supraventricular arrhythmias
|
GB0423139D0
(en)
|
2004-10-18 |
2004-11-17 |
Danisco |
Enzymes
|
JP5525689B2
(ja)
*
|
2004-11-02 |
2014-06-18 |
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ セクレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
過剰増殖性障害を処置するための組成物および方法
|
GB0424940D0
(en)
|
2004-11-11 |
2004-12-15 |
Danisco |
Transcription factors
|
EP1812594B1
(en)
|
2004-11-18 |
2013-01-09 |
Eppendorf Array Technologies |
Real-time quantification of multiple targets on a micro-array
|
DE602005025685D1
(de)
|
2004-12-03 |
2011-02-10 |
Schering Corp |
Biologische marker zur vorauswahl von patienten für die anti-igf1r-therapie
|
US7504769B2
(en)
*
|
2004-12-16 |
2009-03-17 |
E. I. Du Pont De Nemours + Company |
Aromatic chalcogen compounds and their use
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
WO2006075335A2
(en)
*
|
2005-01-16 |
2006-07-20 |
Zlango Ltd. |
Communications network system and methods for using same
|
EP1844403A4
(en)
|
2005-01-16 |
2010-06-23 |
Zlango Ltd |
SIGNS COMMUNICATION
|
WO2007080558A2
(en)
*
|
2006-01-16 |
2007-07-19 |
Zlango Ltd. |
Communications network system and methods for using same
|
EP3028765B1
(en)
|
2005-01-31 |
2020-01-08 |
Realbio Technologies Ltd. |
Method of sequentially transferring liquids through a lateral flow capillary device
|
CN103497993A
(zh)
|
2005-02-07 |
2014-01-08 |
基因信息公司 |
轻度骨关节炎生物标志物及其用途
|
EP2316441A1
(en)
|
2005-02-17 |
2011-05-04 |
Hadasit Medical Research Services And Development |
Bisphosphonates for treating endometriosis
|
GB0503546D0
(en)
*
|
2005-02-21 |
2005-03-30 |
Hellenic Pasteur Inst |
Antibody
|
EP1871402B1
(en)
|
2005-02-25 |
2017-07-26 |
State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (A.R.O.), Volcani Center |
Grape cell culture for treating inflammation
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
RU2413735C2
(ru)
|
2005-03-31 |
2011-03-10 |
Эдженсис, Инк. |
Антитела и родственные молекулы, связывающиеся с белками 161p2f10b
|
RS61229B1
(sr)
|
2005-04-04 |
2021-01-29 |
Biogen Ma Inc |
Metodi evaluacije imunskog odgovora na terapijsko sredstvo
|
WO2006109312A2
(en)
*
|
2005-04-15 |
2006-10-19 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease
|
US20130022979A1
(en)
|
2005-04-18 |
2013-01-24 |
Genesis Genomics Inc. |
3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER
|
CN101248180B
(zh)
|
2005-04-18 |
2013-09-25 |
米托米克斯公司 |
作为检测日光照射、前列腺癌和其它癌症的诊断工具的线粒体突变及重排
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
EP1882035A2
(en)
|
2005-05-12 |
2008-01-30 |
Novartis AG |
Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
|
US9943481B2
(en)
|
2005-05-26 |
2018-04-17 |
Biorest Ltd. |
Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
JP2008546385A
(ja)
|
2005-06-16 |
2008-12-25 |
ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド |
Cns疾患を治療するための単離された細胞および単離された細胞を含む集団
|
ES2565670T3
(es)
|
2005-06-20 |
2016-04-06 |
Advanced Cell Diagnostics, Inc. |
Métodos de detección de ácidos nucleicos en células individuales y de identificación de células raras en grandes poblaciones de células heterogéneas
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
EP1904526A4
(en)
|
2005-07-07 |
2009-10-28 |
Fulcrum Sp Ltd |
SP1-POLYPEPTIDES, MODIFIED SP1-POLYPEPTIDES AND APPLICATIONS THEREOF
|
CA2614531C
(en)
|
2005-07-07 |
2015-06-16 |
Avraham Hochberg |
Nucleic acid agents for downregulating h19, and methods of using same
|
BRPI0616012A2
(pt)
|
2005-07-18 |
2011-05-31 |
Protalix Ltd |
administração via mucosa ou intestino de macromoléculas biologicamente ativas
|
JP5017269B2
(ja)
|
2005-07-26 |
2012-09-05 |
ユニヴァーシティ オブ メディシン アンド デンティストリ オブ ニュージャーシィ |
結核状態に特有の抗体プロフィール
|
WO2007019541A2
(en)
*
|
2005-08-08 |
2007-02-15 |
Onconon, Llc. |
Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
EP1928479B1
(en)
|
2005-08-24 |
2016-06-08 |
Yeda Research And Development Co., Ltd. |
Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
|
EP1962719A4
(en)
|
2005-08-29 |
2011-05-04 |
Technion Res And Dev Of Foundation Ltd |
MEDIA FOR BREEDING STEM CELLS
|
SG165322A1
(en)
|
2005-08-31 |
2010-10-28 |
Schering Corp |
Engineered anti-il-23 antibodies
|
US7608395B2
(en)
|
2005-09-15 |
2009-10-27 |
Baylor Research Institute |
Systemic lupus erythematosus diagnostic assay
|
EP1926814B1
(en)
*
|
2005-09-22 |
2010-04-28 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer
|
WO2007041340A2
(en)
*
|
2005-09-30 |
2007-04-12 |
The Trustees Of Columbia University In The City Of New York |
Microfluidic cells with parallel arrays of individual dna molecules
|
US20070202515A1
(en)
*
|
2005-10-12 |
2007-08-30 |
Pathologica, Llc. |
Promac signature application
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
EP1945816B1
(en)
|
2005-10-21 |
2011-07-27 |
GeneNews Inc. |
Method and apparatus for correlating levels of biomarker products with disease
|
BRPI0618965B1
(pt)
|
2005-10-24 |
2021-01-12 |
Evogene Ltd |
método para aumentar a tolerância de uma planta a uma condição de estresse abiótico, método para aumentar a biomassa, vigor e/ou rendimento de uma planta, método para aumentar a eficiência do uso de fertilizante e/ou absorção de uma planta
|
US7842823B2
(en)
*
|
2005-10-27 |
2010-11-30 |
The Regents Of The University Of California |
Fluorogenic probes for reactive oxygen species
|
CN101346393B
(zh)
|
2005-11-02 |
2015-07-22 |
普洛体维生物治疗公司 |
修饰的siRNA分子及其应用
|
US20100028358A1
(en)
|
2005-11-07 |
2010-02-04 |
Wolfram Ruf |
Compositions and Methods for Controlling Tissue Factor Signaling Specificity
|
DE212006000071U1
(de)
|
2005-11-18 |
2008-07-24 |
Board of Regents, The University of Texas System, Austin |
Quantifizierung von Fusionsproteinen und ihrer Aktivität in Folge chromosomaler Translokation
|
AU2006321172B2
(en)
|
2005-11-29 |
2012-02-23 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
US8158360B2
(en)
|
2005-12-08 |
2012-04-17 |
Novartis Ag |
Effects of inhibitors of FGFR3 on gene transcription
|
US20070134814A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Kajander E O |
Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
|
EP2674440B1
(en)
|
2005-12-16 |
2019-07-03 |
IBC Pharmaceuticals, Inc. |
Multivalent immunoglobulin-based bioactive assemblies
|
CN101374860A
(zh)
*
|
2005-12-23 |
2009-02-25 |
技术转让合伙人公司 |
用作神经递质分泌抑制剂和肌肉松弛诱导物的合成肽
|
US7465544B2
(en)
*
|
2006-01-11 |
2008-12-16 |
Wisconsin Alumni Research Foundation |
Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use
|
EP1977312A2
(en)
|
2006-01-16 |
2008-10-08 |
Zlango Ltd. |
Iconic communication
|
JP5829373B2
(ja)
|
2006-01-27 |
2015-12-09 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
Nogoレセプターアンタゴニスト
|
WO2007088051A2
(en)
|
2006-01-31 |
2007-08-09 |
Bayer Schering Pharma Aktiengesellschaft |
Modulation of mdl-1 activity for treatment of inflammatory disease
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US7553941B2
(en)
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting polypeptides and methods of producing same
|
CN101416063A
(zh)
|
2006-02-06 |
2009-04-22 |
拉帕波特家族医学科学研究所 |
用于诊断t1dm的方法和试剂盒
|
PL1986661T3
(pl)
|
2006-02-08 |
2019-02-28 |
Genzyme Corporation |
Terapia genowa choroby Niemanna-Picka typu A
|
JP4896994B2
(ja)
|
2006-02-09 |
2012-03-14 |
ユニバーシティー オブ サウス フロリダ |
Bcl−2レベルの上昇による癌の検出
|
PL2676967T3
(pl)
|
2006-02-28 |
2019-12-31 |
Biogen Ma Inc. |
Metody leczenia chorób zapalnych i autoimmunologicznych za pomocą natalizumabu
|
US20070231319A1
(en)
|
2006-03-03 |
2007-10-04 |
Yednock Theodore A |
Methods of treating inflammatory and autoimmune diseases with natalizumab
|
JP5107943B2
(ja)
|
2006-03-06 |
2012-12-26 |
ゼティク テクノロジーズ リミテッド |
細胞の表現型を特定するための方法および組成物
|
WO2007109733A2
(en)
|
2006-03-21 |
2007-09-27 |
The Johns Hopkins University |
Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
|
PT2548951E
(pt)
|
2006-03-23 |
2016-06-14 |
Pluristem Ltd |
Métodos para expansão celular e usos de células e de meios condicionados produzidos através deles para terapia
|
EP2004858A4
(en)
|
2006-03-28 |
2009-12-09 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
METHOD AND KITS FOR DETERMINING AN INVESTMENT TO WARFARINE RESISTANCE
|
US20070232556A1
(en)
*
|
2006-03-31 |
2007-10-04 |
Montine Thomas J |
Methods and compositions for the treatment of neurological diseases and disorders
|
MX2008012754A
(es)
*
|
2006-04-07 |
2009-04-27 |
Us Gov Health & Human Serv |
Composiciones de anticuerpos y metodos para tratamiento de enfermedad neoplastica.
|
EP2881468B1
(en)
|
2006-04-21 |
2017-04-12 |
Intervet International B.V. |
Pestivirus species
|
FR2900341B1
(fr)
|
2006-04-27 |
2012-09-14 |
Centre Nat Rech Scient |
Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer
|
RU2008148308A
(ru)
*
|
2006-05-09 |
2010-06-20 |
Маск Фаундейшн Фор Рисерч Дивелопмент (Us) |
Определение диастолической сердечной недостаточности при помощи профилей протеазы и ингибитора протеазы в плазме
|
BRPI0712716A2
(pt)
*
|
2006-05-19 |
2012-05-22 |
Teva Pharma |
proteìna de fusão, composição, construção de ácido nucleico, vetor, célula transformada, preparação isolada de corpos de inclusão bacterialmente expressados, processo para produzir uma proteìna de fusão, e, métodos para matar seletivamente uma célula de tumor e para tratar uma célula de tumor que expressa mesotelina em sua superfìcie
|
US20100196336A1
(en)
|
2006-05-23 |
2010-08-05 |
Dongsu Park |
Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
US20080003230A1
(en)
|
2006-07-03 |
2008-01-03 |
Adair Charles D |
Composition for modulating the expression of cell adhesion molecules
|
US20080026394A1
(en)
*
|
2006-07-11 |
2008-01-31 |
Antara Biosciences Inc. |
Methods of detecting one or more cancer markers
|
US8445222B2
(en)
*
|
2006-07-11 |
2013-05-21 |
Musc Foundation For Research Development |
Predicting heart failure following myocardial infarction by protease and protease inhibitor profiling
|
WO2008010934A2
(en)
|
2006-07-14 |
2008-01-24 |
Chemocentryx, Inc. |
Triazolyl phenyl benzenesulfonamides
|
WO2008010228A2
(en)
|
2006-07-20 |
2008-01-24 |
Yeda Research And Development Co. Ltd. |
Photosyntheticorganisms and compositions and methods of generating same
|
EP2053961A4
(en)
*
|
2006-08-09 |
2013-05-01 |
Biogen Idec Inc |
METHOD FOR DISPENSING A MEDICAMENT
|
JP2008043332A
(ja)
|
2006-08-17 |
2008-02-28 |
Panomics Inc |
組織スライドからの核酸定量
|
EP2051997B1
(en)
|
2006-08-22 |
2015-03-18 |
G2 Inflammation Pty Ltd |
Anti-c5ar antibodies with improved properties
|
EP2423332A1
(en)
|
2006-08-25 |
2012-02-29 |
Oncotherapy Science, Inc. |
Prognostic markers and therapeutic targets for lung cancer
|
EP2064319B1
(en)
|
2006-08-28 |
2017-02-22 |
Yeda Research and Development Co. Ltd. |
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns
|
JP2008111824A
(ja)
*
|
2006-09-01 |
2008-05-15 |
Nox Technologies Inc |
腫瘍特異的tNOXアイソフォーム及び方法
|
US7951776B2
(en)
|
2006-09-01 |
2011-05-31 |
American Type Culture Collection |
Methods for treatment of type 1 diabetes
|
US7985542B2
(en)
|
2006-09-07 |
2011-07-26 |
Institut Pasteur |
Genomic morse code
|
ES2457243T3
(es)
*
|
2006-09-08 |
2014-04-25 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Diagnóstico clínico de una fibrosis hepática utilizando APOL1 de suero humano como biomarcador
|
US8055034B2
(en)
*
|
2006-09-13 |
2011-11-08 |
Fluidigm Corporation |
Methods and systems for image processing of microfluidic devices
|
US8050516B2
(en)
*
|
2006-09-13 |
2011-11-01 |
Fluidigm Corporation |
Methods and systems for determining a baseline during image processing
|
US20100129656A1
(en)
|
2006-10-05 |
2010-05-27 |
Technion Research & Develpment Foundation Ltd |
Microtubes and methods of producing same
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
EP2074230B1
(en)
*
|
2006-10-11 |
2012-11-28 |
Janssen Pharmaceutica NV |
Compositions and methods for treating and diagnosing irritable bowel syndrome
|
EP1912067A1
(en)
*
|
2006-10-12 |
2008-04-16 |
Eppendorf Array Technologies S.A. |
Method for quantification of a target compound obtained from a biological sample upon chips
|
EP2426199A3
(en)
|
2006-10-20 |
2012-08-22 |
Danisco US Inc. |
Polyol oxidases
|
US20080305512A1
(en)
*
|
2006-10-26 |
2008-12-11 |
Mattingly Phillip G |
Assay for cardiac troponin autoantibodies
|
US7776605B2
(en)
*
|
2006-10-26 |
2010-08-17 |
Abbott Laboratories |
Assay for cardiac troponin autoantibodies
|
WO2008051762A2
(en)
*
|
2006-10-26 |
2008-05-02 |
Abbott Laboratories |
Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
|
WO2008049930A2
(en)
|
2006-10-27 |
2008-05-02 |
Janssen Pharmaceutica Nv |
A method for profiling kinase inhibitors
|
WO2008066655A2
(en)
|
2006-11-02 |
2008-06-05 |
Yale University |
Assessment of oocyte competence
|
US8293684B2
(en)
*
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
ATE555128T1
(de)
|
2006-11-30 |
2012-05-15 |
Res Dev Foundation |
Verbesserte immunglobulin-bibliotheken
|
WO2008067552A2
(en)
*
|
2006-11-30 |
2008-06-05 |
Fluidigm Corporation |
Method and apparatus for biological sample analysis
|
US8232372B2
(en)
|
2006-12-14 |
2012-07-31 |
Schering Corp. |
Engineered anti-TSLP antibody
|
CA2672756C
(en)
|
2006-12-20 |
2018-11-20 |
Evogene Ltd. |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
|
US8506499B2
(en)
*
|
2007-01-04 |
2013-08-13 |
Musc Foundation For Research Development |
Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling
|
AU2008204338B2
(en)
*
|
2007-01-11 |
2014-03-06 |
Erasmus University Medical Center |
Circular chromosome conformation capture (4C)
|
WO2008089103A2
(en)
|
2007-01-12 |
2008-07-24 |
University Of Maryland, Baltimore |
Targeting ncca-atp channel for organ protection following ischemic episode
|
ATE548454T1
(de)
*
|
2007-01-16 |
2012-03-15 |
Yissum Res Dev Co |
Nukleinsäurewirkstoffe zur stilllegung von h19 zwecks behandlung rheumatoider arthritis
|
ES2378490T3
(es)
|
2007-01-26 |
2012-04-13 |
University Of Louisville Research Foundation, Inc. |
Métodos de detección de autoanticuerpos para diagnosticar y caracterizar trastornos
|
US20100190662A1
(en)
*
|
2007-01-26 |
2010-07-29 |
Rebecca Sutphen |
Methods and materials for detection, diagnosis and management of ovarian cancer
|
US20100196403A1
(en)
*
|
2007-01-29 |
2010-08-05 |
Jacob Hochman |
Antibody conjugates for circumventing multi-drug resistance
|
US8911996B2
(en)
|
2007-01-31 |
2014-12-16 |
Technion Research & Development Foundation Limited |
Electrospun scaffolds and methods of generating and using same
|
CA2676932C
(en)
|
2007-02-01 |
2015-11-24 |
Technion Research & Development Foundation Ltd. |
Albumin fibers and fabrics and methods of generating and using same
|
PE20130588A1
(es)
|
2007-02-02 |
2013-05-21 |
Amgen Inc |
Hepcidina, antagonistas de la hepcidina y metodos de uso
|
US20080220498A1
(en)
*
|
2007-03-06 |
2008-09-11 |
Cervin Marguerite A |
Variant Buttiauxella sp. phytases having altered properties
|
US8143046B2
(en)
*
|
2007-02-07 |
2012-03-27 |
Danisco Us Inc., Genencor Division |
Variant Buttiauxella sp. phytases having altered properties
|
KR100855299B1
(ko)
*
|
2007-02-16 |
2008-08-29 |
건국대학교 산학협력단 |
인간 il-32 특이 항원결정기를 갖는 단일클론항체,특이항체분비 융합 세포주 및 항체들을 이용한 il-32측정법
|
JP2008203195A
(ja)
*
|
2007-02-22 |
2008-09-04 |
Japan Science & Technology Agency |
Bshの免疫測定用キットおよびbshの測定方法
|
DK2426144T3
(en)
|
2007-02-23 |
2019-01-07 |
Merck Sharp & Dohme |
Manipulated Anti-IL-23P19 Antibodies
|
SG178804A1
(en)
|
2007-02-23 |
2012-03-29 |
Schering Corp |
Engineered anti-il-23p19 antibodies
|
ES2662036T3
(es)
|
2007-02-28 |
2018-04-05 |
Yeda Research And Development Company Limited |
Secuencias que se dirigen al núcleo
|
US20100105071A1
(en)
*
|
2007-02-28 |
2010-04-29 |
Children's Medical Center Corporation |
Methods for predicting the onset of menarche
|
BRPI0807991A2
(pt)
|
2007-02-28 |
2014-06-17 |
Schering Corp |
Anticorpos anti-il-23r elaborados.
|
US20100015156A1
(en)
*
|
2007-03-06 |
2010-01-21 |
Cedars-Sinai Medical Center |
Diagnosis of inflammatory bowel disease in children
|
WO2008110006A1
(en)
|
2007-03-12 |
2008-09-18 |
Miraculins Inc. |
Biomarkers of prostate cancer and uses thereof
|
WO2008116150A2
(en)
|
2007-03-21 |
2008-09-25 |
Cedars-Sinai Medical Center |
Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease
|
EP2514766A3
(en)
|
2007-03-29 |
2013-06-05 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
EP2532746A3
(en)
|
2007-03-30 |
2013-08-14 |
EnGeneIC Molecular Delivery Pty Ltd. |
Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
|
KR20100015774A
(ko)
|
2007-04-02 |
2010-02-12 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
암세포 검출 방법 및 그 질병의 진단 및 그 질병의 치료의 모니터링을 위한 상기 방법의 용도
|
EP2132333B1
(en)
|
2007-04-06 |
2011-11-23 |
Becton, Dickinson and Company |
Compositions and methods for the identification of a carbapenemase gene
|
MX355608B
(es)
|
2007-04-09 |
2018-04-24 |
Evogene Ltd |
Polinucleotidos, polipeptidos y metodos para aumentar el contenido de aceite, la velocidad de crecimiento y biomasa de las plantas.
|
CA2683804A1
(en)
*
|
2007-04-13 |
2008-10-23 |
Dana Farber Cancer Institute, Inc. |
Receptor tyrosine kinase profiling
|
CA2683559C
(en)
|
2007-04-13 |
2019-09-24 |
Dana Farber Cancer Institute, Inc. |
Methods for treating cancer resistant to erbb therapeutics
|
US8003314B2
(en)
|
2007-04-16 |
2011-08-23 |
Diagnostic Hybrids, Inc. |
Methods for direct fluorescent antibody virus detection in liquids
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2008129548A2
(en)
*
|
2007-04-23 |
2008-10-30 |
Segev Laboratories Limited |
A system for delivering therapeutic agents into living cells and cells nuclei
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
EP2152905B1
(en)
|
2007-05-01 |
2015-12-02 |
Tel Hashomer Medical Research Infrastructure and Services Ltd. |
Methods and kits for detecting fetal cells in the maternal blood
|
AU2008247819B2
(en)
|
2007-05-01 |
2013-02-14 |
Research Development Foundation |
Immunoglobulin Fc libraries
|
WO2009009215A2
(en)
*
|
2007-05-02 |
2009-01-15 |
Emory University |
Enhancement of glycoprotein incorporation into virus-like particles
|
DK3360571T3
(da)
|
2007-05-03 |
2021-01-04 |
Agency For Science Tech And Research Astarstar |
Antistoffer, der binder til et intracellulært PRL-1- eller PRL-3-polypeptid
|
ES2660667T3
(es)
|
2007-05-07 |
2018-03-23 |
Protalix Ltd. |
Biorreactor desechable a gran escala
|
WO2008150496A2
(en)
*
|
2007-05-31 |
2008-12-11 |
Genelux Corporation |
Assay for sensitivity to chemotherapeutic agents
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
WO2009000089A1
(en)
*
|
2007-06-28 |
2008-12-31 |
University Of Saskatchewan |
Immunomodulatory compositions and methods for treating disease with modified host defense peptides
|
WO2009009662A1
(en)
*
|
2007-07-10 |
2009-01-15 |
University Of South Florida |
Method of predicting non-response to first line chemotherapy
|
WO2009007980A1
(en)
|
2007-07-11 |
2009-01-15 |
Yeda Research And Development Co. Ltd. |
Nucleic acid construct systems capable of diagnosing or treating a cell state
|
ES2383568T3
(es)
|
2007-07-12 |
2012-06-22 |
Chemocentryx, Inc. |
Heteroaril piridil y fenil bencenosulfonamidas condensadas como moduladores de CCR2 para el tratamiento de la inflamación
|
AU2008277257B2
(en)
|
2007-07-15 |
2014-03-06 |
Hillman, Yitzchak Mr |
Disease treatment via antimicrobial peptides or their inhibitors
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
BR122020022199B1
(pt)
|
2007-07-24 |
2021-08-10 |
Evogene Ltd |
Método de aumento da tolerância de uma planta ao estresse abiótico, da biomassa e/ou produtividade de uma planta, e, construção de ácido nucleico isolado
|
WO2009014726A1
(en)
|
2007-07-26 |
2009-01-29 |
The Regents Of The University Of California |
Methods for enhancing bacterial cell display of proteins and peptides
|
EP2537529B1
(en)
|
2007-08-02 |
2018-10-17 |
Gilead Biologics, Inc. |
Loxl2 inhibitory antibodies and uses thereof
|
CN101821284B
(zh)
|
2007-08-03 |
2014-11-19 |
贝林格尔·英格海姆维特梅迪卡有限公司 |
猪痢疾短螺旋体的基因和蛋白质及其用途
|
JP5797403B2
(ja)
|
2007-08-03 |
2015-10-21 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
ヒトモノクローナル抗体およびそれを産生する方法
|
US8420315B2
(en)
|
2007-08-06 |
2013-04-16 |
Orion Genomics Llc |
Single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene
|
US20120028880A1
(en)
|
2007-08-08 |
2012-02-02 |
Renata Pasqualini |
Vegfr-1/nrp-1 targeting peptides
|
WO2009023676A1
(en)
|
2007-08-12 |
2009-02-19 |
Integrated Dna Technologies, Inc. |
Microarray system with improved sequence specificity
|
WO2009023733A1
(en)
*
|
2007-08-13 |
2009-02-19 |
Trustees Of Tufts College |
Methods and microarrays for detecting enteric viruses
|
CA2695969A1
(en)
|
2007-08-15 |
2009-02-19 |
Yeda Research & Development Co. Ltd. |
Regulators of mmp-9 and uses therof
|
AU2008299318A1
(en)
|
2007-09-12 |
2009-03-19 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Methods of treating tumors in immune-privileged sites
|
US20090068669A1
(en)
*
|
2007-09-12 |
2009-03-12 |
Elias Georges |
Slc9a3r1 directed diagnostics for neoplastic disease
|
EP2591789B2
(en)
|
2007-09-19 |
2022-07-20 |
Pluristem Ltd. |
Adherent cells from adipose or placenta tissues and use thereof in therapy
|
EP3136103B1
(en)
|
2007-10-05 |
2018-08-29 |
Affymetrix, Inc. |
Highly multiplexed assays
|
US8088735B2
(en)
|
2007-10-19 |
2012-01-03 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
|
WO2009069123A2
(en)
|
2007-11-26 |
2009-06-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions comprising fibrous polypeptides and polysaccharides
|
ES2535419T3
(es)
|
2007-12-27 |
2015-05-11 |
Protiva Biotherapeutics Inc. |
Silenciamiento de expresión de quinasa tipo polo usando ARN interferente
|
CA2709517C
(en)
|
2007-12-27 |
2019-02-26 |
Evogene Ltd. |
Isolated polypeptides, polynucleotides useful for modifying water use efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
|
BRPI0906429B1
(pt)
|
2008-01-10 |
2021-08-03 |
Research Development Foundation |
Método de identificação de uma infecção por e. chaffeensis em um indivíduo, uso de um ou mais polipeptídeo sintético e kit
|
EP2574628B1
(en)
|
2008-01-25 |
2015-05-20 |
Amgen Inc. |
Ferroportin antibodies and methods of use
|
US20090233295A1
(en)
*
|
2008-01-29 |
2009-09-17 |
Elias Georges |
Trim59 directed diagnostics for neoplastic disease
|
US20110052501A1
(en)
*
|
2008-01-31 |
2011-03-03 |
Liat Dassa |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
CN101939019B
(zh)
|
2008-02-07 |
2014-07-16 |
康奈尔大学 |
用于预防或治疗胰岛素抵抗性的方法
|
JO2913B1
(en)
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
|
WO2009103113A1
(en)
|
2008-02-20 |
2009-08-27 |
G2 Inflammation Pty Ltd |
HUMANIZED ANTI-C5aR ANTIBODIES
|
US9469919B2
(en)
|
2008-02-21 |
2016-10-18 |
Technion Research & Development Foundation Ltd. |
Method of attaching a cell-of-interest to a microtube
|
EP2363407A1
(en)
|
2008-02-28 |
2011-09-07 |
Murdoch University |
Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
|
US20090311695A1
(en)
*
|
2008-03-12 |
2009-12-17 |
Talat Nasim |
Method
|
WO2009117773A1
(en)
|
2008-03-27 |
2009-10-01 |
Murdoch University |
Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
|
CA2719718C
(en)
|
2008-03-28 |
2019-07-02 |
Mitomics, Inc. |
Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor
|
EP2107125A1
(en)
|
2008-03-31 |
2009-10-07 |
Eppendorf Array Technologies SA (EAT) |
Real-time PCR of targets on a micro-array
|
EP2280731A1
(en)
*
|
2008-04-09 |
2011-02-09 |
Technion Research and Development Foundation, Ltd. |
Anti human immunodeficiency antibodies and uses thereof
|
US20110033473A1
(en)
*
|
2008-04-09 |
2011-02-10 |
Yoram Reiter |
Anti influenza antibodies and uses thereof
|
EP2508325A3
(en)
*
|
2008-04-10 |
2013-05-22 |
Objet Ltd. |
System and method for three dimensional model printing
|
JP5475753B2
(ja)
|
2008-04-15 |
2014-04-16 |
プロチバ バイオセラピューティクス インコーポレイティッド |
核酸送達用の脂質製剤
|
CA2721380A1
(en)
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Silencing of csn5 gene expression using interfering rna
|
PL2288376T3
(pl)
|
2008-04-18 |
2016-07-29 |
Collplant Ltd |
Sposoby generowania i wykorzystywania prokolagenu
|
GB0807161D0
(en)
*
|
2008-04-18 |
2008-05-21 |
Danisco |
Process
|
AU2009239333A1
(en)
|
2008-04-21 |
2009-10-29 |
Danziger Innovations Ltd. |
Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
|
EP2274592A4
(en)
*
|
2008-04-23 |
2011-09-07 |
Luminex Corp |
METHOD OF GENERATING A STANDARD FOR SEVERAL ANALYTS APPLIED IN AN ORIGINAL BIOLOGICAL ORIGINATING MATERIAL
|
CN102066579A
(zh)
*
|
2008-04-24 |
2011-05-18 |
纽约市哥伦比亚大学理事会 |
用于dna分子编排的几何图案和脂质双层以及它们的用途
|
DK2281034T3
(en)
|
2008-04-30 |
2016-01-25 |
Dupont Nutrition Biosci Aps |
A method using alcohol dehydrogenase Pseudoglucanobacter saccharoketogenes
|
EP2294087B1
(en)
|
2008-05-01 |
2014-05-14 |
Amgen, Inc. |
Anti-hepcidin antibodies and methods of use
|
JP2010043063A
(ja)
|
2008-05-09 |
2010-02-25 |
Agency For Science Technology & Research |
川崎病の診断及び治療
|
BRPI0822661A2
(pt)
*
|
2008-05-22 |
2015-06-30 |
Centre Nat Rech Scient |
Compostos oticamente puros para eficiência terapêutica melhorada
|
MX2010012697A
(es)
|
2008-05-22 |
2011-03-15 |
Evogene Ltd |
Polinucleotidos y polipeptidos aislados y metodos para usarlos para incrementar el rendimiento de plantas, biomasa, velocidad de crecimiento, vigor, contenido de aceite, tolerancia al estres abiotico de las plantas y eficiencia de uso de nitrogeno.
|
BRPI0909541A2
(pt)
|
2008-05-27 |
2016-10-11 |
Pluristem Ltd |
''método para tratamento de doenças inflamatórias do cólon''
|
US8663987B2
(en)
|
2008-05-28 |
2014-03-04 |
Ramot At Tel-Aviv University Ltd. |
Mesenchymal stem cells for the treatment of CNS diseases
|
WO2009152102A2
(en)
*
|
2008-06-10 |
2009-12-17 |
The Regents Of The University Of California |
Pro-fluorescent probes
|
US9952211B2
(en)
|
2008-06-29 |
2018-04-24 |
Realbio Technologies Ltd. |
Liquid-transfer device particularly useful as a capturing device in a biological assay process
|
US20120122800A1
(en)
|
2008-08-08 |
2012-05-17 |
Genisphere, LLC Hatfield, Pennsylvania |
Long-Acting DNA Dendrimers and Methods Thereof
|
US9580513B2
(en)
|
2008-08-08 |
2017-02-28 |
Agency For Science, Technology And Research (A*Star) |
VHZ for diagnosis and treatment of cancers
|
AR073076A1
(es)
|
2008-08-18 |
2010-10-13 |
Evogene Ltd |
Polipeptidos y polinucleotidos aislados utiles para mejorar la eficacia en el uso de nitrogeno, tolerancia al estres abiotico, rendimiento y biomasa en plantas.
|
CN105708862B
(zh)
|
2008-09-02 |
2020-11-06 |
普拉里斯坦有限公司 |
来自胎盘组织的粘附细胞及其在治疗中的用途
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
WO2010029545A2
(en)
|
2008-09-11 |
2010-03-18 |
Ben Gurion University Of The Negev Research And Development Authority |
Compositions and methods for treating s. pneumoniae infection
|
WO2010031006A1
(en)
|
2008-09-12 |
2010-03-18 |
Cryopraxis Criobiologia Ltda. |
Ischemic tissue cell therapy
|
SG10201504623VA
(en)
|
2008-09-24 |
2015-07-30 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
WO2010036323A1
(en)
|
2008-09-25 |
2010-04-01 |
University Of Massachusetts Medical School |
Method of identifing interactions between genomic loci
|
EP2342356A4
(en)
|
2008-09-29 |
2012-11-21 |
Univ Ben Gurion |
AMYLOID BETA PEPTIDASES AND METHOD OF USE THEREOF
|
US9207242B2
(en)
|
2008-10-09 |
2015-12-08 |
The University Of Hong Kong |
Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
|
MX345298B
(es)
|
2008-10-30 |
2017-01-24 |
Evogene Ltd |
Polinucleótidos y polipéptidos aislados y métodos para utilizarlos para aumentar el rendimiento de la planta, biomasa, tasa de crecimiento, vigor, contenido de aceite, tolerancia al estrés abiótico de las plantas y eficacia en el uso de nitrógeno.
|
AU2009313255B2
(en)
|
2008-11-07 |
2014-08-07 |
Research Development Foundation |
Compositions and methods for the inhibition of Cripto/GRP78 complex formation and signaling
|
WO2010055525A1
(en)
|
2008-11-17 |
2010-05-20 |
Technion Research & Development Foundation Ltd. |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(en)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A cd44vra antibody and diagnostic and therapeutic methods using same
|
WO2010061383A1
(en)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
A method of in-situ enrichment of foods with fructan
|
WO2010062960A2
(en)
|
2008-11-26 |
2010-06-03 |
Cedars-Sinai Medical Center |
METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
|
WO2010064231A1
(en)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
|
US20110287088A1
(en)
|
2008-12-03 |
2011-11-24 |
Research Development Foundation |
Modulation of olfml-3 mediated angiogenesis
|
US20120014927A1
(en)
|
2008-12-03 |
2012-01-19 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
EP2633854B1
(en)
|
2008-12-05 |
2015-09-16 |
Yeda Research And Development Co. Ltd. |
miRNA-9 or miRNA-9* for use in treating ALS
|
JP2012511032A
(ja)
|
2008-12-05 |
2012-05-17 |
アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー |
SPARC結合ScFv
|
EP2373997A1
(en)
|
2008-12-09 |
2011-10-12 |
Dako Denmark A/S |
Method for evaluating pre-treatment
|
WO2010068757A1
(en)
|
2008-12-12 |
2010-06-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods useful for detecting and treating diseases associated with 16p chromosomal disruptions
|
WO2010071610A1
(en)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Severe chikungunya biomarkers
|
US9580752B2
(en)
|
2008-12-24 |
2017-02-28 |
Cedars-Sinai Medical Center |
Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
|
EP2808402A3
(en)
|
2008-12-29 |
2015-03-25 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Methods of predicting responsiveness to interferon treatment
|
DK2376528T3
(en)
|
2008-12-29 |
2015-01-05 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
PEPTIDES AND COMPOSITIONS FOR PREVENTING cell adhesion, and methods of use thereof
|
AR074925A1
(es)
|
2008-12-29 |
2011-02-23 |
Evogene Ltd |
Polinucleotidos, polipeptidos codificados, y metodos para utilizarlos para modular la tolerancia al estres abiotico, biomasa y/o rendimiento en plantas que los expresan
|
WO2010076794A1
(en)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Method of denitrifying brine and systems capable of same
|
US9107935B2
(en)
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
US8691760B2
(en)
|
2009-02-02 |
2014-04-08 |
Ramot At Tel-Aviv University |
Peptides, pharmaceutical compositions comprising same and uses thereof
|
WO2010089707A1
(en)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
|
EP2396661A4
(en)
|
2009-02-11 |
2013-10-30 |
Caris Mpi Inc |
MOLECULAR PROFILING OF TUMORS
|
WO2010093450A2
(en)
|
2009-02-11 |
2010-08-19 |
Ludwing Institute For Cancer Research Ltd. |
Pten phosphorylation-driven resistance to cancer treatment and altered patient prognosis
|
EP2396429B1
(en)
|
2009-02-11 |
2015-05-27 |
Orion Genomics, LLC |
Combinations of polymorphisms for determining allele-specific expression of igf2
|
WO2010096658A1
(en)
|
2009-02-19 |
2010-08-26 |
The Cleveland Clinic Foundation |
Corin as a marker for heart failure
|
EP2465920B1
(en)
|
2009-02-26 |
2017-04-12 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Isolated populations of renal stem cells and methods of isolating and using same
|
AU2010220157C1
(en)
|
2009-03-02 |
2015-08-06 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
|
HUE028729T2
(en)
|
2009-03-09 |
2017-01-30 |
Ramot At Tel-Aviv Univ Ltd |
Compositions for the prevention and treatment of neurodegenerative diseases
|
WO2010103517A1
(en)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Soluble compositions for the treatment of cxcr3-ligand associated diseases
|
US20100240065A1
(en)
*
|
2009-03-18 |
2010-09-23 |
Boehringer Ingelheim International Gmbh |
Prolyl Hydroxylase Compositions and Methods of Use Thereof
|
US8481698B2
(en)
*
|
2009-03-19 |
2013-07-09 |
The President And Fellows Of Harvard College |
Parallel proximity ligation event analysis
|
TW201039841A
(en)
*
|
2009-03-27 |
2010-11-16 |
Gojo Ind Inc |
Compositions and methods for screening and using compounds antagonizing spore-surface interactions
|
EP2411522B1
(en)
|
2009-03-27 |
2017-09-06 |
MDNA Life Sciences Inc. |
Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor
|
EP2414542B1
(en)
|
2009-03-30 |
2017-08-30 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Methods of predicting clinical course and treating multiple sclerosis
|
EP2344179A1
(en)
|
2009-04-01 |
2011-07-20 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
A method of regulating proliferation and differentiation of keratinocyes
|
WO2010116375A1
(en)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Isolated peptides for regulating apoptosis
|
CA2795268A1
(en)
|
2009-04-21 |
2010-10-28 |
Genetic Technologies Limited |
Methods for obtaining fetal genetic material
|
GB0908770D0
(en)
|
2009-04-24 |
2009-07-01 |
Danisco |
Method
|
PL2424896T3
(pl)
|
2009-04-30 |
2016-03-31 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Przeciwciała anty-ceacam1 oraz sposoby ich stosowania
|
WO2010124689A1
(en)
|
2009-05-01 |
2010-11-04 |
Dako Denmark A/S |
New antibody cocktail
|
CN102460174B
(zh)
|
2009-05-14 |
2016-03-16 |
牛津大学之校长及学者 |
使用一组新型低丰度人类血浆蛋白生物标记对肝纤维化进行临床诊断
|
CA2761767A1
(en)
|
2009-05-19 |
2010-11-25 |
Danisco A/S |
Use of amylase and lipolytic enzyme in bread
|
WO2010134073A1
(en)
|
2009-05-19 |
2010-11-25 |
Zetiq Technologies Ltd. |
Kits for and methods of differential staining of cervical cancer cells and/or tissues
|
EP2432499A2
(en)
|
2009-05-20 |
2012-03-28 |
Schering Corporation |
Modulation of pilr receptors to treat microbial infections
|
WO2010137013A1
(en)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Crystallized photosystem i units from the pea plant and their use in solid state devices
|
WO2010137021A2
(en)
|
2009-05-27 |
2010-12-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
CN102639146A
(zh)
|
2009-05-27 |
2012-08-15 |
耶达研究及发展有限公司 |
蛋白酶体抑制剂及其用途
|
EP2435078A1
(en)
|
2009-05-28 |
2012-04-04 |
Yeda Research and Development Co. Ltd. |
Methods of treating inflammation
|
KR20120122869A
(ko)
|
2009-06-02 |
2012-11-07 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
신경변성 질환을 갖는 대상에서 항체에 의해 인식되는 소분자의 확인법
|
CA3095630A1
(en)
|
2009-06-10 |
2010-12-16 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
|
EP2446267A1
(en)
|
2009-06-24 |
2012-05-02 |
Health Corporation - Rambam |
Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
|
JP2012531197A
(ja)
|
2009-06-25 |
2012-12-10 |
デュポン ニュートリション バイオサイエンシーズ エーピーエス |
タンパク質
|
CN102725410B
(zh)
|
2009-06-29 |
2016-03-16 |
西澳大学 |
来自檀香属的萜烯合酶
|
ES2613498T3
(es)
|
2009-07-01 |
2017-05-24 |
Protiva Biotherapeutics Inc. |
Nuevas formulaciones de lípidos para el suministro de agentes terapéuticos a tumores sólidos
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(en)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions and methods for treating cancer
|
JP6193570B2
(ja)
|
2009-07-17 |
2017-09-13 |
バイオアトラ、エルエルシー |
産生宿主における抗体/タンパク質パフォーマンス及び発現の同時で統合された選択及び進化
|
WO2011011447A1
(en)
|
2009-07-20 |
2011-01-27 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing ebola virus gene expression
|
EP2457089B1
(en)
|
2009-07-21 |
2019-08-07 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
A method of diagnosing cancer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
EP2467470A2
(en)
|
2009-08-17 |
2012-06-27 |
Technion Research & Development Foundation Ltd. |
Pericyte progenitor cells and methods of generating and using same
|
SG178845A1
(en)
|
2009-08-21 |
2012-04-27 |
Gilead Biologics Inc |
Catalytic domains from lysyl oxidase and loxl2
|
WO2011021171A1
(en)
|
2009-08-21 |
2011-02-24 |
Beeologics, Llc |
Preventing and curing beneficial insect diseases via plant transcribed molecules
|
CN102596179A
(zh)
|
2009-08-27 |
2012-07-18 |
工业研究与发展基金会有限公司 |
脂质体组合物及其用途
|
RU2595409C2
(ru)
|
2009-09-03 |
2016-08-27 |
Мерк Шарп И Доум Корп., |
Анти-gitr-антитела
|
EP2475784A1
(en)
|
2009-09-08 |
2012-07-18 |
Ramot at Tel-Aviv University Ltd. |
Methods of diagnosing amyotrophic lateral sclerosis (als)
|
EP2475381A2
(en)
|
2009-09-08 |
2012-07-18 |
Yeda Research and Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
US20120171213A1
(en)
|
2009-09-10 |
2012-07-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating tumors
|
US20120244185A1
(en)
|
2009-09-16 |
2012-09-27 |
Vaxart ,Inc. |
Immunization strategy to prevent h1n1 infection
|
CN102498127B
(zh)
|
2009-09-17 |
2015-02-25 |
雷蒙特亚特特拉维夫大学有限公司 |
用于治疗氧化应激相关障碍的肽类
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
EP2478093A2
(en)
|
2009-09-17 |
2012-07-25 |
Yeda Research and Development Co. Ltd. |
Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
CA2775092A1
(en)
|
2009-09-23 |
2011-03-31 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing genes expressed in cancer
|
WO2011038403A1
(en)
|
2009-09-28 |
2011-03-31 |
Yuling Luo |
Methods of detecting nucleic acid sequences with high specificity
|
US20110076232A1
(en)
|
2009-09-29 |
2011-03-31 |
Ludwig Institute For Cancer Research |
Specific binding proteins and uses thereof
|
WO2011040973A2
(en)
|
2009-10-02 |
2011-04-07 |
Ludwig Institute For Cancer Research Ltd. |
Tnf-immunoconjugates with fibroblast activation protein antibodies and methods and uses thereof
|
EP2483316A1
(en)
|
2009-10-02 |
2012-08-08 |
Ludwig Institute for Cancer Research Ltd. |
Anti-fibroblast activation protein antibodies and methods and uses thereof
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
CA2777053A1
(en)
|
2009-10-06 |
2011-04-14 |
The Board Of Trustees Of The University Of Illinois |
Human single-chain t cell receptors
|
US9377458B2
(en)
|
2009-10-11 |
2016-06-28 |
Biogen Ma Inc. |
Anti-VLA-4 related assays
|
CN105368836A
(zh)
|
2009-10-14 |
2016-03-02 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
用于控制蜂中的瓦螨的组合物
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
CA2777663A1
(en)
|
2009-10-16 |
2011-04-21 |
University Of Medicine And Dentistry Of New Jersey |
Method for treating chronic nerve tissue injury using a cell therapy strategy
|
WO2011048600A1
(en)
|
2009-10-21 |
2011-04-28 |
Danziger Innovations Ltd. |
Generating genotypic variations in plant genomes by gamete infection
|
US20160186266A1
(en)
|
2009-10-27 |
2016-06-30 |
Carislife Sciences, Inc. |
Molecular profiling for personalized medicine
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
CA2783437C
(en)
|
2009-11-12 |
2020-08-04 |
Technion Research & Development Foundation Ltd. |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
WO2011058555A1
(en)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
A method of editing dna in a cell and constructs capable of same
|
EP2498806B1
(en)
|
2009-11-12 |
2014-12-31 |
Ramot at Tel-Aviv University Ltd. |
Compositions comprising pedf and uses of same in the treatment and prevention of ovary-related syndromes
|
GB0920089D0
(en)
|
2009-11-17 |
2009-12-30 |
Danisco |
Method
|
WO2011061736A1
(en)
|
2009-11-17 |
2011-05-26 |
Protalix Ltd. |
Alkaline alpha galactosidase for the treatment of fabry disease
|
CN102770529B
(zh)
|
2009-11-17 |
2018-06-05 |
Musc研究发展基金会 |
针对人核仁素的人单克隆抗体
|
US8592151B2
(en)
*
|
2009-11-17 |
2013-11-26 |
Musc Foundation For Research Development |
Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids
|
US9910040B2
(en)
|
2012-07-09 |
2018-03-06 |
Sevident, Inc. |
Molecular nets comprising capture agents and linking agents
|
US20120273993A1
(en)
|
2009-11-24 |
2012-11-01 |
Collplant Ltd. |
Method of generating collagen fibers
|
US9733242B2
(en)
|
2012-10-07 |
2017-08-15 |
Sevident, Inc. |
Devices for capturing analyte
|
ES2553712T3
(es)
|
2009-11-30 |
2015-12-11 |
Pluristem Ltd. |
Células adherentes de la placenta y uso de las mismas en el tratamiento de enfermedad
|
US8652788B2
(en)
*
|
2009-12-02 |
2014-02-18 |
Abbott Laboratories |
Assay for diagnosis of cardiac myocyte damage
|
US8835120B2
(en)
*
|
2009-12-02 |
2014-09-16 |
Abbott Laboratories |
Assay for cardiac troponin-T (cTnT)
|
US20110136141A1
(en)
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Peptide reagents and method for inhibiting autoantibody antigen binding
|
US8183002B2
(en)
|
2009-12-03 |
2012-05-22 |
Abbott Laboratories |
Autoantibody enhanced immunoassays and kits
|
WO2011067745A2
(en)
|
2009-12-06 |
2011-06-09 |
Rosetta Green Ltd. |
Compositions and methods for enhancing plants resistance to abiotic stress
|
EP2510098B1
(en)
|
2009-12-09 |
2015-02-11 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the cns
|
WO2011084357A1
(en)
|
2009-12-17 |
2011-07-14 |
Schering Corporation |
Modulation of pilr to treat immune disorders
|
GB0922377D0
(en)
|
2009-12-22 |
2010-02-03 |
Arab Gulf University The |
Mutant LDL receptor
|
CA3172119A1
(en)
|
2009-12-28 |
2011-07-07 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
CN107254439B
(zh)
|
2009-12-29 |
2022-01-11 |
加米达细胞有限公司 |
增强自然杀伤细胞增殖和活性的方法
|
WO2011084882A2
(en)
|
2010-01-05 |
2011-07-14 |
Contrafect Corporation |
Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
|
CA2786374C
(en)
|
2010-01-05 |
2019-01-22 |
Vascular Biogenics Ltd. |
Methods for use of a specific anti-angiogenic adenoviral agent
|
US11287423B2
(en)
|
2010-01-11 |
2022-03-29 |
Biogen Ma Inc. |
Assay for JC virus antibodies
|
FI3339865T5
(fi)
|
2010-01-11 |
2023-04-15 |
|
Jc-viruksen vasta-aineiden määritys
|
SG10201500015TA
(en)
|
2010-01-12 |
2015-02-27 |
Vascular Biogenics Ltd |
Methods of producing adenovirus vectors and viral preparations generated thereby
|
US8697078B2
(en)
|
2010-01-27 |
2014-04-15 |
Yeda Research And Development Co. Ltd. |
Antibodies that inhibit metalloproteins
|
ES2719502T3
(es)
|
2010-01-29 |
2019-07-10 |
Advanced Cell Diagnostics Inc |
Métodos de detección in situ de ácidos nucleicos
|
US8574832B2
(en)
|
2010-02-03 |
2013-11-05 |
Massachusetts Institute Of Technology |
Methods for preparing sequencing libraries
|
SG183174A1
(en)
|
2010-02-04 |
2012-09-27 |
Gilead Biologics Inc |
Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
|
TWI504410B
(zh)
|
2010-02-08 |
2015-10-21 |
Agensys Inc |
結合至161p2f10b蛋白之抗體藥物結合物(adc)
|
US9410131B2
(en)
|
2010-02-11 |
2016-08-09 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
WO2011104708A2
(en)
|
2010-02-24 |
2011-09-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
WO2011107939A1
(en)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
|
WO2011107994A1
(en)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Methods of measuring protein stability
|
EP2545176B1
(en)
|
2010-03-08 |
2016-05-11 |
Yeda Research and Development Co. Ltd. |
Recombinant protein production in heterologous systems
|
MY163887A
(en)
|
2010-03-08 |
2017-11-15 |
Monsanto Technology Llc |
Polynucleotide molecules for gene regulations in plants
|
WO2011111050A2
(en)
|
2010-03-11 |
2011-09-15 |
Jacob Edrei |
Methods of generating hydrogen
|
WO2011114251A1
(en)
|
2010-03-18 |
2011-09-22 |
Danisco A/S |
Foodstuff
|
EP2556085A2
(en)
|
2010-04-05 |
2013-02-13 |
Bar-Ilan University |
Protease-activatable pore-forming polypeptides
|
SG184466A1
(en)
|
2010-04-06 |
2012-11-29 |
Massachusetts Inst Technology |
Gene-expression profiling with reduced numbers of transcript measurements
|
US9125931B2
(en)
|
2010-04-06 |
2015-09-08 |
Massachusetts Institute Of Technology |
Post-transcriptional regulation of RNA-related processes using encoded protein-binding RNA aptamers
|
EP2557913B1
(en)
|
2010-04-12 |
2016-08-03 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransferase of a red microalga and uses thereof
|
US8927274B2
(en)
|
2010-04-12 |
2015-01-06 |
Technion Research & Development Foundation Limited |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
WO2011129382A1
(en)
|
2010-04-16 |
2011-10-20 |
Abbott Japan Co. Ltd. |
Methods and reagents for diagnosing rheumatoid arthritis
|
RU2012148398A
(ru)
|
2010-04-18 |
2014-05-27 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
МОЛЕКУЛЫ И СПОСОБЫ ПРИМЕНЕНИЯ МОЛЕКУЛ ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНЕЙ, АССОЦИИРОВАННЫХ С ErbB/ErbB ЛИГАНДАМИ
|
AU2011246876B2
(en)
|
2010-04-28 |
2016-06-23 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
|
US20130053277A1
(en)
|
2010-05-04 |
2013-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
EP2566500B1
(en)
|
2010-05-05 |
2017-04-12 |
Rappaport Family Institute for Research in the Medical Sciences |
Ccl1 for use in therapy
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
US20120190563A1
(en)
|
2010-05-07 |
2012-07-26 |
Abbott Laboratories |
Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
|
MX2012012986A
(es)
|
2010-05-07 |
2013-03-05 |
Abbvie Inc |
Metodos para predecir la sensibilidad al tratamiento con un inhibidor de cinasa de tirosina dirigido.
|
EP2569417B1
(en)
|
2010-05-13 |
2018-04-18 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Isolated populations of adult renal cells and methods of isolating and using same
|
EP2572197A4
(en)
|
2010-05-18 |
2013-08-28 |
Texas A & M Univ Sys |
METHOD AND COMPOSITION FOR DIAGNOSING AND MONITORING INFLAMMATORY DISEASES
|
EP2808344A1
(en)
|
2010-06-01 |
2014-12-03 |
Monash University |
Antibodies directed to the receptor tyrosine kinase c-Met
|
EP2575859B1
(en)
|
2010-06-03 |
2018-09-19 |
Ramot at Tel Aviv University, Ltd. |
Methods of treating diabetes and compositions capable of same
|
KR20130123357A
(ko)
|
2010-06-07 |
2013-11-12 |
오스나트 에슈어-파비안 |
저산소증과 관련된 질환의 진단방법 및 키트
|
BR112012032126A2
(pt)
|
2010-06-16 |
2017-10-17 |
Futuragene Israel Ltd Empresa Isralense |
polinucleotídeo isolado, estrutura de ácido nucléico, sistema de estrutura de ácido nucléico, polipeptídeo isolado, planta, composição inseticida, e método para controlar ou exterminar um inseto
|
EP2582842A2
(en)
|
2010-06-16 |
2013-04-24 |
Yissum Research Development Company of The Hebrew University of Jerusalem |
Method of diagnosing and treating cancer
|
US20130316338A1
(en)
|
2010-06-29 |
2013-11-28 |
The United States Government As Represented By The Department Of Veterans Affairs |
CCR6 As A Biomarker of Alzheimer's Disease
|
GB201011513D0
(en)
|
2010-07-08 |
2010-08-25 |
Danisco |
Method
|
EP2593468B1
(en)
|
2010-07-12 |
2020-06-10 |
The State of Israel, Ministry of Agriculture and Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center |
Isolated polynucleotides and methods and plants using same for regulating plant acidity
|
EP2407242A1
(en)
|
2010-07-13 |
2012-01-18 |
Dublin City University |
Direct clone analysis and selection technology
|
CN103108955B
(zh)
|
2010-07-15 |
2015-11-25 |
工业研究与发展基金会有限公司 |
用于提高植物中非生物胁迫耐受性的核酸构建体
|
EP2593480A2
(en)
|
2010-07-15 |
2013-05-22 |
Technion Research & Development Foundation Ltd. |
Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
|
US9695410B2
(en)
|
2010-07-15 |
2017-07-04 |
Technion Research & Development Foundation Limited |
Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides
|
DK3435087T3
(da)
|
2010-07-16 |
2023-11-27 |
Bioatla Inc |
Hidtil ukendte fremgangsmåder til proteinevolution
|
CN103153467A
(zh)
|
2010-07-16 |
2013-06-12 |
范德比尔特大学 |
用于提取、浓缩和检测分子物类的使用表面张力阀的低资源处理器
|
CA2804914A1
(en)
|
2010-07-22 |
2012-01-26 |
Nadir Askenasy |
Regulatory immune cells with enhanced targeted cell death effect
|
CA2806306A1
(en)
|
2010-07-23 |
2012-01-26 |
Luminex Corporation |
Co-coupling to control reactivity of reagents in immunoassays
|
US9120862B2
(en)
|
2010-07-26 |
2015-09-01 |
Abbott Laboratories |
Antibodies relating to PIVKA-II and uses thereof
|
US9144585B2
(en)
|
2010-07-27 |
2015-09-29 |
Technion Research & Development Foundation Limited |
Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
|
US20130130311A1
(en)
|
2010-07-27 |
2013-05-23 |
Yeda Research And Development Co., Ltd. |
Methods and systems for assessing clonality of cell cultures
|
WO2012014207A2
(en)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
|
US8901074B2
(en)
|
2010-08-04 |
2014-12-02 |
Ramot At Tel-Aviv University |
Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
|
US8956859B1
(en)
|
2010-08-13 |
2015-02-17 |
Aviex Technologies Llc |
Compositions and methods for determining successful immunization by one or more vaccines
|
SG187830A1
(en)
|
2010-08-22 |
2013-03-28 |
Univ Ramot |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(en)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of improving transplantation using sdf-1alpha
|
MX365161B
(es)
|
2010-08-30 |
2019-05-24 |
Evogene Ltd |
Polinucleótidos y polipéptidos aislados, y métodos para utilizarlos para aumentar la eficacia en el uso de nitrógeno, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o tolerancia al estrés abiótico.
|
WO2012032520A1
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
US10214722B2
(en)
|
2010-09-07 |
2019-02-26 |
Technion Research & Development Foundation Limited |
Methods for expanding and maintaining human pluripotent stem cells (PSCs) in an undifferentiated state in a single cell suspension culture
|
WO2012032510A1
(en)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Primers for amplifying dna and methods of selecting same
|
WO2012032519A2
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing parkinson's disease
|
EP2614083A2
(en)
|
2010-09-08 |
2013-07-17 |
Yeda Research and Development Co. Ltd |
An immunosuppressive drug combination for a stable and long term engraftment
|
MX357746B
(es)
|
2010-09-08 |
2018-07-23 |
Yeda Res And Development Co Ltd Star |
Uso de células t de memoria central anti-tercera parte para el tratamiento anti-leucemia/linfoma.
|
EP2616539A1
(en)
|
2010-09-15 |
2013-07-24 |
Ramot at Tel-Aviv University Ltd. |
Methods of expanding and redifferentiating islet beta cells
|
AU2011305696A1
(en)
|
2010-09-20 |
2013-05-02 |
Advanced Cell Diagnostics, Inc. |
Biomarkers for differentiating melanoma from benign nevus in the skin
|
US20130210901A1
(en)
|
2010-09-20 |
2013-08-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
KR102504750B1
(ko)
|
2010-09-29 |
2023-03-02 |
어젠시스 인코포레이티드 |
191p4d12 단백질에 결합하는 항체 약물 컨쥬게이트(adc)
|
AU2011311665A1
(en)
|
2010-10-04 |
2013-05-02 |
Centre National De La Recherche Scientifique (Cnrs) |
Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans
|
EP2441520A1
(en)
|
2010-10-12 |
2012-04-18 |
Eppendorf AG |
Real-time amplification and micro-array based detection of nucleic acid targets in a flow chip assay
|
US8951983B2
(en)
|
2010-10-17 |
2015-02-10 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for the treatment of insulin-associated medical conditions
|
WO2012052878A1
(en)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
|
ES2562821T3
(es)
|
2010-10-21 |
2016-03-08 |
Advanced Cell Diagnostics, Inc. |
Método ultrasensible para la detección in situ de ácidos nucleicos
|
US20130216603A1
(en)
|
2010-10-27 |
2013-08-22 |
Nanocyte (Israel) Ltd. |
Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
|
ES2688457T3
(es)
|
2010-10-28 |
2018-11-02 |
Yeda Research And Development Co. Ltd. |
Métodos de generación de anticuerpos contra metaloenzimas
|
US20130227724A1
(en)
|
2010-11-03 |
2013-08-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Transgenic plants with improved saccharification yields and methods of generating same
|
US9410132B2
(en)
|
2010-11-04 |
2016-08-09 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-CoA: diacylglycerol acyltransferase 1-like gene (PtDGAT1) and uses thereof
|
TW201225972A
(en)
|
2010-11-15 |
2012-07-01 |
Univ Ramot |
Dipeptide analogs for treating conditions associated with amyloid fibril formation
|
US10117895B2
(en)
|
2010-11-17 |
2018-11-06 |
Ben-Gurion University Of The Negev Research And Development Authority |
T-cell therapy to neurodegenerative diseases
|
US9574171B2
(en)
|
2010-12-02 |
2017-02-21 |
Technion Research & Development Foundation Ltd. |
Methods of generating corneal cells and cell populations comprising same
|
US20120183960A1
(en)
|
2010-12-07 |
2012-07-19 |
Enterologics, Inc. |
Method for identifying e. coli m-17
|
EP2652125B1
(en)
|
2010-12-15 |
2017-04-26 |
Kadimastem Ltd. |
Insulin producing cells derived from pluripotent stem cells
|
CA3095614A1
(en)
|
2010-12-22 |
2012-06-28 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing abiotic stress tolerance, yield, growth rate, vigor, biomass, oil content, and/or nitrogen use efficiency of plants
|
AR084358A1
(es)
|
2010-12-27 |
2013-05-08 |
Lilly Co Eli |
Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
|
BR112013016535A2
(pt)
|
2010-12-28 |
2016-09-20 |
Bio Fd&C Co Ltd |
extratos vegetais para o tratamento e prevenção de infecções
|
AU2011352207B2
(en)
|
2010-12-31 |
2016-03-03 |
Bioatla, Llc |
Comprehensive monoclonal antibody generation
|
EP3216878B1
(en)
|
2011-01-17 |
2019-04-03 |
Life Technologies Corporation |
Workflow for detection of ligands using nucleic acids
|
BR112013018516B1
(pt)
|
2011-01-20 |
2023-11-07 |
Protalix Ltd |
Construto de expressão de ácido nucleico, método de produção de uma proteína alfa-galactosidase humana recombinante, proteína alfagalactosidase humana, composição farmacêutica, e, uso de uma proteína alfagalactosidase humana ou de uma composição
|
US20120214152A1
(en)
|
2011-01-28 |
2012-08-23 |
Xiao-Jun Ma |
Rnascope® hpv assay for determining hpv status in head and neck cancers and cervical lesions
|
WO2012104851A1
(en)
|
2011-01-31 |
2012-08-09 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
US8658128B2
(en)
|
2011-02-03 |
2014-02-25 |
Pop Test Cortisol Llc |
System and method for diagnosis and treatment
|
EP2673299B1
(en)
|
2011-02-07 |
2017-05-10 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides
|
WO2012114339A1
(en)
|
2011-02-23 |
2012-08-30 |
Rappaport Family Institute For Research In The Medical Sciences |
High affinity molecules capable of binding a type a plexin receptor and uses of same
|
US9212258B2
(en)
|
2011-02-23 |
2015-12-15 |
The Board Of Trustees Of The University Of Illinois |
Amphiphilic dendron-coils, micelles thereof and uses
|
CN103597078B
(zh)
|
2011-03-02 |
2016-12-14 |
富途锐基尼以色列有限公司 |
具有功能失调的t3ss蛋白的抗菌性转基因植物
|
US9365828B2
(en)
|
2011-03-03 |
2016-06-14 |
Ramot At Tel-Aviv University Ltd. |
Genetically modified muscle cells which express neurotrophic factors
|
CA2829110C
(en)
|
2011-03-06 |
2019-01-15 |
Merck Serono S.A. |
Low fucose cell lines and uses thereof
|
EP2683835B1
(en)
|
2011-03-08 |
2017-01-11 |
King Abdullah University Of Science And Technology |
Molecular biomarker set for early detection of ovarian cancer
|
WO2012120518A1
(en)
|
2011-03-08 |
2012-09-13 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (pku)
|
AU2012229156A1
(en)
|
2011-03-11 |
2013-10-31 |
Board Of Regents Of The University Of Nebraska |
Biomarker for coronary artery disease
|
US20140086839A1
(en)
|
2011-03-17 |
2014-03-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Quinolone analogs for treating autoimmune diseases
|
JP2014510084A
(ja)
|
2011-03-17 |
2014-04-24 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド |
二重特異性および単一特異性の非対称な抗体ならびにそれらの作製方法
|
CA2830602A1
(en)
|
2011-03-22 |
2012-09-27 |
Thomas J. Fahey, Iii |
Distinguishing benign and malignant indeterminate thyroid lesions
|
EP2689008B1
(en)
|
2011-03-22 |
2017-09-27 |
Pluristem Ltd. |
Methods for treating radiation or chemical injury
|
CN103648517B
(zh)
|
2011-03-24 |
2016-04-20 |
纽瑞姆制药(1991)有限公司 |
神经保护肽
|
WO2012131680A2
(en)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating inflammation
|
US20140005070A1
(en)
|
2011-03-28 |
2014-01-02 |
Novartis Ag |
Markers associated with cyclin-dependent kinase inhibitors
|
SI2694106T1
(en)
|
2011-04-01 |
2018-04-30 |
Immunogen, Inc. |
Methods for increasing the effectiveness of treatment with FOLR1 receptor cancer
|
WO2012137202A1
(en)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
|
US9790262B2
(en)
|
2011-04-05 |
2017-10-17 |
Longevity Biotech, Inc. |
Compositions comprising glucagon analogs and methods of making and using the same
|
ES2627154T3
(es)
|
2011-04-06 |
2017-07-26 |
Ramot At Tel-Aviv University Ltd. |
Métodos de seguimiento y análisis de perfiles de actividad metabólica, usos diagnósticos y terapéuticos de los mismos
|
BR112013025811A2
(pt)
|
2011-04-08 |
2016-11-29 |
Danisco Us Inc |
"composição e método para remover uma mancha de base lipídica de uma superfície"
|
WO2012142164A1
(en)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
|
ES2768296T3
(es)
|
2011-04-15 |
2020-06-22 |
Pluristem Ltd |
Métodos y sistemas para recoger células
|
US9034322B2
(en)
|
2011-04-21 |
2015-05-19 |
The Rockefeller University |
Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
|
WO2012150598A2
(en)
|
2011-05-03 |
2012-11-08 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
US9192670B2
(en)
|
2011-05-04 |
2015-11-24 |
Ramot At Tel-Aviv University Ltd. |
Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
|
WO2012153333A1
(en)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Regeneration and repair of mesenchymal tissue using amelogenin
|
WO2012153336A2
(en)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Methods and device for lightening skin complexion
|
WO2012156976A1
(en)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of producing artemisinin in non-host plants and vectors for use in same
|
JP6457263B2
(ja)
|
2011-05-20 |
2019-01-23 |
オリゴメリックス インコーポレイテッド |
タウプロテアーゼ組成物および使用方法
|
JP2014515476A
(ja)
|
2011-05-20 |
2014-06-30 |
アボットジャパン株式会社 |
非特異的結合を減少させるためのイムノアッセイ方法及び試薬
|
WO2012160526A2
(en)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations of microorganism comprising particles and uses of same
|
CA2836503C
(en)
|
2011-05-23 |
2020-09-22 |
Yeda Research And Development Co. Ltd. |
Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
|
SG195190A1
(en)
|
2011-05-31 |
2013-12-30 |
Hutchison Biofilm Medical Solutions Ltd |
Dispersion and detachment of cell aggregates
|
EP3575792B1
(en)
|
2011-05-31 |
2022-11-30 |
Biogen MA Inc. |
Method of assessing risk of pml
|
US20140113376A1
(en)
|
2011-06-01 |
2014-04-24 |
Rotem Sorek |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
DK3798230T3
(en)
|
2011-06-06 |
2022-10-31 |
Novo Nordisk As |
Terapeutiske antistoffer
|
ES2670596T3
(es)
|
2011-06-14 |
2018-05-31 |
Yeda Research And Development Co. Ltd. |
Terapia de combinación para prevenir la formación del DCIS y la progresión hasta cáncer de mama
|
RU2014101662A
(ru)
|
2011-06-23 |
2015-07-27 |
Каиима Био Агритех Лтд. |
Мягкая пшеница, растения или их части с частично или полностью мультиплицированным геномом, гибриды и их продукты, а также способы их получения и применения
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
WO2013010170A1
(en)
|
2011-07-14 |
2013-01-17 |
Lovell Mark A |
Process for detection of alzheimer's disease from a serum sample
|
CA2842321C
(en)
|
2011-07-18 |
2022-05-03 |
President And Fellows Of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
CA2841722A1
(en)
|
2011-07-20 |
2013-01-24 |
Kaiima Bio Agritech Ltd. |
Maize plants having a partially or fully multiplied genome and uses thereof
|
US20130030452A1
(en)
|
2011-07-27 |
2013-01-31 |
Health Corporation - Rambam |
Devices for surgical applications
|
CA2844012C
(en)
|
2011-08-04 |
2021-03-16 |
Yeda Research And Development Co. Ltd. |
Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
|
AU2012294814A1
(en)
|
2011-08-05 |
2014-02-27 |
Research Development Foundation |
Improved methods and compositions for modulation of Olfml3 mediated angiogenesis
|
WO2013021389A2
(en)
|
2011-08-09 |
2013-02-14 |
Yeda Research And Development Co.Ltd. |
Downregulation of mir-7 for promotion of beta cell differentiation and insulin production
|
EP2741602A1
(en)
|
2011-08-14 |
2014-06-18 |
Kaiima Bio Agritech Ltd. |
Durum wheat plants having a partially or fully multiplied genome and uses thereof
|
JP6317670B2
(ja)
|
2011-08-15 |
2018-04-25 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
ブドウ球菌プロテインaに対する抗体に関連した組成物および方法
|
WO2013025479A1
(en)
|
2011-08-16 |
2013-02-21 |
Emory University |
Jaml specific binding agents, antibodies, and uses related thereto
|
EP2753367A4
(en)
|
2011-09-07 |
2015-10-14 |
Yeda Res & Dev |
OLFACTORY SIGNATURE AND ODORING MIXTURE THEREWITH
|
ES2657552T3
(es)
|
2011-09-08 |
2018-03-05 |
Yeda Research And Development Co. Ltd. |
Nuevos biomarcadores de riesgo para el cáncer de pulmón
|
SG11201400513PA
(en)
|
2011-09-08 |
2014-06-27 |
Yeda Res & Dev |
Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
|
BR112014005958A2
(pt)
|
2011-09-13 |
2020-10-13 |
Monsanto Technology Llc |
métodos e composições químicas agrícolas para controle de planta, método de redução de expressão de um gene accase em uma planta, cassete de expressão microbiana, método para fazer um polinucleotídeo, método de identificação de polinucleotídeos úteis na modulação de expressão do gene accase e composição herbicida
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2013040057A1
(en)
|
2011-09-13 |
2013-03-21 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
CA2848685A1
(en)
|
2011-09-13 |
2013-03-21 |
Monsanto Technology Llc |
Methods and compositions for weed control comprising topical application of a glutamine synthetase polynucleotide
|
UY34328A
(es)
|
2011-09-13 |
2013-04-30 |
Monsanto Technology Llc |
?composiciones y métodos para controlar malezas comprendiendo un polinucleótido y agente de transferencia, y que modulan protoporfirinógeno ix oxidasa?.
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US9840715B1
(en)
|
2011-09-13 |
2017-12-12 |
Monsanto Technology Llc |
Methods and compositions for delaying senescence and improving disease tolerance and yield in plants
|
US9920326B1
(en)
|
2011-09-14 |
2018-03-20 |
Monsanto Technology Llc |
Methods and compositions for increasing invertase activity in plants
|
US9249467B2
(en)
|
2011-09-16 |
2016-02-02 |
Steven Goodison |
Bladder cancer detection composition, kit and associated methods
|
EP2764093B1
(en)
|
2011-10-05 |
2018-04-18 |
The Rockefeller University |
Dimeric bacteriophage lysins
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
WO2013054320A1
(en)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
|
CN104011068A
(zh)
|
2011-10-21 |
2014-08-27 |
奥古雷克斯生命科学公司 |
衍生自瓜氨酸化的14-3-3的抗原及其在风湿性关节炎诊断中的用途
|
EP2771464B1
(en)
|
2011-10-27 |
2018-03-21 |
Yeda Research and Development Co. Ltd. |
Methods of treating cancer
|
WO2013064163A1
(en)
|
2011-11-01 |
2013-05-10 |
Academisch Medisch Centrum |
Methylation markers for colorectal cancer
|
MX356814B
(es)
|
2011-11-03 |
2018-06-13 |
Quark Pharmaceuticals Inc |
Métodos y composiciones para neuroprotección.
|
WO2013070821A1
(en)
|
2011-11-08 |
2013-05-16 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
US9736998B2
(en)
|
2011-11-23 |
2017-08-22 |
Danziger Dan Flower Farm |
Otomeria plants
|
US9617331B2
(en)
|
2011-11-27 |
2017-04-11 |
Yeda Research And Development Co. Ltd. |
Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
|
EP2788009B1
(en)
|
2011-12-08 |
2016-05-25 |
Yeda Research and Development Co. Ltd. |
Mammalian fetal pulmonary cells and therapeutic use of same
|
CA2859167C
(en)
|
2011-12-12 |
2021-03-16 |
Step Ahead Innovations, Inc. |
Submerged chemical indicator and holder
|
WO2013093921A1
(en)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Collagen coated synthetic polymer fibers
|
BR112014015959A8
(pt)
|
2011-12-22 |
2017-07-04 |
Yeda Res & Dev |
método para o tratamento de um indivíduo em necessidade de um enxerto de célula não singênico ou tecido, método para tratar um indivíduo que precisa de um transplante de célula hematopoiética imatura, método para induzir a tolerância específica do doador em um indivíduo que precisa de uma célula não singênica ou enxerto de tecido, e método para tratar um indivíduo que precisa de uma célula não singênica ou enxerto de tecido
|
CN105833925B
(zh)
|
2011-12-22 |
2018-11-13 |
瑞尔比奥技术有限公司 |
用于分析物测定的序贯侧向流动毛细管装置
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
WO2013098820A1
(en)
|
2011-12-28 |
2013-07-04 |
Kaiima Bio Agritech Ltd. |
Cultivated sorghum plant having a partially or fully multiplied genome and uses of same
|
EP2798081A1
(en)
|
2011-12-29 |
2014-11-05 |
Baylor Research Institute |
Biomarkers for kawasaki disease
|
US20150216998A1
(en)
|
2012-01-01 |
2015-08-06 |
Ramot At Tel-Aviv University Ltd. |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
WO2013112216A1
(en)
|
2012-01-24 |
2013-08-01 |
Cd Diagnostics, Llc |
System for detecting infection in synovial fluid
|
WO2013114363A2
(en)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Antimicrobial agents
|
US9603907B2
(en)
|
2012-02-01 |
2017-03-28 |
Protalix Ltd. |
Dry powder formulations of dNase I
|
WO2013118120A2
(en)
|
2012-02-06 |
2013-08-15 |
Rosetta Green Ltd. |
Isolated polynucleotides expressing or modulating micrornas or targets of same, transgenic plants comprising same and uses thereof in improving nitrogen use efficiency, abiotic stress tolerance, biomass, vigor or yield of a plant
|
WO2013121426A1
(en)
|
2012-02-13 |
2013-08-22 |
Gamida-Cell Ltd. |
Culturing of mesenchymal stem cells
|
HUE053068T2
(hu)
|
2012-02-14 |
2021-06-28 |
Opko Biologics Ltd |
Hosszú hatástartamú koagulációs faktorok és alkalmazásaik
|
BR112014021067A2
(pt)
|
2012-02-19 |
2018-10-30 |
Protalix Ltd |
formas unitárias de dosagem oral e usos das mesmas para o tratamento da doença de gaucher
|
WO2013124816A2
(en)
|
2012-02-22 |
2013-08-29 |
Brainstem Biotec Ltd. |
Generation of neural stem cells and motor neurons
|
EP3401393B1
(en)
|
2012-02-22 |
2020-02-19 |
Exostem Biotec Ltd |
Micrornas for the generation of astrocytes
|
US9352042B2
(en)
|
2012-02-24 |
2016-05-31 |
Protiva Biotherapeutics, Inc. |
Trialkyl cationic lipids and methods of use thereof
|
WO2013130811A1
(en)
|
2012-02-29 |
2013-09-06 |
Chemocentryx, Inc. |
Pyrazol-1-yl benzene sulfonamides as ccr9 antagonists
|
EP2833714A1
(en)
|
2012-03-01 |
2015-02-11 |
The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
|
EP3483184A1
(en)
|
2012-03-07 |
2019-05-15 |
Yeda Research and Development Co. Ltd |
Compositions for inhibition of quiescinsulfhydryl oxidase (qsox1) and uses of same
|
US9567392B2
(en)
|
2012-03-20 |
2017-02-14 |
Biogen Ma Inc. |
JCV neutralizing antibodies
|
WO2013140389A1
(en)
|
2012-03-22 |
2013-09-26 |
Ramot At Tel-Aviv University Ltd. |
Plif multimeric peptides and uses thereof
|
EP2830663B1
(en)
|
2012-03-30 |
2019-02-06 |
Sorrento Therapeutics Inc. |
Fully human antibodies that bind to vegfr2
|
US20140178869A1
(en)
|
2012-04-05 |
2014-06-26 |
Advanced Cell Diagnostics, Inc. |
Detection of immunoglobulin light chain restriction by rna in situ hybridization
|
IN2014MN01886A
(xx)
|
2012-04-18 |
2015-07-10 |
Univ Ramot |
|
MY167814A
(en)
|
2012-04-19 |
2018-09-26 |
Opko Biologics Ltd |
Long-acting oxyntomodulin variants and methods of producing same
|
US20130280696A1
(en)
|
2012-04-23 |
2013-10-24 |
Elliott Millenson |
Devices and methods for detecting analyte in bodily fluid
|
US9439942B2
(en)
|
2012-04-24 |
2016-09-13 |
Biokine Therapeutics Ltd. |
Peptides and use thereof in the treatment of large cell lung cancer
|
CN104703622B
(zh)
|
2012-04-26 |
2017-05-24 |
芝加哥大学 |
与金黄色葡萄球菌疾病期间抵消凝固酶活性的抗体相关的组合物和方法
|
JP6181158B2
(ja)
|
2012-05-09 |
2017-08-16 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
TNF−α阻害剤としてのTACEプロドメインの変異体およびその医学的使用
|
MX2019001355A
(es)
|
2012-05-10 |
2023-01-17 |
Bioatla Llc |
Anticuerpos monoclonales multiespecíficos.
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
MX360866B
(es)
|
2012-05-24 |
2018-11-09 |
A B Seeds Ltd |
Composiciones y métodos para silenciar la expresión genética.
|
SG11201408330XA
(en)
|
2012-05-24 |
2015-01-29 |
Mountgate Group Ltd |
Compositions and methods related to prevention and treatment of rabies infection
|
KR102163408B1
(ko)
|
2012-05-31 |
2020-10-08 |
소렌토 쎄라퓨틱스, 인코포레이티드 |
Pd-l1에 결합하는 항원 결합 단백질
|
CN104582770B
(zh)
|
2012-06-01 |
2019-01-29 |
西奈山伊坎医学院 |
在感染的治疗和预防中的神经酰胺水平
|
US9731048B2
(en)
|
2012-06-03 |
2017-08-15 |
Ben-Gurion University Of The Negev Research And Development Authority |
Functionalized titanium binding peptides and implants coated with same
|
KR102092025B1
(ko)
|
2012-06-04 |
2020-03-24 |
옵코 바이오로직스 리미티드 |
페길화된 옥신토모둘린 변이체
|
CN109503714A
(zh)
|
2012-06-21 |
2019-03-22 |
索伦托治疗有限公司 |
与c-Met结合的抗原结合蛋白
|
CN105051065A
(zh)
|
2012-06-22 |
2015-11-11 |
索伦托治疗有限公司 |
与ccr2结合的抗原结合蛋白
|
CA2875710C
(en)
|
2012-06-22 |
2021-06-29 |
John Wayne Cancer Institute |
Molecular malignancy in melanocytic lesions
|
EP2870110A1
(en)
|
2012-07-03 |
2015-05-13 |
Nanospun Technologies Ltd. |
Methods and devices for adsorption and biodegradation of petroleum
|
ES2776365T3
(es)
|
2012-07-09 |
2020-07-30 |
Novartis Ag |
Biomarcadores asociados con inhibidores de CDK
|
CA2876512C
(en)
|
2012-07-11 |
2022-12-13 |
Imstem Biotechnology, Inc. |
Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
|
WO2014014788A2
(en)
|
2012-07-18 |
2014-01-23 |
President And Fellows Of Harvard College |
Modification of surfaces for simulataneous repellency and targeted binding of desired moieties
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
WO2014018375A1
(en)
|
2012-07-23 |
2014-01-30 |
Xenon Pharmaceuticals Inc. |
Cyp8b1 and uses thereof in therapeutic and diagnostic methods
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
IN2015DN00880A
(xx)
|
2012-07-27 |
2015-06-12 |
Univ Illinois |
|
EP3594331A1
(en)
|
2012-07-29 |
2020-01-15 |
Yeda Research and Development Co. Ltd. |
Use of the reductive glycine pathway for generating formatotrophic and autotrophic microorganisms
|
WO2014020608A1
(en)
|
2012-07-31 |
2014-02-06 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing and treating motor neuron diseases
|
US20150159222A1
(en)
|
2012-07-31 |
2015-06-11 |
Novartis Ag |
Markers associated with human double minute 2 inhibitors
|
BR112015001435B1
(pt)
|
2012-08-06 |
2022-01-18 |
Brainstorm Cell Therapeutics Ltd |
Métodos para geração de células que secretam fator neurotrófico derivado do cérebro (bdnf), fator neurotrófico derivado da glia (gdnf), fator de crescimento de hepatócitos (hgf) e fator de crescimento endotelial vascular (vegf) em que as referidas células não secretam fator de crescimento do nervo(ngf)
|
CA2882745C
(en)
|
2012-08-23 |
2022-03-29 |
Agensys, Inc. |
Antibody drug conjugates (adc) that bind to 158p1d7 proteins
|
US20140068814A1
(en)
|
2012-09-03 |
2014-03-06 |
A.B. Seeds Ltd. |
Method of improving abiotic stress tolerance of plants and plants generated thereby
|
EP2895197B1
(en)
|
2012-09-12 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Immunoparticles and methods of generating and using same
|
EP3677310A1
(en)
|
2012-10-08 |
2020-07-08 |
St. Jude Children's Research Hospital |
Therapies based on control of regulatory t cell stability and function via a neuropilin-1:semaphorin axis
|
WO2014057490A1
(en)
|
2012-10-09 |
2014-04-17 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
|
JP6324974B2
(ja)
|
2012-10-12 |
2018-05-23 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ |
タウの毒性オリゴマー形態を特異的に認識する抗体ベースの試薬
|
US10077451B2
(en)
|
2012-10-18 |
2018-09-18 |
Monsanto Technology Llc |
Methods and compositions for plant pest control
|
EP2909230B1
(en)
|
2012-10-19 |
2019-05-22 |
Danisco US Inc. |
Stabilization of biomimetic membranes
|
US9395369B2
(en)
|
2012-10-19 |
2016-07-19 |
Regents Of The University Of Minnesota |
Guinea pig cytomegalovirus (CIDMTR strain)
|
US20150354006A1
(en)
|
2012-10-19 |
2015-12-10 |
Novartis Ag |
Markers for acute lymphoblastic leukemia
|
AU2013336237A1
(en)
|
2012-10-22 |
2015-06-11 |
Sabag-Rfa Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
EP2912062A1
(en)
|
2012-10-24 |
2015-09-02 |
Yeda Research and Development Co. Ltd. |
Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
|
WO2014066590A1
(en)
|
2012-10-24 |
2014-05-01 |
Research Development Foundation |
Jam-c antibodies and methods for treatment of cancer
|
US9926564B2
(en)
|
2012-10-29 |
2018-03-27 |
Yeda Research And Development Co. Ltd. |
Aptamers, multimeric aptamers and uses thereof
|
MX363326B
(es)
|
2012-11-20 |
2019-03-20 |
Opko Biologics Ltd |
Metodo para incrementar el volumen hidrodinamico de polipeptidos mediante la union a peptidos carboxi-terminales de gonadotrofina.
|
JP2016502536A
(ja)
|
2012-11-29 |
2016-01-28 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
腫瘍転移を防止し、がんを処置および予後診断し、推定転移阻害剤である薬剤を同定する方法
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
WO2014106838A2
(en)
|
2013-01-01 |
2014-07-10 |
A.B. Seeds Ltd. |
Methods of introducing dsrna to plant seeds for modulating gene expression
|
US10047399B2
(en)
|
2013-01-07 |
2018-08-14 |
The Cleveland Clinic Foundation |
ABCA1 downregulation in prostate cancer
|
WO2014108850A2
(en)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
High throughput transcriptome analysis
|
WO2014108854A1
(en)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
|
JP6411372B2
(ja)
|
2013-01-17 |
2018-10-24 |
ノベルラスディクス リミテッド |
患者特有のドライバー変異を特定するための方法およびシステム
|
WO2014116721A1
(en)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
US10000767B2
(en)
|
2013-01-28 |
2018-06-19 |
Monsanto Technology Llc |
Methods and compositions for plant pest control
|
US9411930B2
(en)
|
2013-02-01 |
2016-08-09 |
The Regents Of The University Of California |
Methods for genome assembly and haplotype phasing
|
GB2547875B
(en)
|
2013-02-01 |
2017-12-13 |
Univ California |
Methods for meta-genomics analysis of microbes
|
CA2899865C
(en)
|
2013-02-01 |
2023-10-10 |
Kapil BHARTI |
Method for generating retinal pigment epithelium (rpe) cells from induced pluripotent stem cells (ipscs)
|
EP2950808B1
(en)
|
2013-02-04 |
2019-08-21 |
Ramot at Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
US20160008282A1
(en)
|
2013-02-22 |
2016-01-14 |
The Board Of Trustees Of The Universityof Illinois |
Transdermal Drug Delivery Using Amphiphilic Dendron-Coil Micelles
|
EP2964668B1
(en)
|
2013-03-06 |
2019-11-27 |
Protalix Ltd. |
Tnf alpha inhibitor polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
|
CA2902727C
(en)
|
2013-03-06 |
2020-08-18 |
Protalix Ltd. |
Use of plant cells expressing a tnfalpha polypeptide inhibitor in therapy
|
TWI582239B
(zh)
|
2013-03-11 |
2017-05-11 |
諾華公司 |
與wnt抑制劑相關之標記
|
US10612019B2
(en)
|
2013-03-13 |
2020-04-07 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
AU2014249015B2
(en)
|
2013-03-13 |
2020-04-16 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US20140283211A1
(en)
|
2013-03-14 |
2014-09-18 |
Monsanto Technology Llc |
Methods and Compositions for Plant Pest Control
|
WO2014159242A1
(en)
|
2013-03-14 |
2014-10-02 |
Novartis Ag |
Notch 3 mutants and uses thereof
|
US9273349B2
(en)
|
2013-03-14 |
2016-03-01 |
Affymetrix, Inc. |
Detection of nucleic acids
|
MX2015012922A
(es)
|
2013-03-14 |
2016-04-04 |
Ren Liu |
Tratamiento del cancer usando anticuerpos que se unen a grp78 en la superficie celular.
|
EP2970479B1
(en)
|
2013-03-14 |
2019-04-24 |
Novartis AG |
Antibodies against notch 3
|
WO2014151683A1
(en)
|
2013-03-15 |
2014-09-25 |
Bayer Healthcare Llc |
Gla domains as targeting agents
|
EP2970909A4
(en)
|
2013-03-15 |
2017-02-15 |
The University of Chicago |
Methods and compositions related to t-cell activity
|
WO2014144170A1
(en)
|
2013-03-15 |
2014-09-18 |
The Cleveland Clinic Foundation |
In-vitro method for monoclonal antibody production using non-human act1 -deficient mice
|
US9789164B2
(en)
|
2013-03-15 |
2017-10-17 |
Longevity Biotech, Inc. |
Peptides comprising non-natural amino acids and methods of making and using the same
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2014147622A1
(en)
|
2013-03-21 |
2014-09-25 |
Collplant Ltd. |
Compositions comprising collagen and prp for tissue regeneration
|
ES2643321T3
(es)
|
2013-03-24 |
2017-11-22 |
Biokine Therapeutics Ltd. |
Una combinación de un antagonista de CXCR4 y citarabina para su uso en el tratamiento de la leucemia mieloide
|
JP6671276B2
(ja)
|
2013-03-27 |
2020-03-25 |
セダーズ−シナイ メディカル センター |
Tl1a機能および関連するシグナル経路の抑制による線維症および炎症の緩和および回復
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
RU2015149680A
(ru)
|
2013-04-21 |
2017-05-24 |
Йеда Ресеарч Энд Девелопмент Ко. Лтд. |
Агенты для подавления активности и/или снижения количества bcl-xl и/или bcl-w
|
CN105531365A
(zh)
|
2013-04-23 |
2016-04-27 |
耶达研究及发展有限公司 |
分离的幼稚多能干细胞和产生所述细胞的方法
|
US20160091485A1
(en)
|
2013-04-25 |
2016-03-31 |
The Broad Institute, Inc. |
Markers for ezh2 inhibitors
|
EP2989119B1
(en)
|
2013-04-25 |
2018-03-21 |
Yeda Research and Development Co., Ltd. |
Use of inhibitory peptides for the treatment of inflammatory diseases
|
WO2014188423A1
(en)
|
2013-05-21 |
2014-11-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mast cell related pathologies
|
CA2913155A1
(en)
|
2013-05-21 |
2014-11-27 |
President And Fellows Of Harvard College |
Engineered heme-binding compositions and uses thereof
|
SG11201509636XA
(en)
|
2013-05-27 |
2015-12-30 |
Rakuto Bio Technologies Ltd |
Enzymatic system-containing cosmetic compositions
|
EP3004334A4
(en)
|
2013-05-28 |
2016-12-21 |
Biogen Ma Inc |
METHODS OF EVALUATION RISK OF DEVELOPMENT OF PML
|
ES2754177T3
(es)
|
2013-06-12 |
2020-04-16 |
Massachusetts Gen Hospital |
Métodos para la detección multiplexada de moléculas diana y sus usos
|
SG10201710528WA
(en)
|
2013-06-18 |
2018-01-30 |
Dnatrix Inc |
Treatment of brain cancer with oncolytic adenovirus
|
WO2014205230A1
(en)
|
2013-06-19 |
2014-12-24 |
Step Ahead Innovations Inc. |
Aquatic environment water parameter testing systems and methods
|
ES2938044T3
(es)
|
2013-06-24 |
2023-04-04 |
Univ Ramot |
Estructura a base de epiplón y sistema de suministro
|
US20160296609A1
(en)
|
2013-06-28 |
2016-10-13 |
Baylor Research Institute |
Dendritic cell asgpr targeting immunotherapeutics for multiple sclerosis
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
BR112016000555B1
(pt)
|
2013-07-19 |
2022-12-27 |
Monsanto Technology Llc |
Método para controlar uma infestação da espécie de leptinotarsa em uma planta, composição inseticida e construção de dna recombinante
|
EP3022295A4
(en)
|
2013-07-19 |
2017-03-01 |
Cedars-Sinai Medical Center |
Signature of tl1a (tnfsf15) signaling pathway
|
WO2015015489A1
(en)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Antibody for treating diabetes and autoimmune diseases
|
EP3027220A1
(en)
|
2013-08-01 |
2016-06-08 |
Agensys, Inc. |
Antibody drug conjugates (adc) that bind to cd37 proteins
|
EP3036005A4
(en)
|
2013-08-21 |
2017-04-26 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for targeting connexin hemichannels
|
EP3039030B1
(en)
|
2013-08-29 |
2018-09-19 |
Yeda Research and Development Co. Ltd. |
Selective inhibitors of alpha2 isoform of na,k-atpase and use for reduction of intra-ocular pressure
|
IL293871A
(en)
|
2013-08-30 |
2022-08-01 |
Immunogen Inc |
Antibodies and assays for the detection of folate receptor 1
|
US20160251410A1
(en)
|
2013-09-03 |
2016-09-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants from cellular scaffolding and blood vessel stalk
|
WO2015033344A1
(en)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
|
WO2015037009A1
(en)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Isolated proteins capable of binding plexin-a4 and methods of producing and using same
|
ES2717446T3
(es)
|
2013-09-17 |
2019-06-21 |
Yeda Res & Dev |
Péptidos derivados de ERK y usos de los mismos
|
CN105960453A
(zh)
|
2013-10-01 |
2016-09-21 |
卡迪马干细胞有限公司 |
从人多能干细胞定向分化星形胶质细胞用于肌萎缩侧索硬化(als)的治疗和药物筛选
|
BR112016007391A2
(pt)
|
2013-10-03 |
2017-08-01 |
Oklahoma Med Res Found |
biomarcadores da atividade, da intensidade e da fase aguda da doença lúpus eritematoso sistêmico
|
US9476884B2
(en)
|
2013-10-04 |
2016-10-25 |
University Of Massachusetts |
Hybridization- independent labeling of repetitive DNA sequence in human chromosomes
|
KR102444140B1
(ko)
|
2013-10-21 |
2022-09-15 |
옵코 바이오로직스 리미티드 |
장시간-작용하는 폴리펩티드, 그의 생산 방법, 및 그의 투여 방법
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
EP3060656A1
(en)
|
2013-10-24 |
2016-08-31 |
Yeda Research and Development Co., Ltd. |
Polynucleotides encoding brex system polypeptides and methods of using same
|
AU2014343214B2
(en)
|
2013-10-31 |
2020-04-09 |
Biolinerx Ltd. |
Methods of treating acute myeloid leukemia with a FLT3 mutation
|
CA2929533C
(en)
|
2013-11-04 |
2023-06-06 |
Monsanto Technology Llc |
Compositions and methods for controlling arthropod parasite and pest infestations
|
WO2015070009A2
(en)
|
2013-11-08 |
2015-05-14 |
The Board Of Regents Of The University Of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
US10172916B2
(en)
|
2013-11-15 |
2019-01-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of treating heart failure with agonists of hypocretin receptor 2
|
IL245703B
(en)
|
2013-11-20 |
2022-07-01 |
Univ Iowa Res Found |
Methods and preparations for the treatment of amyloid deposits
|
MX2016006625A
(es)
|
2013-11-22 |
2016-12-02 |
Univ Illinois |
Receptores de células t humanas con alta afinidad modificados por medio de manipulación genética.
|
WO2015079411A1
(en)
|
2013-11-28 |
2015-06-04 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Rna polymerase i inhibitors and uses thereof
|
EP3074044A2
(en)
|
2013-11-28 |
2016-10-05 |
Yeda Research and Development Co., Ltd. |
Synaptojanin-2 inhibitors and uses thereof
|
ES2697757T3
(es)
|
2013-12-10 |
2019-01-28 |
Yeda Res & Dev |
Uso de enzimas que catalizan la síntesis de piruvato a partir de formiato y acetil-CoA y bacterias que expresan la misma
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
EP3083658B1
(en)
|
2013-12-18 |
2019-05-08 |
President and Fellows of Harvard College |
Crp capture/detection of gram positive bacteria
|
WO2015094527A1
(en)
|
2013-12-19 |
2015-06-25 |
Danisco Us Inc. |
Use of hydrophobins to increase gas transferin aerobic fermentation processes
|
US11293929B2
(en)
|
2014-01-07 |
2022-04-05 |
Bioatla, Inc. |
Proteins targeting orthologs
|
JP7037884B2
(ja)
|
2014-01-13 |
2022-03-17 |
ベイラー リサーチ インスティテュート |
Hpv及びhpv関連疾患に対する新規のワクチン
|
MX368629B
(es)
|
2014-01-15 |
2019-10-08 |
Monsanto Technology Llc |
Metodos y composiciones para el control de malezas utilizando polinucleotidos de 5-enolpiruvilshikimato-3-fosfato sintasa (epsps).
|
MX2016009954A
(es)
|
2014-01-29 |
2017-02-23 |
Dana Farber Cancer Inst Inc |
Anticuerpos contra el dominio extracelular de muc1-c (muc1-c/ecd).
|
US20160340659A1
(en)
|
2014-01-30 |
2016-11-24 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same
|
US20170042893A1
(en)
|
2014-02-03 |
2017-02-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Use of casein kinase i inhibitors for depleting stem cells
|
WO2015118537A2
(en)
|
2014-02-05 |
2015-08-13 |
Yeda Research And Development Co. Ltd. |
Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
|
EP3102607B1
(en)
|
2014-02-06 |
2018-08-22 |
Yeda Research and Development Co. Ltd. |
Anti cd84 antibodies, compositions comprising same and uses thereof
|
WO2015120273A1
(en)
|
2014-02-07 |
2015-08-13 |
The General Hospital Corporation |
Differential diagnosis of hepatic neoplasms
|
US20170101633A1
(en)
|
2014-02-10 |
2017-04-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
WO2015121859A1
(en)
|
2014-02-11 |
2015-08-20 |
Brainstorm Cell Therapeutics Ltd. |
Method of qualifying cells
|
US20150232935A1
(en)
|
2014-02-14 |
2015-08-20 |
The General Hospital Corporation |
Methods for diagnosing igg4-related disease
|
WO2015131099A1
(en)
|
2014-02-28 |
2015-09-03 |
The General Hospital Corporation |
Diagnosis of multiple myeloma and lymphoma
|
WO2015132784A1
(en)
|
2014-03-03 |
2015-09-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method and device for detection of pseudomonas aeruginosa
|
EP2923709A1
(en)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Multi-component-multistage malaria vaccine
|
BR112016022711A2
(pt)
|
2014-04-01 |
2017-10-31 |
Monsanto Technology Llc |
composições e métodos para controle de pragas de inseto
|
CA2945438C
(en)
|
2014-04-10 |
2023-08-22 |
Bonus Therapeutics Ltd. |
Bone repair compositions
|
DK4026917T3
(da)
|
2014-04-14 |
2024-02-12 |
Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd |
Fremgangsmåde og kit til bestemmelse af cellers eller vævs død eller dna's vævs- eller celleoprindelse ved dna-methyleringsanalyse
|
EP3132057B1
(en)
|
2014-04-17 |
2019-10-16 |
Yeda Research and Development Co. Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
AP2016009504A0
(en)
|
2014-04-27 |
2016-10-31 |
Ccam Biotherapeutics Ltd |
Humanized antibodies against ceacam1
|
EP3058085B1
(en)
|
2014-04-28 |
2021-02-17 |
Yeda Research and Development Co., Ltd. |
Microbiome response to agents
|
WO2015170325A2
(en)
|
2014-05-04 |
2015-11-12 |
Forrest Innovations Ltd. |
Compositions and methods for reducing pathogen-induced citrus greening
|
EP2942627A1
(en)
|
2014-05-05 |
2015-11-11 |
MicroBPlex, Inc. |
Media elaborated with newly synthesized antibodies (mensa) from recently proliferated antibody secreting cells (asc) and uses thereof
|
AU2015255883A1
(en)
|
2014-05-08 |
2016-10-27 |
Novodiax, Inc. |
Direct immunohistochemistry assay
|
WO2015179435A1
(en)
|
2014-05-19 |
2015-11-26 |
Bayer Healthcare Llc |
Optimized humanized monoclonal antibodies against activated protein c and uses thereof
|
US10294482B2
(en)
|
2014-05-22 |
2019-05-21 |
Yeda Research And Development Co. Ltd. |
Recombinant microorganisms capable of carbon fixation
|
WO2015186129A1
(en)
|
2014-06-02 |
2015-12-10 |
Technion Research & Development Foundation Limited. |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
EP3149155B1
(en)
|
2014-06-02 |
2020-09-23 |
Kadimastem Ltd. |
Methods of inducing myelination and maturation of oligodendrocytes
|
CA2953347A1
(en)
|
2014-06-23 |
2015-12-30 |
Monsanto Technology Llc |
Compositions and methods for regulating gene expression via rna interference
|
EP3145951A1
(en)
|
2014-06-24 |
2017-03-29 |
InSight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
JP6587288B2
(ja)
|
2014-06-25 |
2019-10-09 |
テル ハショマー メディカル リサーチ インフラストラクチャー アンド サーヴィシーズ リミテッド |
がん幹細胞の同定ならびに診断および処置のためのその使用
|
EP3161138A4
(en)
|
2014-06-25 |
2017-12-06 |
Monsanto Technology LLC |
Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
|
EP3160448A4
(en)
|
2014-06-26 |
2018-11-14 |
Ramot at Tel-Aviv University Ltd. |
Liposomal formulations for delivery of nucleic acids
|
WO2016005985A2
(en)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming cells
|
ES2799404T3
(es)
|
2014-07-15 |
2020-12-17 |
Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd |
Polipéptidos de CD44 aislados y usos de los mismos
|
CN106715719B
(zh)
|
2014-07-21 |
2022-08-02 |
福尔生物治疗有限公司 |
用于确定患者特定突变的药物反应的方法
|
CA2955414A1
(en)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Methods and systems for determining oncogenic index of patient specific mutations
|
RU2021123470A
(ru)
|
2014-07-29 |
2021-09-06 |
Монсанто Текнолоджи Ллс |
Композиции и способы борьбы с насекомыми-вредителями
|
CN108064274A
(zh)
|
2014-07-30 |
2018-05-22 |
耶达研究及发展有限公司 |
用于培养多能干细胞的培养基
|
EP4219710A3
(en)
|
2014-08-01 |
2023-08-16 |
Dovetail Genomics, LLC |
Tagging nucleic acids for sequence assembly
|
CN111624346A
(zh)
|
2014-08-14 |
2020-09-04 |
米密德诊断学有限公司 |
用于预测及/或决定预后的套组
|
WO2016028523A2
(en)
|
2014-08-22 |
2016-02-25 |
Sorrento Therapeutics, Inc. |
Antigen binding proteins that bind cxcr3
|
WO2016030899A1
(en)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral scleroses
|
EP2992895A1
(en)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Three-component-multistage malaria vaccine
|
WO2016038609A1
(en)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Anti-her3 antibodies and uses of same
|
CA2959775A1
(en)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (tki)
|
EP3191592A1
(en)
|
2014-09-11 |
2017-07-19 |
Novartis AG |
Inhibition of prmt5 to treat mtap-deficiency-related diseases
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
NMDA receptor antagonists for the treatment of Gaucher disease
|
AU2015318018B2
(en)
|
2014-09-16 |
2017-05-11 |
Synermore Biologics (Suzhou) Co. Ltd. |
Anti-EGFR antibody and uses of same
|
US10174320B2
(en)
|
2014-09-21 |
2019-01-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Downregulating miR-132 for the treatment of lipid related disorders
|
JP6954834B2
(ja)
|
2014-10-06 |
2021-10-27 |
ケモセントリックス,インコーポレイティド |
CCケモカイン受容体9(CCR9)の阻害剤と抗α4β7インテグリン遮断抗体の併用療法
|
WO2016061111A1
(en)
|
2014-10-13 |
2016-04-21 |
Life Technologies Corporation |
Methods, kits & compositions for determining gene copy numbers
|
DE102015220401B4
(de)
|
2014-10-20 |
2022-12-29 |
Gen-Probe Incorporated |
Erythrozyten-Lyselösung
|
CA2965438A1
(en)
|
2014-10-24 |
2016-04-28 |
Dupont Nutrition Biosciences Aps |
Use of proline tolerant tripeptidyl peptidases in feed additive compositions
|
US20170306360A1
(en)
|
2014-10-24 |
2017-10-26 |
Danisco Us Inc. |
Method for producing alcohol by use of a tripeptidyl peptidase
|
WO2016075697A1
(en)
|
2014-11-13 |
2016-05-19 |
Enzootic Holdings Ltd. |
Functional sex-reversal of decapod crustacean females
|
EP3221470B1
(en)
|
2014-11-17 |
2019-08-14 |
Yeda Research and Development Co., Ltd. |
Method of analyzing microbiome
|
EP3220945A2
(en)
|
2014-11-17 |
2017-09-27 |
Yeda Research and Development Co., Ltd. |
Methods of treating diseases related to mitochondrial function
|
WO2016079219A1
(en)
|
2014-11-19 |
2016-05-26 |
Koninklijke Philips N.V. |
Diagnostic method employing hnl
|
EP3221455B1
(en)
|
2014-11-20 |
2020-08-12 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
|
CN107208070B
(zh)
|
2014-11-26 |
2021-09-07 |
技术创新动力基金(以色列)有限合伙公司 |
细菌基因的靶向消除
|
CA2968808A1
(en)
|
2014-11-27 |
2016-06-02 |
Danziger Innovations Ltd. |
Nucleic acid constructs for genome editing
|
US11279974B2
(en)
|
2014-12-01 |
2022-03-22 |
The Broad Institute, Inc. |
Method for in situ determination of nucleic acid proximity
|
US10479997B2
(en)
|
2014-12-01 |
2019-11-19 |
Novartis Ag |
Compositions and methods for diagnosis and treatment of prostate cancer
|
EP4242329A3
(en)
|
2014-12-08 |
2023-10-25 |
Berg LLC |
Use of markers including filamin a in the diagnosis and treatment of prostate cancer
|
WO2016092555A2
(en)
|
2014-12-11 |
2016-06-16 |
Yeda Research And Development Co. Ltd. |
Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
WO2016103269A1
(en)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations of neural progenitor cells and methods of producing and using same
|
KR20170091157A
(ko)
|
2014-12-23 |
2017-08-08 |
4디 파마 리서치 리미티드 |
피린 폴리펩티드 및 면역 조정
|
KR101942955B1
(ko)
|
2014-12-23 |
2019-01-28 |
4디 파마 리서치 리미티드 |
면역 조정
|
JP6882981B2
(ja)
|
2014-12-30 |
2021-06-02 |
セル キュア ニューロサイエンシズ リミテッド |
Rpe細胞集団およびそれを作製する方法
|
ES2880346T3
(es)
|
2014-12-30 |
2021-11-24 |
Cell Cure Neurosciences Ltd |
Evaluación de poblaciones de células epiteliales de pigmento retiniano
|
KR102359257B1
(ko)
|
2014-12-30 |
2022-02-07 |
셀 큐어 뉴로사이언시스 리미티드 |
망막 질환의 치료 방법
|
MX2017008567A
(es)
|
2015-01-04 |
2018-04-26 |
Protalix Ltd |
Dnasa modificada y usos de la misma.
|
WO2016116935A1
(en)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Use of rasa2 as a prognostic and therapeutic marker for melanoma
|
PL3256589T3
(pl)
|
2015-01-22 |
2022-02-21 |
Monsanto Technology Llc |
Kompozycje i sposoby kontrolowania leptinotarsa
|
AU2016219511B2
(en)
|
2015-02-09 |
2020-11-12 |
Research Development Foundation |
Engineered immunoglobulin Fc polypeptides displaying improved complement activation
|
US10202453B2
(en)
|
2015-02-13 |
2019-02-12 |
Sorrento Therapeutics, Inc. |
Antibody therapeutics that bind CTLA4
|
WO2016134034A1
(en)
|
2015-02-17 |
2016-08-25 |
Dovetail Genomics Llc |
Nucleic acid sequence assembly
|
US10479825B2
(en)
|
2015-02-25 |
2019-11-19 |
Vanderbilt University |
Antibody-mediated neutralization of Marburg virus
|
WO2016135732A1
(en)
|
2015-02-26 |
2016-09-01 |
Yeda Research And Development Co. Ltd. |
Method of promoting hair growth
|
TWI719967B
(zh)
|
2015-03-09 |
2021-03-01 |
美商艾澤西公司 |
結合至flt3蛋白之抗體藥物結合物(adc)
|
EP3268475B1
(en)
|
2015-03-11 |
2020-10-21 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Decoy oligonucleotides for the treatment of diseases
|
WO2016145409A1
(en)
|
2015-03-11 |
2016-09-15 |
The Broad Institute, Inc. |
Genotype and phenotype coupling
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Antibodies against amphigoline, medical preparations containing them and their use
|
US11807896B2
(en)
|
2015-03-26 |
2023-11-07 |
Dovetail Genomics, Llc |
Physical linkage preservation in DNA storage
|
EP4218771A1
(en)
|
2015-03-27 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Methods of treating motor neuron diseases
|
CA2981142A1
(en)
|
2015-03-27 |
2016-10-06 |
University Of Southern California |
Car t-cell therapy directed to lhr for the treatment of solid tumors
|
EP3277308A1
(en)
|
2015-03-31 |
2018-02-07 |
Yeda Research and Development Co., Ltd. |
Glutamate oxaloacetate transaminase 1 (got1), preparations and methods of generating same and uses thereof
|
US9612534B2
(en)
|
2015-03-31 |
2017-04-04 |
Tokyo Electron Limited |
Exposure dose homogenization through rotation, translation, and variable processing conditions
|
WO2016157192A1
(en)
|
2015-04-01 |
2016-10-06 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Erodium crassifolium l'her plant extracts and uses thereof
|
HUE057044T2
(hu)
|
2015-04-07 |
2022-04-28 |
Ela Pharma Ltd |
Sejt- vagy szövetnekrózis kezelésére és/vagy megelõzésére szolgáló, katepszin C-t és/vagy CELA1-et és/vagy CELA3A-t és/vagy szerkezetileg rokon enzimeket specifikusan targetáló készítmények
|
TW201702264A
(zh)
|
2015-04-08 |
2017-01-16 |
索倫多醫療公司 |
結合cd38之抗體治療劑
|
EP3081575A1
(en)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anti-plasmodium parasite antibodies
|
CA2986202C
(en)
|
2015-04-27 |
2023-08-22 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Egr1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
|
ES2911341T3
(es)
|
2015-04-29 |
2022-05-18 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
Composiciones antifitopatogénicas
|
US20190031759A1
(en)
|
2015-04-30 |
2019-01-31 |
Technion Research & Development Foundation Limited |
Chimeric antigen receptors and methods of their use
|
WO2016178207A1
(en)
|
2015-05-04 |
2016-11-10 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for fragmenting dna
|
EP3091026B1
(en)
|
2015-05-08 |
2019-02-20 |
Centrillion Technology Holdings Corporation |
Disulfide-linked reversible terminators
|
US20180161300A1
(en)
|
2015-05-11 |
2018-06-14 |
Yeda Research And Development Co., Ltd. |
Citrin inhibitors for the treatment of cancer
|
WO2016185471A1
(en)
|
2015-05-17 |
2016-11-24 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Compositions and methods for treating cancer
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
WO2016185481A2
(en)
|
2015-05-20 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
MX2017014787A
(es)
|
2015-05-21 |
2018-05-01 |
Yeda Res & Dev |
Poblaciones bacterianas para promover la salud.
|
KR20180014754A
(ko)
|
2015-05-29 |
2018-02-09 |
옵코 바이오로직스 리미티드 |
페길화된 옥신토모둘린 변이체
|
CN107750125A
(zh)
|
2015-06-02 |
2018-03-02 |
孟山都技术有限公司 |
用于将多核苷酸递送至植物中的组合物和方法
|
WO2016196782A1
(en)
|
2015-06-03 |
2016-12-08 |
Monsanto Technology Llc |
Methods and compositions for introducing nucleic acids into plants
|
EP3302559B1
(en)
|
2015-06-04 |
2022-01-12 |
University of Southern California |
Lym-1 and lym-2 targeted car cell immunotherapy
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
MX2017016529A
(es)
|
2015-06-15 |
2018-03-12 |
4D Pharma Res Ltd |
Composiciones que comprenden cepas bacterianas.
|
AU2016278067B2
(en)
|
2015-06-15 |
2022-09-22 |
Cj Bioscience, Inc. |
Compositions comprising bacterial strains
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
ES2742514T3
(es)
|
2015-06-15 |
2020-02-14 |
4D Pharma Res Ltd |
Composiciones que comprenden cepas bacterianas
|
ES2917884T3
(es)
|
2015-06-18 |
2022-07-12 |
Yeda Res & Dev |
Protocolos de acondicionamiento y uso de los mismos para la regeneración de tejidos
|
WO2016203476A1
(en)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and compositions for diagnosing and treating urothelial cancer
|
KR102172937B1
(ko)
|
2015-06-19 |
2020-11-03 |
옵코 바이오로직스 리미티드 |
장기-작용성 응고 인자 및 그의 제조 방법
|
BR112017028035A2
(pt)
|
2015-06-26 |
2018-08-28 |
Dupont Nutrition Biosci Aps |
aminopeptidases para hidrolisados de proteína
|
GB2556004A
(en)
|
2015-07-10 |
2018-05-16 |
Univ West Virginia |
Markers of stroke and stroke severity
|
CN111375066B
(zh)
|
2015-07-16 |
2023-04-25 |
百欧肯治疗有限公司 |
治疗癌症的组合物及方法
|
ES2963038T3
(es)
|
2015-07-16 |
2024-03-25 |
Yeda Res & Dev |
Uso de células T de memoria central antitercero
|
US10668094B2
(en)
|
2015-07-19 |
2020-06-02 |
Yeda Research And Development Co. Ltd. |
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure
|
WO2017015334A1
(en)
|
2015-07-21 |
2017-01-26 |
Saint Louis University |
Compositions and methods for diagnosing and treating endometriosis-related infertility
|
CA2993023C
(en)
|
2015-07-22 |
2020-04-28 |
Phytopharma International Ltd. |
Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby
|
US11230696B2
(en)
|
2015-07-29 |
2022-01-25 |
Hadasit Medical Research Services And Development Ltd. |
Large scale production of retinal pigment epithelial cells
|
WO2017021963A1
(en)
|
2015-08-03 |
2017-02-09 |
Biokine Therapeutics Ltd. |
Cxcr4 binding agents for treatment of diseases
|
WO2017021961A1
(en)
|
2015-08-04 |
2017-02-09 |
Yeda Research And Development Co. Ltd. |
Methods of screening for riboswitches and attenuators
|
EP3331572A4
(en)
|
2015-08-04 |
2019-05-01 |
CD Diagnostics, Inc. |
METHOD FOR DETECTING UNWANTED LOCAL TISSUE ACTION NEKROSIS
|
EA201890442A1
(ru)
|
2015-08-05 |
2018-07-31 |
Селл Кьюр Нейросайансес Лтд. |
Получение фоторецепторов для лечения заболеваний сетчатки
|
CN108138144A
(zh)
|
2015-08-05 |
2018-06-08 |
细胞治疗神经科学有限公司 |
视网膜色素上皮细胞的制备
|
US10435457B2
(en)
|
2015-08-06 |
2019-10-08 |
President And Fellows Of Harvard College |
Microbe-binding molecules and uses thereof
|
EP3334449B1
(en)
|
2015-08-10 |
2021-09-29 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Methods and pharmaceutical compositions for improving wound healing using cd24
|
WO2017025967A1
(en)
|
2015-08-13 |
2017-02-16 |
Forrest Innovations Ltd. |
Formulations and compositions for delivery of nucleic acids to plant cells
|
WO2017031370A1
(en)
|
2015-08-18 |
2017-02-23 |
The Broad Institute, Inc. |
Methods and compositions for altering function and structure of chromatin loops and/or domains
|
WO2017033188A1
(en)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Algal oil and biofuel and methods of producing same
|
DK3341725T3
(da)
|
2015-08-25 |
2021-09-06 |
Prothena Biosciences Ltd |
Fremgangsmåder til detektering af phosphoryleret alpha-synuklein
|
US10526408B2
(en)
|
2015-08-28 |
2020-01-07 |
Research Development Foundation |
Engineered antibody FC variants
|
WO2017040813A2
(en)
|
2015-09-02 |
2017-03-09 |
University Of Massachusetts |
Detection of gene loci with crispr arrayed repeats and/or polychromatic single guide ribonucleic acids
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
CA3036409C
(en)
|
2015-09-08 |
2023-07-11 |
Erik J. Sontheimer |
Dnase h activity of neisseria meningitidis cas9
|
WO2017042816A1
(en)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Ablation of perforin positive dendritic cells in cancer treatment
|
WO2017053567A1
(en)
|
2015-09-22 |
2017-03-30 |
Delta Tm Technologies |
Designing customized protein-specific buffer systems
|
WO2017059108A1
(en)
|
2015-09-29 |
2017-04-06 |
Htg Molecular Diagnostics, Inc. |
Methods for subtyping diffuse b-cell lymphoma (dlbcl)
|
AU2016334401A1
(en)
|
2015-10-10 |
2018-04-26 |
Intrexon Corporation |
Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
|
EP3913068B1
(en)
|
2015-10-12 |
2023-08-02 |
Advanced Cell Diagnostics, Inc. |
In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto
|
CN108368542B
(zh)
|
2015-10-19 |
2022-04-08 |
多弗泰尔基因组学有限责任公司 |
用于基因组组装、单元型定相以及独立于靶标的核酸检测的方法
|
EP3365376A1
(en)
|
2015-10-25 |
2018-08-29 |
Yeda Research and Development Co., Ltd. |
Antibodies targeting quiescin sulfhydryl oxidase (qsox1) and uses of same
|
WO2017072763A1
(en)
|
2015-10-26 |
2017-05-04 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
CA3187317A1
(en)
|
2015-10-27 |
2017-05-04 |
Jay Pharma, Inc. |
Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method for inducing the division of cardiomyocytes and treating heart diseases
|
WO2017077539A1
(en)
|
2015-11-03 |
2017-05-11 |
Ariel-University Research And Development Company Ltd. |
Compositions for regeneration and repair of neural tissue
|
AU2016354440B2
(en)
|
2015-11-09 |
2023-09-28 |
The Children's Hospital Of Philadelphia |
Glypican 2 as a cancer marker and therapeutic target
|
WO2017081689A1
(en)
|
2015-11-11 |
2017-05-18 |
Ramot At Tel-Aviv University Ltd. |
Methods of detecting 5-hydroxymethylcytosine and diagnosing of cancer
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
LT3209310T
(lt)
|
2015-11-20 |
2018-04-25 |
4D Pharma Research Limited |
Kompozicijos, apimančios bakterinius kamienus
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
JP6909230B2
(ja)
|
2015-11-30 |
2021-07-28 |
カディマステム リミテッド |
膵臓内分泌細胞の分化および精製のための方法
|
CN108925136B
(zh)
|
2015-12-02 |
2022-02-01 |
斯特赛恩斯公司 |
特异于糖基化的btla(b和t淋巴细胞衰减因子)的抗体
|
CN109415437B
(zh)
|
2015-12-02 |
2022-02-01 |
斯特库伯株式会社 |
与btn1a1免疫特异性结合的抗体和分子及其治疗用途
|
EP3176183A1
(en)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions and methods for treating cancer not resistant to a tyrosine kinase inhibitor (tki)
|
JP2019507582A
(ja)
|
2015-12-04 |
2019-03-22 |
ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム |
免疫療法用のslc45a2ペプチド
|
EP3389678B1
(en)
|
2015-12-16 |
2022-06-15 |
Ramot at Tel-Aviv University Ltd. |
Particles comprising decellularized omentum
|
JOP20200228A1
(ar)
|
2015-12-21 |
2017-06-16 |
Novartis Ag |
تركيبات وطرق لخفض تعبير البروتين tau
|
EP3393524B1
(en)
|
2015-12-22 |
2022-04-06 |
The Regents of The University of Colorado, A Body Corporate |
Protecting rnas from degradation using engineered viral rnas
|
US10561706B2
(en)
|
2015-12-28 |
2020-02-18 |
B. G. Negev Technologies And Applications |
Isolated polypeptide and compositions comprising same
|
CA3009127A1
(en)
|
2016-01-06 |
2017-07-13 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating malignant, autoimmune and inflammatory diseases
|
WO2017122203A1
(en)
|
2016-01-11 |
2017-07-20 |
Technion Research & Development Foundation Limited |
Methods of determining prognosis of sepsis and treating same
|
MX2018008910A
(es)
|
2016-01-21 |
2019-03-28 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
Plantas partenocarpicas y procedimientos de produccion de las mismas.
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
CA3013051A1
(en)
|
2016-01-29 |
2017-08-03 |
Heyue Zhou |
Antigen binding proteins that bind pd-l1
|
US11261433B2
(en)
|
2016-01-31 |
2022-03-01 |
Hadasit Medical Research Services And Development Ltd. |
Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
|
EP3411390A1
(en)
|
2016-02-04 |
2018-12-12 |
Yeda Research and Development Co. Ltd |
Peptides and use of same in the treatment of diseases, disorders or conditions associated with a mutant p53
|
WO2017139419A1
(en)
|
2016-02-11 |
2017-08-17 |
Qiagen Waltham, Inc. |
Polyphenolic additives in sequencing-by-synthesis
|
WO2017139415A2
(en)
|
2016-02-11 |
2017-08-17 |
Qiagen Waltham, Inc. |
Scavenger compounds for improved sequencing-by-synthesis
|
US20190142875A1
(en)
|
2016-02-14 |
2019-05-16 |
Yeda Research And Development Co. Ltd. |
Microbiome-based diagnosis, prediction and treatment of relapsing obesity
|
WO2017138008A2
(en)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
AU2017220830A1
(en)
|
2016-02-16 |
2018-09-06 |
Yeda Research And Development Co. Ltd. |
Non-protein phenylalanine analogues for inhibiting cyanobacteria and plant growth
|
US20200200735A9
(en)
|
2016-02-22 |
2020-06-25 |
Ursure, Inc. |
System and method for detecting therapeutic agents to monitor adherence to a treatment regimen
|
EP3420108A4
(en)
|
2016-02-23 |
2019-11-06 |
Dovetail Genomics LLC |
GENERATION OF LIVE PHASES FOR THE GENERATION ARRANGEMENT AND HAPLOTYPE PHASE RULES
|
US11053476B2
(en)
|
2016-02-23 |
2021-07-06 |
Exostem Biotec Ltd. |
Generation of cancer stem cells and use thereof
|
WO2017147060A1
(en)
|
2016-02-25 |
2017-08-31 |
Dupont Nutrition Biosciences Aps |
Method for producing a protein hydrolysate employing an aspergillus fumigatus tripeptidyl peptidase
|
US10889637B2
(en)
|
2016-02-26 |
2021-01-12 |
The Board Of Regents Of The University Of Texas System |
Methods of treating an osteolytic tumor and spinal cord injury by administering connexin (Cx) 43 hemichannel-binding antibodies
|
BR112018067522A2
(pt)
|
2016-03-01 |
2019-02-05 |
Univ Of Rijeka Faculty Of Medicine |
anticorpos específicos para receptor de poliovírus humano (pvr)
|
IL294121B2
(en)
|
2016-03-03 |
2023-09-01 |
Memed Diagnostics Ltd |
An RNA test to diagnose the type of infection
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
DK3313423T3
(da)
|
2016-03-04 |
2019-05-20 |
4D Pharma Plc |
Sammensætninger omfattende bakterielle blautia-stammer til behandling af visceral hypersensitivitet
|
US20190216891A1
(en)
|
2016-03-06 |
2019-07-18 |
Yeda Research And Development Co., Ltd. |
Method for modulating myelination
|
KR102464372B1
(ko)
|
2016-03-17 |
2022-11-04 |
세다르스-신나이 메디칼 센터 |
Rnaset2를 통한 염증성 장 질환의 진단 방법
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
|
CN109641935A
(zh)
|
2016-03-25 |
2019-04-16 |
莫拉利达尔·瑞迪·穆拉 |
组合合成和生物标志物开发
|
CN109195991B
(zh)
|
2016-03-29 |
2023-10-31 |
斯特库比股份有限公司 |
对糖基化pd-l1特异的双重功能抗体及其使用方法
|
EP3436480A4
(en)
|
2016-03-30 |
2019-11-27 |
Musc Foundation for Research Development |
METHOD FOR THE TREATMENT AND DIAGNOSIS OF CANCER BY TARGETING GLYCOPROTEIN A REPETITION PREDOMINANT (GARP) AND FOR EFFECTIVE IMMUNOTHERAPY ALONE OR IN COMBINATION
|
DE202017007129U1
(de)
|
2016-04-27 |
2019-08-29 |
Gen-Probe Incorporated |
Lysereagenz für Blutzellen
|
WO2017194589A1
(en)
|
2016-05-10 |
2017-11-16 |
Vib Vzw |
Inhibition of tau-mediated early synaptic dysfunction
|
IL262946B2
(en)
|
2016-05-13 |
2023-03-01 |
Dovetail Genomics Llc |
Retrieving long-range grip information from preserved samples
|
US11919971B2
(en)
|
2016-05-16 |
2024-03-05 |
President And Fellows Of Harvard College |
Aqueous biomolecule coupling on CO2-plasma-activated surfaces
|
WO2017203520A1
(en)
|
2016-05-22 |
2017-11-30 |
Yeda Research And Development Co. Ltd. |
Methods of using pulmonary cells for transplantation and induction of tolerance
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of substances to treat drug-resistant tumors
|
WO2017208247A1
(en)
|
2016-06-02 |
2017-12-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
WO2017212476A1
(en)
|
2016-06-05 |
2017-12-14 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Novel molecules for the treatment of inflammation
|
JP7042755B2
(ja)
|
2016-06-05 |
2022-03-28 |
バーグ エルエルシー |
患者層別化及び潜在的バイオマーカー同定のためのシステム及び方法
|
US20190160152A1
(en)
|
2016-06-09 |
2019-05-30 |
Opko Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
CN109689894A
(zh)
|
2016-06-19 |
2019-04-26 |
耶路撒冷希伯来大学伊萨姆研发有限公司 |
在人单倍体细胞中筛选化学疗法抗性
|
US10961504B2
(en)
|
2016-06-27 |
2021-03-30 |
Yeda Research And Development Co. Ltd. |
Veto cells generated from memory T cells
|
CN109416357B
(zh)
|
2016-06-30 |
2022-07-15 |
西门子医疗系统荷兰有限公司 |
用于检测包含多个细胞的体液样本中的分析物的设备、系统和方法
|
EP4184167A1
(en)
|
2016-07-10 |
2023-05-24 |
MeMed Diagnostics Ltd. |
Early diagnosis of infections
|
WO2018011795A1
(en)
|
2016-07-10 |
2018-01-18 |
Memed Diagnostics Ltd. |
Protein signatures for distinguishing between bacterial and viral infections
|
WO2018011805A2
(en)
|
2016-07-11 |
2018-01-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Systems and methods for growing cells in vitro
|
US20190224244A1
(en)
|
2016-07-11 |
2019-07-25 |
Bonus Therapeutics Ltd. |
Cell compositions for tissue regeneration
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combined treatment to increase endogenous synthesis of nitric oxide
|
BR112019000610A2
(pt)
|
2016-07-11 |
2019-07-02 |
Opko Biologics Ltd |
fator vii de coagulação de longa ação e métodos de produção do mesmo
|
TW201821093A
(zh)
|
2016-07-13 |
2018-06-16 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
WO2018015296A1
(en)
|
2016-07-20 |
2018-01-25 |
Vib Vzw |
Therapeutic agents for neurological and psychiatric disorders
|
KR20190031299A
(ko)
|
2016-07-20 |
2019-03-25 |
주식회사 에스티큐브 |
글리코실화된 pd-l1에 결합하는 항체의 조합을 사용하는 암 치료 방법
|
WO2018020489A1
(en)
|
2016-07-24 |
2018-02-01 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
US10982252B2
(en)
|
2016-08-08 |
2021-04-20 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Bacterial systems for analyzing ubiquitylated polypeptides
|
EP3504553B1
(en)
|
2016-08-10 |
2022-04-20 |
Memed Diagnostics Ltd. |
System and method for analysis of biological data
|
ES2925527T3
(es)
|
2016-08-14 |
2022-10-18 |
Univ Ramot |
Exosomas derivados de células mesenquimales para tratar trastornos neurológicos
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(en)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating autoimmune diseases
|
JP2020501506A
(ja)
|
2016-09-07 |
2020-01-23 |
イッサム リサーチ デベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー. |
抗NKp46抗体およびその治療的使用
|
EP3512943B1
(en)
|
2016-09-14 |
2023-04-12 |
Yeda Research and Development Co. Ltd. |
Crisp-seq, an integrated method for massively parallel single cell rna-seq and crispr pooled screens
|
US11385241B2
(en)
|
2016-09-29 |
2022-07-12 |
Memed Diagnostics Ltd. |
Methods of prognosis and treatment
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of circadian rhythm disorder
|
US20180128828A1
(en)
|
2016-11-04 |
2018-05-10 |
James W. Stave |
Direct detection of microorganisms in patient samples by immunoassay
|
EP3538093B1
(en)
|
2016-11-09 |
2023-10-25 |
Qiagen Sciences, LLC |
Photoprotective mixtures as imaging reagents in sequencing-by-synthesis
|
WO2018087759A1
(en)
|
2016-11-10 |
2018-05-17 |
Yeda Research And Development Co. Ltd. |
Phosphotriesterases for treating or preventing organophosphate exposure associated damage
|
IL266751B
(en)
|
2016-11-23 |
2022-07-01 |
Chemocentryx Inc |
A method for the treatment of focal segmental tuberous sclerosis
|
EP3545095A1
(en)
|
2016-11-28 |
2019-10-02 |
Yeda Research and Development Co., Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
|
WO2018100431A1
(en)
|
2016-11-29 |
2018-06-07 |
Genomic Vision |
Method for designing a set of polynucleotide sequences for analysis of specific events in a genetic region of interest
|
EP3548015A1
(en)
|
2016-11-30 |
2019-10-09 |
Yeda Research and Development Co. Ltd. |
Methods of treating liver toxicity and disorders
|
MX2018016003A
(es)
|
2016-12-01 |
2019-05-16 |
Univ Ramot |
Tratamiento combinado para lesiones neurológicas.
|
EP3329905A1
(en)
|
2016-12-05 |
2018-06-06 |
Nuritas Limited |
Topical cosmetic compositions comprising an oligopeptide against anti-aging of the skin
|
ES2932498T3
(es)
|
2016-12-05 |
2023-01-20 |
Nuritas Ltd |
Composiciones que comprenden el péptido WKDEAGKPLVK
|
EP3329930A1
(en)
|
2016-12-05 |
2018-06-06 |
Nuritas Limited |
Pharmaceuctical compositions
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
WO2018134824A1
(en)
|
2017-01-18 |
2018-07-26 |
Yeda Research And Development Co. Ltd. |
Genetically modified veto cells and use of same in immunotherapy
|
WO2018137705A1
(en)
|
2017-01-26 |
2018-08-02 |
Zai Lab (Shanghai) Co., Ltd. |
Cd47 antigen binding unit and uses thereof
|
EP3574114B1
(en)
|
2017-01-26 |
2022-06-29 |
Oklahoma Medical Research Foundation |
Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
WO2018146162A1
(en)
|
2017-02-07 |
2018-08-16 |
Academisch Medisch Centrum |
Molecular biomarker for prognosis of sepsis patients
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods for growing t cells in culture and their use
|
WO2018163051A1
(en)
|
2017-03-06 |
2018-09-13 |
Novartis Ag |
Methods of treatment of cancer with reduced ubb expression
|
WO2018167780A1
(en)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Methods of prognosing and treating cancer
|
WO2018167778A1
(en)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing and prognosing cancer
|
JP2020511539A
(ja)
|
2017-03-16 |
2020-04-16 |
リネージ セル セラピューティクス インコーポレイテッド |
網膜疾患治療法の治療効果を測定する方法
|
ES2963461T3
(es)
|
2017-04-05 |
2024-03-27 |
Yeda Res & Dev |
Sistema de cultivo ex vivo y métodos de utilización del mismo
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
EP3621991A2
(en)
|
2017-05-10 |
2020-03-18 |
Ariel Scientific Innovations Ltd. |
Methods of purifying antibodies
|
ES2939298T3
(es)
|
2017-05-21 |
2023-04-20 |
Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct |
Combinación de marcadores para el diagnóstico del cáncer
|
KR20200019882A
(ko)
|
2017-05-22 |
2020-02-25 |
4디 파마 리서치 리미티드 |
세균 균주를 포함하는 조성물
|
EP3634991A1
(en)
|
2017-05-23 |
2020-04-15 |
Technion Research & Development Foundation Limited |
Agents which inhibit gads dimerization and methods of use thereof
|
MA41708A
(fr)
|
2017-05-24 |
2020-04-08 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
CN111051346A
(zh)
|
2017-05-31 |
2020-04-21 |
斯特库伯株式会社 |
使用免疫特异性结合btn1a1的抗体和分子治疗癌症的方法
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
CA3065301A1
(en)
|
2017-05-31 |
2018-12-06 |
Stcube & Co., Inc. |
Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof
|
EP3630973A1
(en)
|
2017-05-31 |
2020-04-08 |
Tropic Biosciences UK Limited |
Methods of selecting cells comprising genome editing events
|
US11542331B2
(en)
|
2017-06-06 |
2023-01-03 |
Stcube & Co., Inc. |
Methods of treating cancer using antibodies and molecules that bind to BTN1A1 or BTN1A1-ligands
|
WO2018229764A1
(en)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Treatment of advanced or progressive multiple sclerosis
|
LT3638271T
(lt)
|
2017-06-14 |
2021-01-11 |
4D Pharma Research Limited |
Kompozicijos, apimančios bakterines padermes
|
ES2823053T3
(es)
|
2017-06-14 |
2021-05-07 |
4D Pharma Res Ltd |
Composiciones que comprenden una cepa bacteriana del género Megasphaera y usos de las mismas
|
US20200165671A1
(en)
|
2017-07-13 |
2020-05-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Detecting tissue-specific dna
|
WO2019012544A1
(en)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
STRATEGY FOR DOUBLE PROBE DROPLETS FOR SPECIFIC DETECTION OF CIRCULATING DNA MOLECULES SPECIFIC TO A TISSUE
|
US20200340057A1
(en)
|
2017-07-13 |
2020-10-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Dna targets as tissue-specific methylation markers
|
WO2019018747A1
(en)
|
2017-07-20 |
2019-01-24 |
Trustees Of Boston University |
DETECTION ASSAY OF TENOFOVIR
|
WO2019016772A2
(en)
|
2017-07-21 |
2019-01-24 |
Novartis Ag |
COMPOSITIONS AND METHODS FOR TREATING CANCER
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
US11692166B2
(en)
|
2017-08-23 |
2023-07-04 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
BR112020003533A2
(pt)
|
2017-08-25 |
2020-11-17 |
Five Prime Therapeutics, Inc. |
anticorpos b7-h4 e métodos de uso dos mesmos
|
JP7145895B2
(ja)
|
2017-09-01 |
2022-10-03 |
四川科倫博泰生物医薬股▲フン▼有限公司 |
組換え二重特異性抗体
|
CA3074291A1
(en)
|
2017-09-05 |
2019-03-14 |
GLAdiator Biosciences, Inc. |
Delivery of payloads to stem cells
|
WO2019055825A1
(en)
|
2017-09-15 |
2019-03-21 |
The Regents Of The University Of California |
INHIBITION OF AMINOACYLASE 3 (AA3) IN THE TREATMENT OF CANCER
|
AU2018336126A1
(en)
|
2017-09-19 |
2020-04-30 |
Tropic Biosciences UK Limited |
Modifying the specificity of non-coding RNA molecules for silencing gene expression in eukaryotic cells
|
CA3078809A1
(en)
|
2017-10-11 |
2019-04-18 |
Chemocentryx, Inc. |
Treatment of focal segmental glomerulosclerosis with ccr2 antagonists
|
EP3694545A4
(en)
|
2017-10-11 |
2021-12-01 |
Board Of Regents, The University Of Texas System |
HUMAN PD-L1 ANTIBODIES AND METHOD OF USING THEM
|
JP2021502125A
(ja)
|
2017-11-09 |
2021-01-28 |
ピンテオン セラピューティクス インコーポレイテッド |
ヒト化コンホメーション特異的リン酸化タウ抗体の作製および使用のための方法および組成物
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
IL274979B1
(en)
|
2017-11-29 |
2024-03-01 |
Univ Ramot |
Methods for the prevention and treatment of neurogenic seizures
|
CN111615332A
(zh)
|
2017-11-29 |
2020-09-01 |
维德奥特有限公司 |
用于控制苋属杂草的组成物,套组及方法
|
WO2019106680A1
(en)
|
2017-12-03 |
2019-06-06 |
Yeda Research And Development Co. Ltd. |
Treatment of an ischemic heart disease
|
CN109870581B
(zh)
|
2017-12-04 |
2021-05-04 |
厦门万泰凯瑞生物技术有限公司 |
一种定量检测HBsAg的试剂盒及方法
|
CA3085324A1
(en)
|
2017-12-15 |
2019-06-20 |
Syngenta Participations Ag |
Non-antibody ligands for detecting target proteins
|
EP3723785A1
(en)
|
2017-12-17 |
2020-10-21 |
Yeda Research and Development Co. Ltd |
Cop9 signalosome (csn) complex modulators and uses thereof
|
WO2019130313A1
(en)
|
2017-12-28 |
2019-07-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method to reproduce circadian rhythms on a microfluidic chip
|
EP3735589A2
(en)
|
2018-01-05 |
2020-11-11 |
Vanderbilt University |
Antibody-mediated neutralization of chikungunya virus
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
WO2019155459A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Inhibitors of the 20s proteasome
|
EP3749368A1
(en)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunction
|
WO2019155041A1
(en)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
|
WO2019165217A1
(en)
|
2018-02-22 |
2019-08-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cd153 and/or cd30 in infection
|
WO2019162945A1
(en)
|
2018-02-23 |
2019-08-29 |
Carmel Haifa University Economic Corporation Ltd. |
Methods for treating memory impairment and cognitive dysfunction
|
WO2019167047A1
(en)
|
2018-02-28 |
2019-09-06 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods of diagnosing and treating bladder cancer
|
AU2019228600A1
(en)
|
2018-03-02 |
2020-09-24 |
Five Prime Therapeutics, Inc. |
B7-H4 antibodies and methods of use thereof
|
WO2019175869A1
(en)
|
2018-03-12 |
2019-09-19 |
Yeda Research And Development Co. Ltd |
Treatment of a heart disease
|
US20210214445A1
(en)
|
2018-03-23 |
2021-07-15 |
Board Of Regents, The University Of Texas System |
Dual specificity antibodies to pd-l1 and pd-l2 and methods of use therefor
|
JP2021519283A
(ja)
|
2018-03-29 |
2021-08-10 |
テクニオン・リサーチ・アンド・ディベロップメント・ファウンデーション・リミテッド |
Pten阻害剤を含む小胞およびその使用
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
EP3774047A1
(en)
|
2018-03-29 |
2021-02-17 |
Yeda Research and Development Co. Ltd |
Use of electric field gradients to control gene expression
|
EP3775273B1
(en)
|
2018-04-09 |
2023-01-18 |
Advanced Cell Diagnostics, Inc. |
Methods to further enhance signal amplification for the in situ detection of nucleic acids
|
JP7328324B2
(ja)
|
2018-04-24 |
2023-08-16 |
アンプソース・バイオファーマ・シャンハイ・インコーポレイテッド |
Tim-3に対する抗体およびその使用
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
US20210123016A1
(en)
|
2018-05-02 |
2021-04-29 |
Novartis Ag |
Regulators of human pluripotent stem cells and uses thereof
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neo-antigens
|
WO2019220441A1
(en)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions and methods for treating cancer resistant to an anti-cancer agent
|
US20210121491A1
(en)
|
2018-05-27 |
2021-04-29 |
Biolinerx Ltd. |
Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
EP3802839A1
(en)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
WO2019234750A1
(en)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Methods of regenerating and transforming cannabis
|
EP3820498A1
(en)
|
2018-06-14 |
2021-05-19 |
University College Cork-National University of Ireland Cork |
Peptide for disease treatment
|
TW202016144A
(zh)
|
2018-06-21 |
2020-05-01 |
日商第一三共股份有限公司 |
包括cd3抗原結合片段之組成物及其用途
|
US11873322B2
(en)
|
2018-06-25 |
2024-01-16 |
Yeda Research And Development Co. Ltd. |
Systems and methods for increasing efficiency of genome editing
|
AU2019297677A1
(en)
|
2018-07-04 |
2021-02-25 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
WO2020012467A2
(en)
|
2018-07-08 |
2020-01-16 |
Yeda Research And Development Co. Ltd. |
Person-specific assessment of probiotics responsiveness
|
JP7395517B2
(ja)
|
2018-07-11 |
2023-12-11 |
イミュニティ ファルマ リミテッド |
ペプチド化合物およびその治療的用途
|
CA3104780A1
(en)
|
2018-07-11 |
2020-01-16 |
Kahr Medical Ltd. |
Sirpalpha-4-1bbl variant fusion protein and methods of use thereof
|
US20210310082A1
(en)
|
2018-07-31 |
2021-10-07 |
Collplant Ltd. |
Tobacco transgenic event and methods for detection and use thereof
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
CN113227359A
(zh)
|
2018-08-24 |
2021-08-06 |
耶达研究及发展有限公司 |
调节m2巨噬细胞极化的方法及其在治疗中的用途
|
TW202019480A
(zh)
|
2018-09-13 |
2020-06-01 |
美國德州系統大學評議委員會 |
新穎lilrb4抗體及其用途
|
CA3112135A1
(en)
|
2018-09-20 |
2020-03-26 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral sclerosis
|
WO2020065647A1
(en)
|
2018-09-25 |
2020-04-02 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
US20220048940A1
(en)
|
2018-09-28 |
2022-02-17 |
Centrillion Technology Holdings Corporation |
Disulfide-linked reversible terminators
|
EA202191033A1
(ru)
|
2018-10-15 |
2021-12-21 |
Юниверсити Оф Массачусетс |
Программируемое редактирование оснований днк посредством слитых белков nme2cas9-дезаминаза
|
WO2020081204A1
(en)
|
2018-10-18 |
2020-04-23 |
Oklahoma Medical Research Foundation |
Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
|
US20210403552A1
(en)
|
2018-10-22 |
2021-12-30 |
Shanghai GenBase Biotechnology Co., Ltd. |
Anti-cldn18.2 antibody and uses thereof
|
EP3870614A1
(en)
|
2018-10-23 |
2021-09-01 |
GlyCardial Diagnostics, S.L. |
Antibodies specific for glycosylated apoj and uses thereof
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
CN111196851B
(zh)
|
2018-11-20 |
2021-11-16 |
厦门万泰凯瑞生物技术有限公司 |
针对人抗缪勒管激素的特异性抗体及其应用
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
US20220089776A1
(en)
|
2018-11-28 |
2022-03-24 |
Oregon Health & Science University |
Therapeutic factor xii antibody
|
AU2019389175A1
(en)
|
2018-11-30 |
2021-06-10 |
Caris Mpi, Inc. |
Next-generation molecular profiling
|
CN113166246A
(zh)
|
2018-12-28 |
2021-07-23 |
四川科伦博泰生物医药股份有限公司 |
一种抗体及其用途
|
WO2020152686A1
(en)
|
2019-01-23 |
2020-07-30 |
Yeda Research And Development Co. Ltd. |
Culture media for pluripotent stem cells
|
EP3914734B1
(en)
|
2019-01-25 |
2024-03-13 |
President and Fellows of Harvard College |
Compositions and method for synthesizing nucleic acids
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
WO2020168162A1
(en)
|
2019-02-15 |
2020-08-20 |
Bio-Techne Corporation |
Methods for multiplex detection of nucleic acids by in situ hybridization
|
WO2020170239A1
(en)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of generating organoids for high throughput screening of drugs
|
EP3927378A1
(en)
|
2019-02-21 |
2021-12-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Method for reduction drug-induced nephrotoxicity
|
CN113692225B
(zh)
|
2019-03-05 |
2023-04-18 |
以色列农业和农村发展部农业研究组织(范卡尼中心) |
经基因组编辑的鸟类
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
EP3946611A2
(en)
|
2019-03-31 |
2022-02-09 |
Yeda Research and Development Co. Ltd |
Anti-viral and anti-tumoral compounds
|
JP2022528595A
(ja)
|
2019-04-16 |
2022-06-15 |
シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド |
抗FXI/FXIa抗体及びその使用
|
AU2020265250A1
(en)
|
2019-04-30 |
2021-11-18 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for determining effectiveness of frataxin replacement therapy
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
EP3969619A1
(en)
|
2019-05-13 |
2022-03-23 |
Yeda Research and Development Co. Ltd |
Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
EP3973049A1
(en)
|
2019-05-22 |
2022-03-30 |
Hadasit Medical Research Services and Development Ltd. |
Methods of culturing human pluripotent cells
|
IT201900007222A1
(it)
|
2019-05-24 |
2020-11-24 |
Univ Degli Studi Di Torino |
Composizione di liposomi e metodo di dosaggio basato sull'uso degli stessi
|
GB2598520A
(en)
|
2019-05-28 |
2022-03-02 |
Univ Shanghai Tech |
Composition and methods to treat ectodermal dysplasia 2, Clouston type
|
JP2022536326A
(ja)
|
2019-06-12 |
2022-08-15 |
ハダシット メディカル リサーチ サービシーズ アンド ディベロップメント リミテッド |
オリゴデンドロサイトの産生方法
|
EP3983540A1
(en)
|
2019-06-16 |
2022-04-20 |
Yeda Research and Development Co. Ltd |
Method for stabilizing intracellular rna
|
US20220251193A1
(en)
|
2019-06-27 |
2022-08-11 |
Ramot At Tel-Aviv University Ltd. |
Semaphorin 3a antibodies and uses thereof
|
JP2022538647A
(ja)
|
2019-07-04 |
2022-09-05 |
ウッコ インコーポレイテッド |
脱エピトープ化されたアルファグリアジン、ならびにセリアック病およびグルテン過敏症の管理のためのその使用
|
WO2021005599A1
(en)
|
2019-07-11 |
2021-01-14 |
Kahr Medical Ltd. |
Heterodimers and methods of use thereof
|
EP3999851A4
(en)
|
2019-07-16 |
2023-04-12 |
Ramot at Tel-Aviv University Ltd. |
COMPOSITIONS AND METHODS FOR TREATMENT OF TUBERCULOSIS
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
AU2020317009A1
(en)
|
2019-07-19 |
2022-02-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric antigen receptors containing Glypican 2 binding domains
|
KR20220038415A
(ko)
|
2019-07-26 |
2022-03-28 |
벤더르빌트 유니버시티 |
엔테로바이러스 d68에 대한 인간 모노클로날 항체
|
EP4004548A1
(en)
|
2019-07-29 |
2022-06-01 |
Yeda Research and Development Co. Ltd |
Methods of treating and diagnosing lung cancer
|
EP4004212A1
(en)
|
2019-07-30 |
2022-06-01 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Institute) |
Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
|
WO2021028909A1
(en)
|
2019-08-12 |
2021-02-18 |
Yeda Research And Development Co. Ltd. |
Dna repair blood test for predicting response of lung cancer patients to immunotherapy
|
EP3783012A1
(en)
|
2019-08-20 |
2021-02-24 |
Nuritas Limited |
An antimicrobial peptide
|
EP4017518A1
(en)
|
2019-08-20 |
2022-06-29 |
Nuritas Limited |
Peptides for treating muscle atrophy
|
WO2021033176A1
(en)
|
2019-08-22 |
2021-02-25 |
Ariel Scientific Innovations Ltd. |
Scaled-up methods for purifying antibodies
|
EP4021463A1
(en)
|
2019-08-27 |
2022-07-06 |
Yeda Research and Development Co. Ltd |
Treatment of bacterial vaginosis
|
WO2021048852A1
(en)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Methods of treating breast cancer
|
WO2021051390A1
(zh)
|
2019-09-20 |
2021-03-25 |
上海吉倍生物技术有限公司 |
靶向bcma的抗体及嵌合抗原受体
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembling protein complexes on a chip
|
WO2021062323A1
(en)
|
2019-09-26 |
2021-04-01 |
Stcube & Co. |
Antibodies specific to glycosylated ctla-4 and methods of use thereof
|
CN114206931A
(zh)
|
2019-09-30 |
2022-03-18 |
四川科伦博泰生物医药股份有限公司 |
抗pd-1抗体及其用途
|
JP2022552282A
(ja)
|
2019-10-09 |
2022-12-15 |
エスティーキューブ アンド カンパニー |
グリコシル化lag3に対して特異的な抗体およびその使用方法
|
CA3154368A1
(en)
|
2019-10-22 |
2021-04-29 |
Nora KHALDI |
Treatment of non-alcoholic fatty liver disease
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
US20240117386A1
(en)
|
2019-10-31 |
2024-04-11 |
Yeda Research And Development Co. Ltd. |
Engineered autotrophic bacteria for co2 conversion to organic materials
|
JP2023501004A
(ja)
|
2019-11-11 |
2023-01-17 |
アイビーアイ-エージー イノベイティブ バイオ インセクティサイズ リミテッド |
昆虫防除ナノボディおよびその使用
|
US20230022576A1
(en)
|
2019-11-19 |
2023-01-26 |
Protalix Ltd. |
Removal of constructs from transformed cells
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
US10792360B1
(en)
|
2019-11-21 |
2020-10-06 |
Chemocentryx, Inc. |
Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies
|
EP4069865A4
(en)
|
2019-12-02 |
2023-12-20 |
Caris MPI, Inc. |
PLATINUM RESISTANCE TEST FOR PAN CANCER
|
EP4073246A4
(en)
|
2019-12-12 |
2023-12-06 |
President And Fellows Of Harvard College |
COMPOSITIONS AND METHODS FOR LIGHT DIRECTED BIOMOLECULAR BARCOding
|
MX2022004919A
(es)
|
2019-12-13 |
2022-05-16 |
Sichuan Kelun Biotech Biopharmaceutical Co Ltd |
Anticuerpo anti-linfopoyetina estromal timica (tslp) y sus usos.
|
CA3164996A1
(en)
|
2019-12-20 |
2021-06-14 |
Novarock Biotherapeutics, Ltd. |
Anti-interleukin-23 p19 antibodies and methods of use thereof
|
EP4077731A1
(en)
|
2019-12-22 |
2022-10-26 |
Yeda Research and Development Co. Ltd |
Diagnosis of frontotemporal dementia
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
EP3842452A1
(en)
|
2019-12-26 |
2021-06-30 |
Universitat Autònoma de Barcelona |
Scaffold proteins and therapeutic nanoconjugates based on nidogen
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
US20230048361A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
US20230048719A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
|
CN113061165A
(zh)
|
2020-01-02 |
2021-07-02 |
厦门大学 |
EB病毒BNLF2b基因编码多肽及其检测用途
|
IL272074A
(en)
|
2020-01-15 |
2021-07-29 |
Immunity Pharma Ltd |
Peptide compounds and their use in methods of treating diseases
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multi-target antibodies for use in the treatment of diseases
|
WO2021152584A1
(en)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Methods of analyzing cell membranes
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
WO2021152586A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Methods of analyzing microbiome, immunoglobulin profile and physiological state
|
EP4096647A1
(en)
|
2020-01-30 |
2022-12-07 |
Yeda Research and Development Co. Ltd |
Treating acute liver disease with tlr-mik inhibitors
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Cancer treatment methods
|
EP4169939A4
(en)
|
2020-01-31 |
2024-02-21 |
Fundacao Oswaldo Cruz |
ANTIBODY, ITS USE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, METHOD FOR DIAGNOSING FUNGAL INFECTIONS, KIT FOR DIAGNOSING FUNGAL INFECTIONS AND METHODS FOR TREATING FUNGAL INFECTIONS
|
WO2021156490A2
(en)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Corona virus binders
|
EP3862014A1
(en)
|
2020-02-07 |
2021-08-11 |
Nuritas Limited |
Treatment of panx1 associated diseases
|
WO2021156878A2
(en)
|
2020-02-09 |
2021-08-12 |
Nlc Pharma Ltd |
Rapid detection test for sars-cov-2
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
A method for cell cluster analysis
|
AU2021220847A1
(en)
|
2020-02-11 |
2022-09-01 |
Vanderbilt University |
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2)
|
CA3168337A1
(en)
|
2020-02-17 |
2021-08-26 |
Marie-Andree Forget |
Methods for expansion of tumor infiltrating lymphocytes and use thereof
|
CN115698047A
(zh)
|
2020-02-25 |
2023-02-03 |
非营利性组织佛兰芒综合大学生物技术研究所 |
富含亮氨酸的重复激酶2变构调节剂
|
WO2021173674A1
(en)
|
2020-02-26 |
2021-09-02 |
A2 Biotherapeutics, Inc. |
Polypeptides targeting mage-a3 peptide-mhc complexes and methods of use thereof
|
US20230127559A1
(en)
|
2020-03-16 |
2023-04-27 |
Yeda Research And Development Co. Ltd. |
Peptide analogs and use of same in treating diseases, disorders or conditions associated with mutant p53 protein
|
WO2021195385A1
(en)
|
2020-03-26 |
2021-09-30 |
Vanderbilt University |
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-GoV-2)
|
MX2022011892A
(es)
|
2020-03-26 |
2022-10-18 |
Univ Vanderbilt |
Anticuerpos monoclonales humanos dirigidos contra el coronavirus 2 del sindrome respiratorio agudo grave (sars-cov-2).
|
AU2021245409A1
(en)
|
2020-03-29 |
2022-11-24 |
Yeda Research And Development Co. Ltd. |
Variants of beta-glucocerebrosidase for use in treating Gaucher Disease
|
IL296698A
(en)
|
2020-03-31 |
2022-11-01 |
Biomuse Ltd |
Bacteria for the prevention and treatment of smoking damage to the lungs
|
TW202203916A
(zh)
|
2020-03-31 |
2022-02-01 |
美商卡默森屈有限公司 |
使用ccr9抑制劑及抗il—23阻斷抗體治療發炎性腸道疾病的組成物及方法
|
EP4133107A1
(en)
|
2020-04-06 |
2023-02-15 |
Yeda Research and Development Co. Ltd |
Methods of diagnosing cancer and predicting responsiveness to therapy
|
EP4132479A1
(en)
|
2020-04-07 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Cannabidiol-containing compositions and uses thereof
|
US20230135456A1
(en)
|
2020-04-13 |
2023-05-04 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
WO2021216728A1
(en)
|
2020-04-22 |
2021-10-28 |
President And Fellows Of Harvard College |
Isothermal methods, compositions, kits, and systems for detecting nucleic acids
|
WO2021229577A1
(en)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagen as a delivery tool for metal-based anti-viral agents
|
JP7407973B2
(ja)
|
2020-05-15 |
2024-01-04 |
シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド |
抗体薬物複合体、その調製方法、およびその使用
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Spatial information is developed for the analysis of individual cells
|
EP4161653A1
(en)
|
2020-06-03 |
2023-04-12 |
Bionecure Therapeutics, Inc. |
Trophoblast cell-surface antigen-2 (trop-2) antibodies
|
US20230293530A1
(en)
|
2020-06-24 |
2023-09-21 |
Yeda Research And Development Co. Ltd. |
Agents for sensitizing solid tumors to treatment
|
EP3939999A1
(en)
|
2020-07-14 |
2022-01-19 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Interleukin 11 receptor alpha subunit (il11ra) neutralizing antibodies and uses thereof
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
US20230309480A1
(en)
|
2020-08-18 |
2023-10-05 |
International Rice Research Institute |
Methods of increasing outcrossing rates in gramineae
|
WO2022047359A1
(en)
|
2020-08-31 |
2022-03-03 |
Berg Llc |
Protein biomarkers for pancreatic cancer
|
WO2022051591A2
(en)
|
2020-09-04 |
2022-03-10 |
Novarock Biotherapeutics, Ltd. |
Nectin-4 antibodies and uses thereof
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Weight regulation method
|
EP4217370A2
(en)
|
2020-09-23 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Methods and compositions for treating coronaviral infections
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
A method for diagnosing breast cancer
|
EP4225902A1
(en)
|
2020-10-05 |
2023-08-16 |
Protalix Ltd. |
Dicer-like knock-out plant cells
|
KR20230104160A
(ko)
|
2020-10-07 |
2023-07-07 |
프로탈릭스 리미티드 |
장기-작용성 데옥시리보뉴클레아제(dnase)
|
EP4228637A1
(en)
|
2020-10-15 |
2023-08-23 |
Yeda Research and Development Co. Ltd |
Method of treating myeloid malignancies
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
WO2022097157A2
(en)
|
2020-11-09 |
2022-05-12 |
1E Therapeutics, Ltd. |
Catalytic sequence based methods of treating or preventing bacterial infections
|
GB202105804D0
(en)
|
2020-11-20 |
2021-06-09 |
Univ Cape Town |
Use of microvirin in the identification of mycobacterium tuberculosis mannose-capped lipoarabinomannan
|
AU2021387979A1
(en)
|
2020-11-26 |
2023-03-30 |
Ukko Inc. |
Modified high molecular weight glutenin subunit and uses thereof
|
CN117460543A
(zh)
|
2020-12-04 |
2024-01-26 |
田纳西大学研究基金会 |
用于诊断淀粉样蛋白病的方法
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling the ubiquitination process of mlkl for disease treatment
|
AU2021411103A1
(en)
|
2020-12-28 |
2023-07-13 |
1E Therapeutics, Ltd. |
P21 mrna target areas for silencing
|
WO2022144883A2
(en)
|
2020-12-28 |
2022-07-07 |
1E Therapeutics, Ltd. |
P21 mrna targeting dnazymes
|
EP4253413A1
(en)
|
2020-12-31 |
2023-10-04 |
Nona Biosciences (Suzhou) Co., Ltd. |
Human lifr antigen binding protein, preparation method therefor, and application thereof
|
JP2024502377A
(ja)
|
2021-01-10 |
2024-01-18 |
スーパーミート ザ エッセンス オブ ミート リミテッド |
培養肉産業用の多能性幹細胞凝集体及びそれから得られる微小組織
|
WO2022153286A1
(en)
|
2021-01-14 |
2022-07-21 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
|
CN116917326A
(zh)
|
2021-01-22 |
2023-10-20 |
博泰康医药公司 |
抗her-2/trop-2构建体及其用途
|
GB2603166A
(en)
|
2021-01-29 |
2022-08-03 |
Thelper As |
Therapeutic and Diagnostic Agents and Uses Thereof
|
CA3206117A1
(en)
|
2021-02-09 |
2022-08-18 |
Medilink Therapeutics (Suzhou) Co., Ltd. |
Bioactive substance conjugate, preparation method therefor and use thereof
|
JP2024506954A
(ja)
|
2021-02-18 |
2024-02-15 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ワクチン作製用の遺伝子改変細菌
|
JP2024506955A
(ja)
|
2021-02-18 |
2024-02-15 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ワクチンを作製する方法
|
IL305318A
(en)
|
2021-02-19 |
2023-10-01 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders
|
WO2022183502A1
(zh)
|
2021-03-05 |
2022-09-09 |
上海吉倍生物技术有限公司 |
抗cldn6抗体及其用途
|
EP4304660A1
(en)
|
2021-03-08 |
2024-01-17 |
ImmunoGen, Inc. |
Methods for increasing efficacy of immunoconjugates targeting adam9 for the treatment of cancer
|
JP2024508597A
(ja)
|
2021-03-09 |
2024-02-28 |
四川科倫博泰生物医薬股▲フン▼有限公司 |
Ror1結合タンパク質及びその用途
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for growing mouse embryos outside the uterus
|
CA3213424A1
(en)
|
2021-03-30 |
2022-10-06 |
Lior Moshe ZELCBUCH |
Pseudomonas bacteriophage and uses thereof
|
CA3214821A1
(en)
|
2021-04-06 |
2022-10-13 |
Guisong WANG |
Protein markers for estrogen receptor (er)-positive-like and estrogen receptor (er)-negative-like breast cancer
|
WO2022216841A1
(en)
|
2021-04-06 |
2022-10-13 |
Berg Llc |
Protein markers for estrogen receptor (er)-positive luminal a(la)-like and luminal b1 (lb1)-like breast cancer
|
EP4320443A1
(en)
|
2021-04-06 |
2024-02-14 |
BPGbio, Inc. |
Protein markers for the prognosis of breast cancer progression
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
|
AU2022259536A1
(en)
|
2021-04-14 |
2023-11-09 |
University College Cork - National University Of Ireland, Cork |
Treatment of cerebrovascular events and neurological disorders
|
WO2022219168A1
(en)
|
2021-04-14 |
2022-10-20 |
University College Cork - National University Of Ireland, Cork |
Psg1 for use in the treatment of osteoarthritis
|
CA3215979A1
(en)
|
2021-04-19 |
2022-10-27 |
Ghassan SAED |
Methods for detecting or treating endometrial and ovarian hyperproliferative disorders
|
CA3218291A1
(en)
|
2021-05-12 |
2022-11-17 |
Lior Moshe ZELCBUCH |
Staphylococcus bacteriophage and uses thereof
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
WO2022259242A1
(en)
|
2021-06-06 |
2022-12-15 |
Yeda Research And Development Co. Ltd. |
Combined treatment for cancer
|
CA3230677A1
(en)
|
2021-06-13 |
2022-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming human cells
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
KR20240035997A
(ko)
|
2021-06-16 |
2024-03-19 |
시드엑스 테크놀로지스 인코포레이티드 |
마티올라 종자들을 선별하는 방법들
|
WO2023275255A1
(en)
|
2021-07-02 |
2023-01-05 |
Tropic Biosciences UK Limited |
Delay or prevention of browning in banana fruit
|
CA3223081A1
(en)
|
2021-07-15 |
2023-01-19 |
Samir Mitragotri |
Compositions and methods relating to cells with adhered particles
|
AU2022313138A1
(en)
|
2021-07-18 |
2024-02-29 |
Gamida-Cell Ltd. |
Therapeutic nk cell populations
|
WO2023002492A1
(en)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Codon optimization of nucleic acids
|
WO2023016828A2
(en)
|
2021-07-30 |
2023-02-16 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders for targeted protein degradation
|
WO2023012798A2
(en)
|
2021-08-02 |
2023-02-09 |
Yeda Research And Development Co. Ltd. |
Antibodies for the treatment of cancer
|
EP4130028A1
(en)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Engineered tcr complex and methods of using same
|
CA3226947A1
(en)
|
2021-08-03 |
2023-02-09 |
Muhammad YASSIN |
Engineered tcr complex and methods of using same
|
WO2023018621A1
(en)
|
2021-08-10 |
2023-02-16 |
Gamida-Cell Ltd. |
Engineered nk cells, methods of their production and uses thereof
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in the treatment of diseases
|
WO2023081070A1
(en)
|
2021-11-02 |
2023-05-11 |
University Of Massachusetts |
Nme2Cas9 INLAID DOMAIN FUSION PROTEINS
|
TW202323301A
(zh)
|
2021-11-19 |
2023-06-16 |
英商米羅比奧有限公司 |
經工程改造之pd-1抗體及其用途
|
WO2023105526A1
(en)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Multipotent lung progenitor cells for lung regeneration
|
GB202201137D0
(en)
|
2022-01-28 |
2022-03-16 |
Thelper As |
Therapeutic and diagnostic agents and uses thereof
|
WO2023144798A1
(en)
|
2022-01-31 |
2023-08-03 |
Genevant Sciences Gmbh |
Ionizable cationic lipids for lipid nanoparticles
|
EP4238988A1
(en)
|
2022-03-01 |
2023-09-06 |
Consejo Superior De Investigaciones Científicas |
Antibodies against sars-cov-2 and uses thereof
|
GB202204813D0
(en)
|
2022-04-01 |
2022-05-18 |
Bradcode Ltd |
Human monoclonal antibodies and methods of use thereof
|
WO2023192976A1
(en)
|
2022-04-01 |
2023-10-05 |
Board Of Regents, The University Of Texas System |
Dual specificity antibodies to human pd-l1 and pd-l2 and methods of use therefor
|
US20230357851A1
(en)
|
2022-04-06 |
2023-11-09 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for monitoring frataxin-replacement therapy
|
WO2023196866A1
(en)
|
2022-04-06 |
2023-10-12 |
Mirobio Limited |
Engineered cd200r antibodies and uses thereof
|
WO2023209708A1
(en)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions for altering cyclic adp-ribose secondary messenger signalling
|
WO2023239710A1
(en)
|
2022-06-08 |
2023-12-14 |
Onkure, Inc. |
Benzopyrimidin-4(3h)-ones as pi3k inhibitors
|
WO2023240201A1
(en)
|
2022-06-08 |
2023-12-14 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for monitoring progression and treatment of leigh syndrome
|
WO2023239940A1
(en)
|
2022-06-10 |
2023-12-14 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|
WO2024028794A1
(en)
|
2022-08-02 |
2024-02-08 |
Temple Therapeutics BV |
Methods for treating endometrial and ovarian hyperproliferative disorders
|
WO2024040020A1
(en)
|
2022-08-15 |
2024-02-22 |
Absci Corporation |
Quantitative affinity activity specific cell enrichment
|
WO2024038160A1
(en)
|
2022-08-18 |
2024-02-22 |
Vib Vzw |
Means and methods to modulate neuron excitability
|
WO2024054469A1
(en)
|
2022-09-08 |
2024-03-14 |
Onkure, Inc. |
Isoquinolones as pi3k inhibitors
|
WO2024064024A1
(en)
|
2022-09-19 |
2024-03-28 |
Onkure, Inc. |
((4-oxo-3,4-dihydroquinazolin-8-yl)methyl)amine derivatives as p13k inhibitors for the treatment of cancer
|
WO2024064002A1
(en)
|
2022-09-20 |
2024-03-28 |
Onkure, Inc. |
Hdac inhibitor oki-179 for the treatment of cancers resulting from a mapk pathway mutation
|
WO2024068744A1
(en)
|
2022-09-27 |
2024-04-04 |
Vib Vzw |
Antivirals against human parainfluenza virus
|